

<!-- RR Donnelley Xcelerate Instance Document, based on XBRL 2.1  http://www.edgar-online.com/ -->
<!-- Version:  6.20.1 -->
<!-- Round: 5 -->
<!-- Creation date: 2013-03-29T06:18:30Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2012-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:galt="http://www.galectintherapeutics.com/20121231" xmlns:us-types="http://fasb.org/us-types/2012-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2012-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2012-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:utr="http://www.xbrl.org/2009/utr">
  <xbrll:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="galt-20121231.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" />
  <us-gaap:SharePrice contextRef="eol_PE87402---1210-K0013_STD_0_20030131_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_7A2B30FB-8F42-4D2C-A7BE-3AA3C588955B_1002_0">6.00</us-gaap:SharePrice>
  <galt:CommonStockAdditionalSharesIssued contextRef="eol_PE87402---1210-K0013_STD_0_20030131_0" unitRef="shares" decimals="INF" id="id_1168147_7A2B30FB-8F42-4D2C-A7BE-3AA3C588955B_1002_2">2042</galt:CommonStockAdditionalSharesIssued>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20040812_0_510623x531324" unitRef="iso4217_USD" decimals="0" id="id_1168147_50DF7FFA-B3A8-4741-B478-1A281CD41D5F_3001_8">4786000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20040812_0_510623x531324" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_1168147_50DF7FFA-B3A8-4741-B478-1A281CD41D5F_3001_6">4.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE87402---1210-K0013_STD_0_20040812_0_510623x531324" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_50DF7FFA-B3A8-4741-B478-1A281CD41D5F_3001_1">18.00</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20040812_0_510623x547978" unitRef="iso4217_USD" decimals="0" id="id_1168147_50DF7FFA-B3A8-4741-B478-1A281CD41D5F_4001_9">239000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20040812_0_510623x547978" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_1168147_50DF7FFA-B3A8-4741-B478-1A281CD41D5F_4001_7">4.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:SharePrice contextRef="eol_PE87402---1210-K0013_STD_0_20080204_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_1DFED9B8-9083-4FA3-AA98-28025451C0A0_5003_11">3.54</us-gaap:SharePrice>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20080204_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_1DFED9B8-9083-4FA3-AA98-28025451C0A0_5003_8">984000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20080204_0" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_1168147_1DFED9B8-9083-4FA3-AA98-28025451C0A0_5003_7">9.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:DividendsPayableAmountPerShare contextRef="eol_PE87402---1210-K0013_STD_0_20080204_0_504957x513639_513696x498640" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_788AD345-0F59-42B7-A37E-DBFD3D632D69_6001_6">6.00</us-gaap:DividendsPayableAmountPerShare>
  <galt:NumberOfConsecutiveTradingDays contextRef="eol_PE87402---1210-K0013_STD_0_20080204_0_513696x498640" id="id_1168147_788AD345-0F59-42B7-A37E-DBFD3D632D69_7001_8">P20D</galt:NumberOfConsecutiveTradingDays>
  <us-gaap:SharePrice contextRef="eol_PE87402---1210-K0013_STD_0_20080225_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_E00CB1DB-C74F-4132-A83E-2FB087D6F812_3001_5">2.40</us-gaap:SharePrice>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20080225_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_E00CB1DB-C74F-4132-A83E-2FB087D6F812_3001_4">2281000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE87402---1210-K0013_STD_0_20080225_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_06B4A6DA-1335-46D0-9255-D5E4599DC8D6_4001_1">3.00</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20080225_0_509379x517822" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_1168147_06B4A6DA-1335-46D0-9255-D5E4599DC8D6_5001_4">3.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20080225_0_509379x517822" id="id_1168147_06B4A6DA-1335-46D0-9255-D5E4599DC8D6_5001_2">2013-08-25</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20080225_0_509379x517822_510623x547978" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_1168147_06B4A6DA-1335-46D0-9255-D5E4599DC8D6_6001_8">4.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20080225_0_509379x517823" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_1168147_06B4A6DA-1335-46D0-9255-D5E4599DC8D6_7001_6">3.78</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:FairValueAssumptionsExercisePrice contextRef="eol_PE87402---1210-K0013_STD_0_20080225_0_509379x517824" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_1168147_E00CB1DB-C74F-4132-A83E-2FB087D6F812_4001_7">4.20</us-gaap:FairValueAssumptionsExercisePrice>
  <us-gaap:FairValueAssumptionsExercisePrice contextRef="eol_PE87402---1210-K0013_STD_0_20080225_0_509379x517825" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_1168147_E00CB1DB-C74F-4132-A83E-2FB087D6F812_5001_11">3.78</us-gaap:FairValueAssumptionsExercisePrice>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1210-K0013_STD_0_20090212_0_513696x511225" unitRef="shares" decimals="INF" id="id_1168147_2F78167B-BF5C-4605-ACDD-6696A8DC798E_2001_2">2000000</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1210-K0013_STD_0_20090212_0_513696x516922" unitRef="shares" decimals="INF" id="id_1168147_AFD2EEDC-169B-471F-B627-62AF28222E1C_5001_1">600000</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20090228_0" unitRef="iso4217_USD" decimals="-5" id="id_1168147_B96E0376-3DC7-4105-A45B-54F2D5B85A0B_1001_0">1000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <galt:MinimumCompanyMarketCapitalization contextRef="eol_PE87402---1210-K0013_STD_0_20090228_0" unitRef="iso4217_USD" decimals="-6" id="id_1168147_B96E0376-3DC7-4105-A45B-54F2D5B85A0B_1001_5">100000000</galt:MinimumCompanyMarketCapitalization>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="eol_PE87402---1210-K0013_STD_0_20090228_0_498429x515840" unitRef="shares" decimals="INF" id="id_1168147_8304045E-60A2-4799-962C-9685E6AA4779_1001_0">3333334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:EquityMethodInvestments contextRef="eol_PE87402---1210-K0013_STD_0_20090228_0_504957x513639" unitRef="iso4217_USD" decimals="-5" id="id_1168147_B96E0376-3DC7-4105-A45B-54F2D5B85A0B_2001_2">10000000</us-gaap:EquityMethodInvestments>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="eol_PE87402---1210-K0013_STD_0_20090228_0_504957x513639" unitRef="shares" decimals="INF" id="id_1168147_B96E0376-3DC7-4105-A45B-54F2D5B85A0B_2001_4">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1210-K0013_STD_0_20090513_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_B95C0865-F3BB-42BD-9B7B-155EC333F480_5001_1">300000</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1210-K0013_STD_0_20090812_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_39C98554-DA99-49AD-8F70-911757D237B4_5001_1">100000</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1210-K0013_STD_0_20091104_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_F7A01913-F2CB-4C70-85B5-28AEB5496597_5001_1">103333</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE87402---1210-K0013_STD_0_20101229_0_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_80DC06BD-87DA-4167-89C3-5188D6510EEA_1001_0">1000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE87402---1210-K0013_STD_0_20101229_0_513696x501142" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_80DC06BD-87DA-4167-89C3-5188D6510EEA_1001_1">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <galt:PreferredStockStatedValuePerShare contextRef="eol_PE87402---1210-K0013_STD_0_20101229_0_513696x501142" unitRef="iso4217_USD_per_shares" decimals="0" id="id_1168147_80DC06BD-87DA-4167-89C3-5188D6510EEA_1001_2">10000</galt:PreferredStockStatedValuePerShare>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20101230_0" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_1168147_EC123E1B-D5D7-4E4D-B32D-B1D6EF5867E2_2001_6">7.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <dei:EntityCommonStockSharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20130327_0" unitRef="shares" decimals="INF" id="id_1168147_74A16C2A-DCB4-4A42-BF0A-D0CFB9A0FDE8_2_500008">16109090</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:TemporaryEquityRedemptionValue contextRef="eol_PE87402---1210-K0013_STD_0_20130329_0_506663x511390_513696x501142" unitRef="iso4217_USD" decimals="0" id="id_1168147_ECA4B083-20A9-46C0-8130-AD8E950277AB_2002_0">5151000</us-gaap:TemporaryEquityRedemptionValue>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20040407_0_510623x531324" unitRef="iso4217_USD" decimals="0" id="id_1168147_F4673881-5A95-4A92-96E0-2482B64179F4_3001_8">1931000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20040407_0_510623x531324" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_1168147_F4673881-5A95-4A92-96E0-2482B64179F4_3001_6">31.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE87402---1210-K0013_STD_0_20040407_0_510623x531324" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_F4673881-5A95-4A92-96E0-2482B64179F4_3001_1">21.60</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20040407_0_510623x547978" unitRef="iso4217_USD" decimals="0" id="id_1168147_F4673881-5A95-4A92-96E0-2482B64179F4_4001_9">154000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20040407_0_510623x547978" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_1168147_F4673881-5A95-4A92-96E0-2482B64179F4_4001_7">31.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20090430_0_509379x517826" unitRef="shares" decimals="0" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_5001_0">55000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20090430_0_509379x517826" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_5001_1">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumber contextRef="eol_PE87402---1210-K0013_STD_0_20090430_0_509379x517826" unitRef="shares" decimals="INF" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_5001_3">41666</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumber>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1210-K0013_STD_0_20100308_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_2D9B45B1-B4AF-4E13-84D8-AD29806424BF_5001_1">111667</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1210-K0013_STD_0_20100430_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_0A901237-551F-4C99-AC9B-6F8DFD11BA79_5001_1">103334</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1210-K0013_STD_0_20100510_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_4204B502-6134-49E4-B7FE-157E05A156D0_5001_1">190000</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20100531_0_509379x537560_542884x531496" unitRef="shares" decimals="0" id="id_1168147_0DB338AE-9AE1-4EF3-BF05-53D6024143B6_2001_0">35001</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20100531_0_509379x537560_542884x531496" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0DB338AE-9AE1-4EF3-BF05-53D6024143B6_2001_1">4.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20100531_0_509379x537560_542884x531497" unitRef="shares" decimals="0" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_4001_0">12000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20100531_0_509379x537560_542884x531497" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_4001_1">15.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:ClassOfWarrantOrRightNumberOfSharesVestingInEqualInstallments contextRef="eol_PE87402---1210-K0013_STD_0_20100531_0_509379x537560_542884x531497" unitRef="shares" decimals="0" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_4001_7">500</galt:ClassOfWarrantOrRightNumberOfSharesVestingInEqualInstallments>
  <us-gaap:FairValueAssumptionsExercisePrice contextRef="eol_PE87402---1210-K0013_STD_0_20120322_0_509379x517826" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_1168147_55B00FEF-F007-4C6A-B1C7-39133A892CC5_3002_4">4.20</us-gaap:FairValueAssumptionsExercisePrice>
  <us-gaap:SharePrice contextRef="eol_PE87402---1210-K0013_STD_0_20120322_0_512722x547416" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_1E3F4273-C2C7-4842-9B3B-380D3FCA3617_2001_6">9.00</us-gaap:SharePrice>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20120322_0_512722x547416" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_1E3F4273-C2C7-4842-9B3B-380D3FCA3617_2001_7">5.63</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:ClassOfWarrantOrRightIssuableWithEachNewShareOfCommonStock contextRef="eol_PE87402---1210-K0013_STD_0_20120322_0_512722x547416" unitRef="shares" decimals="INF" id="id_1168147_1E3F4273-C2C7-4842-9B3B-380D3FCA3617_2001_3">1</galt:ClassOfWarrantOrRightIssuableWithEachNewShareOfCommonStock>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20120322_0_512722x547416" id="id_1168147_1E3F4273-C2C7-4842-9B3B-380D3FCA3617_2001_8">2017-03-28</galt:WarrantExpirationDate>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20120328_0" id="id_1168147_55B00FEF-F007-4C6A-B1C7-39133A892CC5_2001_1">2016-05-02</galt:WarrantExpirationDate>
  <us-gaap:FairValueAssumptionsExercisePrice contextRef="eol_PE87402---1210-K0013_STD_0_20120328_0_509379x517826" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_1168147_F98EDFB8-AA27-4A2E-8918-CAFB5A7AF189_2001_6">4.20</us-gaap:FairValueAssumptionsExercisePrice>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20120328_0_513696x501348" unitRef="shares" decimals="0" id="id_1168147_11FC930A-4460-47C9-9DB7-DFE84A911907_4002_2">1333361</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20120328_0_513696x507958" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_11FC930A-4460-47C9-9DB7-DFE84A911907_5002_3">5.63</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20030531_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_BDD64628-D3F6-4CFF-A671-2A7B7D81FEC4_1001_7">261000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20030531_0" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_1168147_BDD64628-D3F6-4CFF-A671-2A7B7D81FEC4_1001_6">32.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:PurchasePricePerUnitUnderPrivatePlacement contextRef="eol_PE87402---1210-K0013_STD_0_20030531_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_BDD64628-D3F6-4CFF-A671-2A7B7D81FEC4_1001_1">12.00</galt:PurchasePricePerUnitUnderPrivatePlacement>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20080531_0_497730x551558" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_CBE1E091-8750-45B6-B803-4A14093E336D_2001_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20080702_0" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_1168147_03139DDB-C281-48DE-AEFE-F5D7E2AC3029_1001_2">6.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:ClassOfWarrantOrRightTerm contextRef="eol_PE87402---1210-K0013_STD_0_20080702_0" id="id_1168147_03139DDB-C281-48DE-AEFE-F5D7E2AC3029_1001_3">P3Y</galt:ClassOfWarrantOrRightTerm>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20090531_0_509379x517827" unitRef="shares" decimals="0" id="id_1168147_6ED586FF-9B5C-4FA5-8556-BD5D5F1A6262_2001_0">95834</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20090531_0_509379x517827" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_6ED586FF-9B5C-4FA5-8556-BD5D5F1A6262_2001_1">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1210-K0013_STD_0_20090630_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_6C8D77AD-7677-49CA-833F-5CD272602624_5001_1">166666</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <galt:OperatingLeasesMonthlyBaseRentExpense contextRef="eol_PE87402---1210-K0013_STD_0_20110731_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_187E5E2E-021D-4DBC-AB2C-D9A977264A15_1001_2">235000</galt:OperatingLeasesMonthlyBaseRentExpense>
  <dei:EntityPublicFloat contextRef="eol_PE87402---1210-K0013_STD_0_20120630_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_74A16C2A-DCB4-4A42-BF0A-D0CFB9A0FDE8_3_600009">29900000</dei:EntityPublicFloat>
  <us-gaap:SharePrice contextRef="eol_PE87402---1210-K0013_STD_0_20010831_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_A81E0F6C-9C6E-4EB4-86A8-78534CA58FEE_1001_6">13.68</us-gaap:SharePrice>
  <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="eol_PE87402---1210-K0013_STD_0_20010831_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_A81E0F6C-9C6E-4EB4-86A8-78534CA58FEE_1001_1">12.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
  <us-gaap:ConvertibleDebt contextRef="eol_PE87402---1210-K0013_STD_0_20010831_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_A81E0F6C-9C6E-4EB4-86A8-78534CA58FEE_1001_0">1126000</us-gaap:ConvertibleDebt>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20010831_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_A81E0F6C-9C6E-4EB4-86A8-78534CA58FEE_1001_5">503000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20010831_0" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_A81E0F6C-9C6E-4EB4-86A8-78534CA58FEE_1001_4">39.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="eol_PE87402---1210-K0013_STD_0_20011031_0_498429x610126" unitRef="shares" decimals="INF" id="id_1168147_D25B9929-1B80-4EC9-8E55-9690ADD6F9E4_1001_0">833334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <galt:PurchasePricePerUnitUnderPrivatePlacement contextRef="eol_PE87402---1210-K0013_STD_0_20020930_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_97D6DB27-14C1-4A9A-B9F1-4A3694D9CE65_1001_1">6.00</galt:PurchasePricePerUnitUnderPrivatePlacement>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20031002_0_510623x531324" unitRef="iso4217_USD" decimals="0" id="id_1168147_E5203BE0-3399-442B-B3BB-0A71791AD0DC_3001_9">2531000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20031002_0_510623x531324" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_1168147_E5203BE0-3399-442B-B3BB-0A71791AD0DC_3001_6">31.74</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE87402---1210-K0013_STD_0_20031002_0_510623x531324" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_E5203BE0-3399-442B-B3BB-0A71791AD0DC_3001_2">21.00</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20031002_0_510623x547978" unitRef="iso4217_USD" decimals="0" id="id_1168147_E5203BE0-3399-442B-B3BB-0A71791AD0DC_4001_10">191000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20031002_0_510623x547978" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_1168147_E5203BE0-3399-442B-B3BB-0A71791AD0DC_4001_8">41.16</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1210-K0013_STD_0_20090930_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_9106A679-B69E-4163-8FB3-08160784E3FF_5001_1">108333</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20101031_0_509379x537561" unitRef="shares" decimals="0" id="id_1168147_CF0E523E-E16B-4ABB-97BA-033347B4095C_2001_0">100000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20101031_0_509379x537561" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_CF0E523E-E16B-4ABB-97BA-033347B4095C_2001_1">4.26</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumber contextRef="eol_PE87402---1210-K0013_STD_0_20101031_0_509379x537561" unitRef="shares" decimals="INF" id="id_1168147_CF0E523E-E16B-4ABB-97BA-033347B4095C_2001_4">50000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumber>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNextYear contextRef="eol_PE87402---1210-K0013_STD_0_20101031_0_509379x537561" unitRef="shares" decimals="0" id="id_1168147_CF0E523E-E16B-4ABB-97BA-033347B4095C_2001_3">25000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNextYear>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE87402---1210-K0013_STD_0_20011213_0_512768x531939" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_BF863662-0B06-4CD8-953A-B2392714FC4F_2001_0">21.00</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:SharePrice contextRef="eol_PE87402---1210-K0013_STD_0_20011231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_E2B0A2E5-4879-4958-82A2-6685DFDC2EB3_3001_8">13.68</us-gaap:SharePrice>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20011231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_E2B0A2E5-4879-4958-82A2-6685DFDC2EB3_3001_7">886000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20011231_0_509379x517820" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_E2B0A2E5-4879-4958-82A2-6685DFDC2EB3_4001_5">39.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20011231_0_509379x517821" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_E2B0A2E5-4879-4958-82A2-6685DFDC2EB3_5001_6">30.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:SharePrice contextRef="eol_PE87402---1210-K0013_STD_0_20021231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_A031F127-3B2B-4069-A99E-61FC9FFBCA32_1001_4">21.00</us-gaap:SharePrice>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20021231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_A031F127-3B2B-4069-A99E-61FC9FFBCA32_1001_3">236000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable contextRef="eol_PE87402---1210-K0013_STD_0_20021231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_97D6DB27-14C1-4A9A-B9F1-4A3694D9CE65_1002_5">150000</us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20021231_0" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_A031F127-3B2B-4069-A99E-61FC9FFBCA32_1001_1">21.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:CommonStockIssuableSharesIssuable contextRef="eol_PE87402---1210-K0013_STD_0_20021231_0" unitRef="shares" decimals="INF" id="id_1168147_7A2B30FB-8F42-4D2C-A7BE-3AA3C588955B_1001_1">29042</galt:CommonStockIssuableSharesIssuable>
  <galt:CommonStockWarrantsTerm contextRef="eol_PE87402---1210-K0013_STD_0_20021231_0" id="id_1168147_A031F127-3B2B-4069-A99E-61FC9FFBCA32_1001_2">P10Y</galt:CommonStockWarrantsTerm>
  <us-gaap:DeferredCompensationShareBasedArrangementsLiabilityCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20021231_0_504051x610120_508454x506554" unitRef="iso4217_USD" decimals="0" id="id_1168147_2C4093D6-7A65-4E02-952E-760F77A26761_3002_8">11000</us-gaap:DeferredCompensationShareBasedArrangementsLiabilityCurrent>
  <galt:CommonStockIssuableSharesIssuable contextRef="eol_PE87402---1210-K0013_STD_0_20021231_0_504296x533527" unitRef="shares" decimals="INF" id="id_1168147_35EFCD9A-0255-4802-96BD-B42D0201D705_2001_0">350</galt:CommonStockIssuableSharesIssuable>
  <galt:CommonStockIssuableSharesIssuable contextRef="eol_PE87402---1210-K0013_STD_0_20021231_0_504296x604034" unitRef="shares" decimals="INF" id="id_1168147_DA2F657E-1733-4A38-A479-6445B98C7217_2001_0">28917</galt:CommonStockIssuableSharesIssuable>
  <galt:CommonStockIssuableSharesIssuable contextRef="eol_PE87402---1210-K0013_STD_0_20021231_0_504296x624055" unitRef="shares" decimals="INF" id="id_1168147_DA2F657E-1733-4A38-A479-6445B98C7217_3001_1">125</galt:CommonStockIssuableSharesIssuable>
  <galt:CommonStockIssuableSharesIssuable contextRef="eol_PE87402---1210-K0013_STD_0_20021231_0_504296x624057" unitRef="shares" decimals="INF" id="id_1168147_20C940DC-96D2-4CCF-A3D8-818DEECA181B_2001_0">4226</galt:CommonStockIssuableSharesIssuable>
  <galt:CommonStockIssuableSharesIssuable contextRef="eol_PE87402---1210-K0013_STD_0_20030114_0_504296x533527" unitRef="shares" decimals="INF" id="id_1168147_35EFCD9A-0255-4802-96BD-B42D0201D705_2003_0">1167</galt:CommonStockIssuableSharesIssuable>
  <galt:CommonStockIssuableSharesIssuable contextRef="eol_PE87402---1210-K0013_STD_0_20030114_0_504296x604034" unitRef="shares" decimals="INF" id="id_1168147_DA2F657E-1733-4A38-A479-6445B98C7217_2002_0">417</galt:CommonStockIssuableSharesIssuable>
  <galt:CommonStockIssuableSharesIssuable contextRef="eol_PE87402---1210-K0013_STD_0_20030114_0_504296x624055" unitRef="shares" decimals="INF" id="id_1168147_DA2F657E-1733-4A38-A479-6445B98C7217_3002_1">1625</galt:CommonStockIssuableSharesIssuable>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="eol_PE87402---1210-K0013_STD_0_20031231_0_498429x610127" unitRef="shares" decimals="INF" id="id_1168147_9898E0B1-5B76-4A78-A95D-41392AB18C1A_1001_0">166667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <galt:WarrantsExpiredWithoutExercise contextRef="eol_PE87402---1210-K0013_STD_0_20081226_0" unitRef="shares" decimals="0" id="id_1168147_E00CB1DB-C74F-4132-A83E-2FB087D6F812_3003_16">500000</galt:WarrantsExpiredWithoutExercise>
  <galt:ExercisePriceOfWarrantsExpiredWithoutExercise contextRef="eol_PE87402---1210-K0013_STD_0_20081226_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_E00CB1DB-C74F-4132-A83E-2FB087D6F812_3003_17">3.78</galt:ExercisePriceOfWarrantsExpiredWithoutExercise>
  <galt:ClassOfWarrantOrRightIssued contextRef="eol_PE87402---1210-K0013_STD_0_20081231_0_499506x536060" unitRef="shares" decimals="INF" id="id_1168147_49322142-3A8C-4549-B803-B8F29CC608F5_1001_0">1164929</galt:ClassOfWarrantOrRightIssued>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1210-K0013_STD_0_20091208_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_388B2B43-4C03-404C-A6C7-AF780089BD36_5001_1">108333</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20091231_0_513696x516923" unitRef="iso4217_USD" decimals="0" id="id_1168147_639297F8-479A-4F09-899B-F2FB629F7A96_5002_0">5333000</us-gaap:WarrantsAndRightsOutstanding>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1210-K0013_STD_0_20100129_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_A6D1D08E-BA5E-49AB-979C-C930790E6173_5001_1">108334</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_1013_1600001">-1694000</us-gaap:StockholdersEquity>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_DD7E11D3-E508-4A68-939D-30C68D6D67C1_1001_2">6.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_7001_32">5891000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0" unitRef="shares" decimals="INF" id="id_1168147_D38119FE-C309-44C9-B627-B9E50FDE3850_1001_400002">8585872</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0" unitRef="shares" decimals="INF" id="id_1168147_EF3241BF-3468-4E6A-8B5F-2F8915F3B83C_1001_2">1965748</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <galt:WarrantLiabilitiesFairValueDisclosure contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A5D7EC06-14B3-4865-AF3B-46A58A7CC002_1001_1">861000</galt:WarrantLiabilitiesFairValueDisclosure>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x498640" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_1007_1100001">644000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x498640" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_1007_1000001">1592500</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x500343" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_1012_1500001">-56424000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_1005_900001">2073000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x501142" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_1005_800001">212</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x501348" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_1009_1300001">11000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_1009_1200001">10651535</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_1011_1400001">54075000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x516922" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_1001_500001">1664000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x516922" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_1001_400001">900000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_1003_700001">2474000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x516923" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_1003_600001">2100000</us-gaap:SharesOutstanding>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumber contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_507189x599319_509379x517826" unitRef="shares" decimals="INF" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_4002_15">33332</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_508454x512177" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_508AFD0E-A3FF-4563-A319-3D7E002FE501_1001_2">1.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_508454x512177" unitRef="shares" decimals="INF" id="id_1168147_A92B2F3F-3537-40A0-86AD-D5CDAF8F3C66_1001_2">26042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_509379x588296_542884x531496" unitRef="shares" decimals="0" id="id_1168147_7FA0AC05-137E-41EC-BF5E-DC2401FC30A5_2001_0">33334</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_509379x588296_542884x531496" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_7FA0AC05-137E-41EC-BF5E-DC2401FC30A5_2001_1">3.90</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_509379x588296_542884x531497" unitRef="shares" decimals="0" id="id_1168147_952DBBC3-4DBA-40F1-BDD3-B9F631CF015D_2001_0">500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_509379x588296_542884x531497" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_952DBBC3-4DBA-40F1-BDD3-B9F631CF015D_2001_1">7.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20101231_0_513696x516923" unitRef="iso4217_USD" decimals="0" id="id_1168147_639297F8-479A-4F09-899B-F2FB629F7A96_5001_0">4148000</us-gaap:WarrantsAndRightsOutstanding>
  <galt:RedemptionTermNumberOfDaysOfConsecutiveTradingDays contextRef="eol_PE87402---1210-K0013_STD_0_20110131_0_504957x513639_513696x511225" id="id_1168147_75D42140-96F7-401C-8A46-95B8F5F4F9EF_2001_0">P30D</galt:RedemptionTermNumberOfDaysOfConsecutiveTradingDays>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_3">104000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_D26532C2-A89D-404A-8D05-05155E578799_2_3">321000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:DeferredTaxAssetsNet contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_1168147_450AAC60-7232-43AA-859B-1D0658B43839_2_5" />
  <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_450AAC60-7232-43AA-859B-1D0658B43839_2_4">21519000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="pure" decimals="2" id="id_1168147_C1BD8498-ADEF-4902-B4A8-ABC31E2F7CA2_1001_0">0.15</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_53">-2125000</us-gaap:StockholdersEquity>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_18" />
  <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_707D11EF-8180-405C-B2B6-95EE937D4F6D_2_3">97000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_48">50000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_707D11EF-8180-405C-B2B6-95EE937D4F6D_2_1">385000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_50">12919538</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:AccruedProfessionalFeesCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_707D11EF-8180-405C-B2B6-95EE937D4F6D_2_0">69000</us-gaap:AccruedProfessionalFeesCurrent>
  <us-gaap:Liabilities contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_17">2215000</us-gaap:Liabilities>
  <us-gaap:AccountsPayableCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_11">384000</us-gaap:AccountsPayableCurrent>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_450AAC60-7232-43AA-859B-1D0658B43839_2_0">19119000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:DeferredRevenueCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_14">200000</us-gaap:DeferredRevenueCurrent>
  <us-gaap:DeferredTaxAssetsOther contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_450AAC60-7232-43AA-859B-1D0658B43839_2_2">2070000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_52">69137000</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_43">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_450AAC60-7232-43AA-859B-1D0658B43839_2_1">330000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
  <us-gaap:Assets contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_8">6612000</us-gaap:Assets>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_DD7E11D3-E508-4A68-939D-30C68D6D67C1_3001_6">6.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_54">6612000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_6">69000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_2">6397000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="INF" id="id_1168147_5DF9B4B9-8DED-4016-8955-BF0CF2506A9A_1002_2">78000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_49">12919538</us-gaap:CommonStockSharesIssued>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_7">36000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_D38119FE-C309-44C9-B627-B9E50FDE3850_3001_400006">6673405</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_12">1551000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_15">2215000</us-gaap:LiabilitiesCurrent>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_EF3241BF-3468-4E6A-8B5F-2F8915F3B83C_3001_6">3091474</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:CommonStockValue contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_46">13000</us-gaap:CommonStockValue>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD_per_shares" decimals="3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_47">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_5DF9B4B9-8DED-4016-8955-BF0CF2506A9A_1002_3">42000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:AssetsCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_4">6501000</us-gaap:AssetsCurrent>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_45">1562500</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:DeferredTaxAssetsGross contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_450AAC60-7232-43AA-859B-1D0658B43839_2_3">21519000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_44">1562500</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockValue contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_42">632000</us-gaap:PreferredStockValue>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_D26532C2-A89D-404A-8D05-05155E578799_2_4">315000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:DividendsPayableCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_13">80000</us-gaap:DividendsPayableCurrent>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_5">6000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:AdditionalPaidInCapital contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_51">66367000</us-gaap:AdditionalPaidInCapital>
  <galt:UndesignatedCapitalStockValue contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_38" />
  <galt:UndesignatedCapitalStockSharesAuthorized contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_40">20000000</galt:UndesignatedCapitalStockSharesAuthorized>
  <galt:UndesignatedCapitalStockSharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_41">8001000</galt:UndesignatedCapitalStockSharesOutstanding>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_6F174B77-3A8B-4CA7-8F01-94E78DFA58DE_4001_0">166668</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber>
  <galt:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumber contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_9B5DC16D-9A0A-45B4-843D-87D967EF0B53_1002_1">1317480</galt:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumber>
  <galt:UndesignatedCapitalStockNoParValue contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2_39">0.01</galt:UndesignatedCapitalStockNoParValue>
  <galt:ClassOfWarrantOrRightIntrinsicValueOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_A5D7EC06-14B3-4865-AF3B-46A58A7CC002_3001_3">1385</galt:ClassOfWarrantOrRightIntrinsicValueOfWarrantsOrRights>
  <galt:BankDeposit contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_187E5E2E-021D-4DBC-AB2C-D9A977264A15_1002_3">59000</galt:BankDeposit>
  <galt:AccruedSeparationAgreement contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_707D11EF-8180-405C-B2B6-95EE937D4F6D_2_2">1000000</galt:AccruedSeparationAgreement>
  <galt:NumberOfNewDirectorsElected contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_504296x624872" unitRef="Person" decimals="0" id="id_1168147_80D9F01D-9ED8-4A57-BCFC-8B99EB7C33B1_1001_0">2</galt:NumberOfNewDirectorsElected>
  <galt:NumberOfNewDirectorsElected contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_504296x624873" unitRef="Person" decimals="0" id="id_1168147_80D9F01D-9ED8-4A57-BCFC-8B99EB7C33B1_2001_1">2</galt:NumberOfNewDirectorsElected>
  <galt:NumberOfNewDirectorsElected contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_504296x624873_504957x514053" unitRef="Person" decimals="0" id="id_1168147_80D9F01D-9ED8-4A57-BCFC-8B99EB7C33B1_3001_2">3</galt:NumberOfNewDirectorsElected>
  <us-gaap:SharePrice contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_504957x513639" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_83596DD3-C73B-4F1E-AA75-BC5D0F7C6A45_2001_3">9.00</us-gaap:SharePrice>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseNumberOfSharesAvailableForGrant contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_504957x514053" unitRef="shares" decimals="INF" id="id_1168147_70CCFEEF-97E7-4C18-A672-6412C3B6EEFA_1001_0">250000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseNumberOfSharesAvailableForGrant>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x498640" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_3007_1100020">632000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x498640" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_3007_1000020">1562500</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x500343" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_3012_1500020">-69137000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_3005_900020">2154000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x501142" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_3005_800020">220</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x501348" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_3009_1300020">13000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_3009_1200020">12919538</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_3011_1400020">66367000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x516922" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_3001_500020">1681000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x516922" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_3001_400020">900000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_3003_700020">2687000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x516923" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_3003_600020">2100000</us-gaap:SharesOutstanding>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_507189x517783" unitRef="shares" decimals="INF" id="id_1168147_6F174B77-3A8B-4CA7-8F01-94E78DFA58DE_5001_1">83334</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_507189x517784" unitRef="shares" decimals="INF" id="id_1168147_6F174B77-3A8B-4CA7-8F01-94E78DFA58DE_6001_3">83334</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber>
  <galt:TerminationNoticePeriod contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_509379x507958" id="id_1168147_FD6CDE31-E97D-4422-BD3C-4AF8A556C16B_1001_0">P30D</galt:TerminationNoticePeriod>
  <galt:NumberOfTradingDays contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_509379x544385" id="id_1168147_FD6CDE31-E97D-4422-BD3C-4AF8A556C16B_2001_2">P15D</galt:NumberOfTradingDays>
  <galt:CommonStockMarketPrice contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_509379x544385" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_FD6CDE31-E97D-4422-BD3C-4AF8A556C16B_2001_3">7.50</galt:CommonStockMarketPrice>
  <galt:CommonStockMarketPrice contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_509379x544386" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_FD6CDE31-E97D-4422-BD3C-4AF8A556C16B_3001_4">10.50</galt:CommonStockMarketPrice>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_509379x604655" unitRef="iso4217_USD_per_Warrants" decimals="2" id="id_1168147_FD6CDE31-E97D-4422-BD3C-4AF8A556C16B_4001_1">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:AssetsFairValueDisclosure contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_510142x511009_511283x503498" unitRef="iso4217_USD" decimals="0" id="id_1168147_8A9F5783-7B56-446A-ADD5-38D076C6567F_1002_0">6123000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_510903x498304" unitRef="iso4217_USD" decimals="-3" id="id_1168147_D26532C2-A89D-404A-8D05-05155E578799_1002_0">15000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_510903x500372" unitRef="iso4217_USD" decimals="-3" id="id_1168147_D26532C2-A89D-404A-8D05-05155E578799_2002_2">107000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_510903x537720" unitRef="iso4217_USD" decimals="-3" id="id_1168147_D26532C2-A89D-404A-8D05-05155E578799_3002_1">199000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:SharePrice contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x501142" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_F3A23398-78AF-4164-827C-9C9A12FB50DB_3001_2">3.00</us-gaap:SharePrice>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1002_34">220</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1002_33">220</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:PreferredStockRedemptionPricePerShare contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x501142" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_D92F9120-6428-4713-98E2-4F4FD3512C51_3001_2">3.00</us-gaap:PreferredStockRedemptionPricePerShare>
  <us-gaap:PreferredStockLiquidationPreference contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x501142" unitRef="iso4217_USD_per_shares" decimals="0" id="id_1168147_2D46428A-3E53-4790-8D57-0C8C17138C00_2001_0">10000</us-gaap:PreferredStockLiquidationPreference>
  <us-gaap:TemporaryEquitySharesAuthorized contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1002_32">1000</us-gaap:TemporaryEquitySharesAuthorized>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1002_31">2154000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <galt:CommonSharesIssuableUponConversionOfConvertibleStock contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_6D21A9F9-4917-4A3E-B2AA-47B51188D00C_2001_1">1667</galt:CommonSharesIssuableUponConversionOfConvertibleStock>
  <galt:NumberOfConsecutiveTradingDays contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x501142" id="id_1168147_F3A23398-78AF-4164-827C-9C9A12FB50DB_3001_3">P10D</galt:NumberOfConsecutiveTradingDays>
  <galt:ConversionOfStockConversionPrice contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x501142" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6D21A9F9-4917-4A3E-B2AA-47B51188D00C_2001_0">6.00</galt:ConversionOfStockConversionPrice>
  <galt:NumberOfConsecutiveTradingDays contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x511225" id="id_1168147_04843158-7341-46D0-B87B-BB4F3671419B_2001_2">P20D</galt:NumberOfConsecutiveTradingDays>
  <galt:ConversionOfStockConversionPrice contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x511225" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_83596DD3-C73B-4F1E-AA75-BC5D0F7C6A45_3001_1">3.00</galt:ConversionOfStockConversionPrice>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x516922" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2002_22">900000</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x516922" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2002_21">900000</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:TemporaryEquitySharesAuthorized contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x516922" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2002_20">900000</us-gaap:TemporaryEquitySharesAuthorized>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x516922" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2002_19">1681000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_3002_28">2100000</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_3002_27">2100000</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:TemporaryEquitySharesAuthorized contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_3002_26">2100000</us-gaap:TemporaryEquitySharesAuthorized>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_3002_25">2687000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="eol_PE87402---1210-K0013_STD_0_20111231_0_557712x580425" unitRef="iso4217_USD" decimals="0" id="id_1168147_6F174B77-3A8B-4CA7-8F01-94E78DFA58DE_7001_5">1006000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_3">153000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_BBC57197-BEC3-4D15-A7FF-BE7038677714_1_0">49000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_D26532C2-A89D-404A-8D05-05155E578799_1_3">74000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:DeferredTaxAssetsNet contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_1168147_450AAC60-7232-43AA-859B-1D0658B43839_1_5" />
  <us-gaap:SharePrice contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_E8337D03-B5FE-41AF-B629-C6E0AC9E70C9_1001_0">2.05</us-gaap:SharePrice>
  <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_450AAC60-7232-43AA-859B-1D0658B43839_1_4">24991000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_EF3241BF-3468-4E6A-8B5F-2F8915F3B83C_5001_11">2067910</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_53">1165000</us-gaap:StockholdersEquity>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_18" />
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_9B5DC16D-9A0A-45B4-843D-87D967EF0B53_1001_2">5628000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_707D11EF-8180-405C-B2B6-95EE937D4F6D_1_3">10000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A5E01C38-D563-474C-A714-18E08EA50E2E_1001_3">268000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_48">50000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_707D11EF-8180-405C-B2B6-95EE937D4F6D_1_1">42000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_DD7E11D3-E508-4A68-939D-30C68D6D67C1_5001_11">5.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A5E01C38-D563-474C-A714-18E08EA50E2E_1001_2">279000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_50">16060853</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_D5CB6A3D-4FB8-4FCB-8CD0-638BB6AA3972_1_1">923000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1035_1">7424241</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:AccruedProfessionalFeesCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_707D11EF-8180-405C-B2B6-95EE937D4F6D_1_0">109000</us-gaap:AccruedProfessionalFeesCurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_BBC57197-BEC3-4D15-A7FF-BE7038677714_1_1">36000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:Liabilities contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_17">1644000</us-gaap:Liabilities>
  <us-gaap:AccountsPayableCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_11">397000</us-gaap:AccountsPayableCurrent>
  <us-gaap:UnrecognizedTaxBenefits contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_D5CB6A3D-4FB8-4FCB-8CD0-638BB6AA3972_1_0">1082000</us-gaap:UnrecognizedTaxBenefits>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_450AAC60-7232-43AA-859B-1D0658B43839_1_0">21753000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:DeferredTaxAssetsOther contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_450AAC60-7232-43AA-859B-1D0658B43839_1_2">2921000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_52">80018000</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_16">6000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:SecurityDeposit contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_DAED8B74-C888-452F-AEBC-657DBF101DA2_1_0">6000</us-gaap:SecurityDeposit>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_43">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_450AAC60-7232-43AA-859B-1D0658B43839_1_1">317000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
  <us-gaap:Assets contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_8">9561000</us-gaap:Assets>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_DD7E11D3-E508-4A68-939D-30C68D6D67C1_5001_10">5.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_54">9561000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_6">6000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_2">9364000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="INF" id="id_1168147_5DF9B4B9-8DED-4016-8955-BF0CF2506A9A_1001_2">78000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_49">16060853</us-gaap:CommonStockSharesIssued>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_7">30000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_D38119FE-C309-44C9-B627-B9E50FDE3850_5001_400010">7424241</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_12">1161000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_15">1638000</us-gaap:LiabilitiesCurrent>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_EF3241BF-3468-4E6A-8B5F-2F8915F3B83C_5001_10">3539961</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:CommonStockValue contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_46">16000</us-gaap:CommonStockValue>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_47">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_5DF9B4B9-8DED-4016-8955-BF0CF2506A9A_1001_3">48000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:AssetsCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_4">9517000</us-gaap:AssetsCurrent>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_45">1562500</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:DeferredTaxAssetsGross contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_450AAC60-7232-43AA-859B-1D0658B43839_1_3">24991000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_44">1562500</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockValue contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_42">632000</us-gaap:PreferredStockValue>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_BBC57197-BEC3-4D15-A7FF-BE7038677714_1_2">85000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_D26532C2-A89D-404A-8D05-05155E578799_1_4">66000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:DividendsPayableCurrent contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_13">80000</us-gaap:DividendsPayableCurrent>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_5">8000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:AdditionalPaidInCapital contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_51">80535000</us-gaap:AdditionalPaidInCapital>
  <galt:UndesignatedCapitalStockValue contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_38" />
  <galt:UndesignatedCapitalStockSharesAuthorized contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_40">20000000</galt:UndesignatedCapitalStockSharesAuthorized>
  <galt:UndesignatedCapitalStockSharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_41">8001000</galt:UndesignatedCapitalStockSharesOutstanding>
  <galt:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumber contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_9B5DC16D-9A0A-45B4-843D-87D967EF0B53_1001_1">1472051</galt:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumber>
  <galt:NumberOfCompensationPlans contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="pure" decimals="INF" id="id_1168147_F3DBC87F-B35D-40C8-A91C-C1266F721FA8_1_0">3</galt:NumberOfCompensationPlans>
  <galt:UndesignatedCapitalStockNoParValue contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1_39">0.01</galt:UndesignatedCapitalStockNoParValue>
  <galt:DeferredTaxAssetsValuationAllowancePercentage contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="pure" decimals="2" id="id_1168147_3652F6D0-94AB-477B-9DBD-D5D3EA68D1D3_3001_8">1.00</galt:DeferredTaxAssetsValuationAllowancePercentage>
  <galt:OperatingLeasesAnnualRent contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_6A41BFF6-0AB8-411E-A7BC-6052F587C84E_1001_1">15000</galt:OperatingLeasesAnnualRent>
  <galt:UndesignatedCapitalStockSharesAuthorizedButUnissued contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_4D60AE25-CB45-48CC-B061-4428961EFFAA_1_400006">11999000</galt:UndesignatedCapitalStockSharesAuthorizedButUnissued>
  <galt:AccruedSeparationAgreement contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_707D11EF-8180-405C-B2B6-95EE937D4F6D_1_2">1000000</galt:AccruedSeparationAgreement>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_498429x515840" unitRef="shares" decimals="INF" id="id_1168147_8304045E-60A2-4799-962C-9685E6AA4779_1002_1">979259</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_498429x585047" unitRef="shares" decimals="INF" id="id_1168147_DE44A988-F774-4F5B-8EF9-818FF5E73989_2001_1">1440045</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_498429x610126" unitRef="shares" decimals="INF" id="id_1168147_D25B9929-1B80-4EC9-8E55-9690ADD6F9E4_1003_4">291992</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_498429x610127" unitRef="shares" decimals="INF" id="id_1168147_9898E0B1-5B76-4A78-A95D-41392AB18C1A_1002_1">146557</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x498640" unitRef="iso4217_USD" decimals="-3" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_1007_1100007">632000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x498640" unitRef="shares" decimals="INF" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_1007_1000007">1562500</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x500343" unitRef="iso4217_USD" decimals="-3" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_1012_1500007">-80018000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_1005_900007">2154000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x501142" unitRef="shares" decimals="INF" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_1005_800007">220</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x501348" unitRef="iso4217_USD" decimals="-3" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_1009_1300007">16000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_1009_1200007">16060853</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_1011_1400007">80535000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x516922" unitRef="iso4217_USD" decimals="-3" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_1001_500007">1698000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x516922" unitRef="shares" decimals="INF" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_1001_400007">900000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_1003_700007">2900000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x516923" unitRef="shares" decimals="INF" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_1003_600007">2100000</us-gaap:SharesOutstanding>
  <us-gaap:OperatingLossCarryforwards contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_508681x502974" unitRef="iso4217_USD" decimals="0" id="id_1168147_3652F6D0-94AB-477B-9DBD-D5D3EA68D1D3_4001_0">60886000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:OperatingLossCarryforwards contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_508681x509983" unitRef="iso4217_USD" decimals="0" id="id_1168147_3652F6D0-94AB-477B-9DBD-D5D3EA68D1D3_5001_1">25160000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517823_510623x624796" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1001_1">710834</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517823_510623x624796" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1001_2">4.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517823_510623x624796" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1001_4">2013-08-25</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624797" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1002_1">300000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624797" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1002_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624797" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1002_4">2014-02-12</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624798" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1004_1">150000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624798" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1004_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624798" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1004_4">2014-05-13</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624799" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1006_1">83333</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624799" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1006_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624799" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1006_4">2014-06-30</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624804" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1012_1">50000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624804" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1012_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624804" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1012_4">2014-08-12</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624805" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1014_1">54166</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624805" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1014_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624805" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1014_4">2014-09-30</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624806" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1016_1">51666</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624806" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1016_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624806" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1016_4">2014-11-04</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624807" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1018_1">54167</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624807" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1018_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624807" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1018_4">2014-12-08</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624808" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1020_1">54167</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624808" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1020_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624808" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1020_4">2015-01-29</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624809" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1022_1">55834</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624809" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1022_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624809" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1022_4">2015-03-08</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624810" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1024_1">51667</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624810" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1024_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624810" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1024_4">2015-04-30</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624811" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1026_1">95000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624811" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1026_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624811" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1026_4">2015-05-10</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624797" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1003_1">1200000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624797" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1003_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624797" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1003_4">2014-02-12</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624798" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1005_1">600000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624798" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1005_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624798" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1005_4">2014-05-13</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624799" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1007_1">333333</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624799" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1007_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624799" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1007_4">2014-06-30</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624804" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1013_1">200000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624804" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1013_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624804" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1013_4">2014-08-12</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624805" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1015_1">216666</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624805" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1015_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624805" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1015_4">2014-09-30</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624806" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1017_1">206666</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624806" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1017_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624806" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1017_4">2014-11-04</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624807" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1019_1">216667</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624807" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1019_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624807" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1019_4">2014-12-08</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624808" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1021_1">216667</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624808" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1021_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624808" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1021_4">2015-01-29</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624809" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1023_1">223334</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624809" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1023_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624809" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1023_4">2015-03-08</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624810" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1025_1">206667</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624810" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1025_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624810" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1025_4">2015-04-30</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624811" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1027_1">380000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624811" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1027_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624811" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1027_4">2015-05-10</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x531496_510623x624812" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_24001_40">2010-05-25</galt:WarrantIssueDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x531497_510623x624812" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_25001_41">2010-05-25</galt:WarrantIssueDate>
  <us-gaap:AssetsFairValueDisclosure contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510142x511009_511283x503498" unitRef="iso4217_USD" decimals="0" id="id_1168147_8A9F5783-7B56-446A-ADD5-38D076C6567F_1001_0">583000</us-gaap:AssetsFairValueDisclosure>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624796" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_26001_1">2008-02-25</galt:WarrantIssueDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624797" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_27001_3">2009-02-12</galt:WarrantIssueDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624798" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_28001_6">2009-05-13</galt:WarrantIssueDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624799" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_29001_9">2009-06-30</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624800" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1008_1">33333</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624800" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1008_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624800" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1008_4">2013-04-15</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624800" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_30001_12">2009-04-15</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624801" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1009_1">74000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624801" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1009_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624801" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1009_4">2014-05-01</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624801" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_31001_13">2009-05-01</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624802" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1010_1">40000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624802" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1010_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624802" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1010_4">2014-06-30</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624802" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_32001_14">2009-06-30</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624803" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1011_1">16667</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624803" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1011_2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624803" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1011_4">2014-07-26</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624803" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_33001_15">2009-07-26</galt:WarrantIssueDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624804" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_34001_16">2009-08-12</galt:WarrantIssueDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624805" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_35001_19">2009-09-30</galt:WarrantIssueDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624806" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_36001_22">2009-11-04</galt:WarrantIssueDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624807" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_37001_25">2009-12-08</galt:WarrantIssueDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624808" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_38001_28">2010-01-29</galt:WarrantIssueDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624809" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_39001_31">2010-03-08</galt:WarrantIssueDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624810" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_40001_34">2010-04-30</galt:WarrantIssueDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624811" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_41001_37">2010-05-10</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624812_542884x531496" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1028_1">28334</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624812_542884x531496" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1028_2">4.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624812_542884x531496" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1028_4">2014-05-25</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624812_542884x531497" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1029_1">7500</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624812_542884x531497" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1029_2">15.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624812_542884x531497" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1029_4">2014-05-25</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624813" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1030_1">100000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624813" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1030_2">4.26</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624813" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1030_4">2015-06-15</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624813" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_42001_42">2010-06-15</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x625047" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1031_1">33334</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x625047" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1031_2">3.90</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x625047" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1031_4">2015-12-09</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x625047" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_43001_43">2010-12-09</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x625048" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1032_1">500</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x625048" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1032_2">7.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x625048" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1032_4">2015-12-30</galt:WarrantExpirationDate>
  <galt:WarrantIssueDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x625048" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_44001_44">2010-12-30</galt:WarrantIssueDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x678629" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1033_1">1333361</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x678629" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1033_2">5.63</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x678629" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1033_4">2017-03-28</galt:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x678630" unitRef="shares" decimals="INF" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1034_1">46378</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x678630" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1034_2">5.63</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <galt:WarrantExpirationDate contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x678630" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_1034_4">2016-05-02</galt:WarrantExpirationDate>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510903x498304" unitRef="iso4217_USD" decimals="-3" id="id_1168147_D26532C2-A89D-404A-8D05-05155E578799_1001_0">2000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510903x500372" unitRef="iso4217_USD" decimals="-3" id="id_1168147_D26532C2-A89D-404A-8D05-05155E578799_2001_2">59000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_510903x537720" unitRef="iso4217_USD" decimals="-3" id="id_1168147_D26532C2-A89D-404A-8D05-05155E578799_3001_1">13000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:TemporaryEquityLiquidationPreference contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x501142" unitRef="iso4217_USD" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1001_36">2233000</us-gaap:TemporaryEquityLiquidationPreference>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1001_34">220</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1001_33">220</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:TemporaryEquitySharesAuthorized contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1001_32">1000</us-gaap:TemporaryEquitySharesAuthorized>
  <us-gaap:TemporaryEquityRedemptionValue contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x501142" unitRef="iso4217_USD" decimals="0" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1001_35">5204000</us-gaap:TemporaryEquityRedemptionValue>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_1001_31">2154000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <galt:UndesignatedCapitalStockSharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_4D60AE25-CB45-48CC-B061-4428961EFFAA_1001_400005">1000</galt:UndesignatedCapitalStockSharesOutstanding>
  <us-gaap:TemporaryEquityLiquidationPreference contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x516922" unitRef="iso4217_USD" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2001_24">1800000</us-gaap:TemporaryEquityLiquidationPreference>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x516922" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2001_22">900000</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x516922" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2001_21">900000</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:WarrantsAndRightsOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x516922" unitRef="iso4217_USD" decimals="0" id="id_1168147_CA67B86B-A42F-409D-B0B5-78B4BAB62832_3001_0">1296000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:TemporaryEquitySharesAuthorized contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x516922" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2001_20">900000</us-gaap:TemporaryEquitySharesAuthorized>
  <us-gaap:TemporaryEquityRedemptionValue contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x516922" unitRef="iso4217_USD" decimals="0" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2001_23">1800000</us-gaap:TemporaryEquityRedemptionValue>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x516922" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_2001_19">1698000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <galt:UndesignatedCapitalStockSharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x516922" unitRef="shares" decimals="INF" id="id_1168147_4D60AE25-CB45-48CC-B061-4428961EFFAA_2001_400003">900000</galt:UndesignatedCapitalStockSharesOutstanding>
  <us-gaap:TemporaryEquityLiquidationPreference contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x516923" unitRef="iso4217_USD" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_3001_30">4200000</us-gaap:TemporaryEquityLiquidationPreference>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_3001_28">2100000</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_3001_27">2100000</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:TemporaryEquitySharesAuthorized contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_3001_26">2100000</us-gaap:TemporaryEquitySharesAuthorized>
  <us-gaap:TemporaryEquityRedemptionValue contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x516923" unitRef="iso4217_USD" decimals="0" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_3001_29">4200000</us-gaap:TemporaryEquityRedemptionValue>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_9199DF2C-B8DE-46E5-9B9B-A612E86DA66D_3001_25">2900000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <galt:UndesignatedCapitalStockSharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_4D60AE25-CB45-48CC-B061-4428961EFFAA_3001_400004">2100000</galt:UndesignatedCapitalStockSharesOutstanding>
  <galt:UndesignatedCapitalStockSharesOutstanding contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x537761" unitRef="shares" decimals="INF" id="id_1168147_4D60AE25-CB45-48CC-B061-4428961EFFAA_4001_400002">5000000</galt:UndesignatedCapitalStockSharesOutstanding>
  <galt:OperatingLeasesMonthlyBaseRentExpense contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_530649x607894" unitRef="iso4217_USD" decimals="0" id="id_1168147_96C5EC65-7100-4DFA-87ED-214F2EB3B320_2001_2">3000</galt:OperatingLeasesMonthlyBaseRentExpense>
  <galt:LeaseDeposits contextRef="eol_PE87402---1210-K0013_STD_0_20121231_0_530649x607894" unitRef="iso4217_USD" decimals="0" id="id_1168147_96C5EC65-7100-4DFA-87ED-214F2EB3B320_2001_3">6000</galt:LeaseDeposits>
  <galt:CollaborationAgreementAggregateResearchAndDevelopmentFundedByCollaborator contextRef="eol_PE87402---1210-K0013_STD_0_20130201_0_506663x511390" unitRef="iso4217_USD" decimals="0" id="id_1168147_ACFCB530-E7EA-4CC3-84B4-F1F1633703F0_1001_0">154000</galt:CollaborationAgreementAggregateResearchAndDevelopmentFundedByCollaborator>
  <galt:MaximumDevelopmentBudget contextRef="eol_PE87402---1210-K0013_STD_0_20130201_0_506663x511390" unitRef="iso4217_USD" decimals="0" id="id_1168147_7520DFCA-3E20-4E57-8AFB-32AF1F7141C0_1001_0">2155000</galt:MaximumDevelopmentBudget>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1210-K0013_STD_21_20080521_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_1DFED9B8-9083-4FA3-AA98-28025451C0A0_4_13">502000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <galt:ChangeInFairValueOfWarrantLiabilities contextRef="eol_PE87402---1210-K0013_STD_21_20080521_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_1DFED9B8-9083-4FA3-AA98-28025451C0A0_4_12">100000</galt:ChangeInFairValueOfWarrantLiabilities>
  <galt:IssuanceOfEquityWarrantsInConnectionWithEquityOfferings contextRef="eol_PE87402---1210-K0013_STD_21_20120322_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_55B00FEF-F007-4C6A-B1C7-39133A892CC5_2_3">143000</galt:IssuanceOfEquityWarrantsInConnectionWithEquityOfferings>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_21_20120322_0_509379x517826" unitRef="pure" decimals="4" id="id_1168147_55B00FEF-F007-4C6A-B1C7-39133A892CC5_1002_7">0.0078</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_21_20120322_0_509379x517826" unitRef="pure" decimals="2" id="id_1168147_55B00FEF-F007-4C6A-B1C7-39133A892CC5_1002_6">1.17</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsExpectedTerm contextRef="eol_PE87402---1210-K0013_STD_21_20120322_0_509379x517826" id="id_1168147_55B00FEF-F007-4C6A-B1C7-39133A892CC5_1002_5">P4Y1M6D</us-gaap:FairValueAssumptionsExpectedTerm>
  <galt:UnitsIssuedDuringPeriodUnitsNewIssues contextRef="eol_PE87402---1210-K0013_STD_21_20120322_0_512722x547416" unitRef="shares" decimals="INF" id="id_1168147_1E3F4273-C2C7-4842-9B3B-380D3FCA3617_1001_0">1159445</galt:UnitsIssuedDuringPeriodUnitsNewIssues>
  <galt:OpenOptionContractsSharePurchaseMaximumPeriod contextRef="eol_PE87402---1210-K0013_STD_21_20120322_0_512722x547416" id="id_1168147_1E3F4273-C2C7-4842-9B3B-380D3FCA3617_1001_4">P45D</galt:OpenOptionContractsSharePurchaseMaximumPeriod>
  <galt:NumberOfSharesOfCommonStockInEachUnit contextRef="eol_PE87402---1210-K0013_STD_21_20120322_0_512722x547416" unitRef="shares" decimals="INF" id="id_1168147_1E3F4273-C2C7-4842-9B3B-380D3FCA3617_1001_1">2</galt:NumberOfSharesOfCommonStockInEachUnit>
  <galt:NumberOfWarrantSharesInEachUnit contextRef="eol_PE87402---1210-K0013_STD_21_20120322_0_512722x547416" unitRef="shares" decimals="INF" id="id_1168147_1E3F4273-C2C7-4842-9B3B-380D3FCA3617_1001_2">1</galt:NumberOfWarrantSharesInEachUnit>
  <galt:SaleOfStockPursuantToExerciseOfUnderwritersOverAllotmentOption contextRef="eol_PE87402---1210-K0013_STD_21_20120322_0_512722x547416" unitRef="shares" decimals="0" id="id_1168147_1E3F4273-C2C7-4842-9B3B-380D3FCA3617_1001_5">173916</galt:SaleOfStockPursuantToExerciseOfUnderwritersOverAllotmentOption>
  <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits contextRef="eol_PE87402---1210-K0013_STD_22_20120323_0" unitRef="shares" decimals="INF" id="id_1168147_A570FC68-0BED-49E8-B3B2-8B9647F2C354_1_1">3324</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
  <us-gaap:StockholdersEquityNoteStockSplitConversionRatio contextRef="eol_PE87402---1210-K0013_STD_22_20120323_0" unitRef="pure" decimals="INF" id="id_1168147_A570FC68-0BED-49E8-B3B2-8B9647F2C354_1_0">1.6667</us-gaap:StockholdersEquityNoteStockSplitConversionRatio>
  <us-gaap:StockholdersEquityNoteStockSplitConversionRatio contextRef="eol_PE87402---1210-K0013_STD_22_20120323_0_497915x536191" unitRef="pure" decimals="INF" id="id_1168147_11FC930A-4460-47C9-9DB7-DFE84A911907_1001_0">1.6667</us-gaap:StockholdersEquityNoteStockSplitConversionRatio>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_27_20120328_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_F98EDFB8-AA27-4A2E-8918-CAFB5A7AF189_1_4">10403000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_27_20120328_0" unitRef="shares" decimals="INF" id="id_1168147_F98EDFB8-AA27-4A2E-8918-CAFB5A7AF189_1_1">2666722</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="eol_PE87402---1210-K0013_STD_27_20120328_0" unitRef="iso4217_USD" decimals="2" id="id_1168147_55B00FEF-F007-4C6A-B1C7-39133A892CC5_1_2">5.63</galt:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <galt:IssuanceOfEquityWarrantsInConnectionWithEquityOfferings contextRef="eol_PE87402---1210-K0013_STD_27_20120328_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_F98EDFB8-AA27-4A2E-8918-CAFB5A7AF189_1_5">4445000</galt:IssuanceOfEquityWarrantsInConnectionWithEquityOfferings>
  <galt:UnitsIssuedDuringPeriodUnitsNewIssues contextRef="eol_PE87402---1210-K0013_STD_27_20120328_0" unitRef="shares" decimals="INF" id="id_1168147_F98EDFB8-AA27-4A2E-8918-CAFB5A7AF189_1_0">1333361</galt:UnitsIssuedDuringPeriodUnitsNewIssues>
  <galt:CommonStockWarrantsIssued contextRef="eol_PE87402---1210-K0013_STD_27_20120328_0" unitRef="shares" decimals="INF" id="id_1168147_F98EDFB8-AA27-4A2E-8918-CAFB5A7AF189_1_2">1333361</galt:CommonStockWarrantsIssued>
  <galt:ProceedsFromIssuanceOrSaleOfEquityGross contextRef="eol_PE87402---1210-K0013_STD_27_20120328_0" unitRef="iso4217_USD" decimals="-5" id="id_1168147_F98EDFB8-AA27-4A2E-8918-CAFB5A7AF189_1_3">12000000</galt:ProceedsFromIssuanceOrSaleOfEquityGross>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_27_20120328_0" unitRef="shares" decimals="INF" id="id_1168147_55B00FEF-F007-4C6A-B1C7-39133A892CC5_1_0">46378</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_27_20120328_0_509379x517826" unitRef="pure" decimals="4" id="id_1168147_F98EDFB8-AA27-4A2E-8918-CAFB5A7AF189_1001_9">0.0105</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_27_20120328_0_509379x517826" unitRef="pure" decimals="2" id="id_1168147_F98EDFB8-AA27-4A2E-8918-CAFB5A7AF189_1001_8">1.19</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsExpectedTerm contextRef="eol_PE87402---1210-K0013_STD_27_20120328_0_509379x517826" id="id_1168147_F98EDFB8-AA27-4A2E-8918-CAFB5A7AF189_1001_7">P5Y</us-gaap:FairValueAssumptionsExpectedTerm>
  <galt:IssuanceOfCommonStockAndWarrantsShares contextRef="eol_PE87402---1210-K0013_STD_27_20120328_0_513696x501348" unitRef="shares" decimals="INF" id="id_1168147_11FC930A-4460-47C9-9DB7-DFE84A911907_2002_1">2666722</galt:IssuanceOfCommonStockAndWarrantsShares>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_27_20120328_0_513696x534959" unitRef="iso4217_USD" decimals="0" id="id_1168147_11FC930A-4460-47C9-9DB7-DFE84A911907_3002_5">10403000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <galt:GrossProceedsFromIssuanceOfCommonStockAndWarrants contextRef="eol_PE87402---1210-K0013_STD_27_20120328_0_513696x534959" unitRef="iso4217_USD" decimals="0" id="id_1168147_11FC930A-4460-47C9-9DB7-DFE84A911907_3002_4">12000000</galt:GrossProceedsFromIssuanceOfCommonStockAndWarrants>
  <us-gaap:RoyaltyRevenue contextRef="eol_PE87402---1210-K0013_STD_28_20090228_0" unitRef="iso4217_USD" decimals="-6" id="id_1168147_B96E0376-3DC7-4105-A45B-54F2D5B85A0B_1_3">50000000</us-gaap:RoyaltyRevenue>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_28_20090228_0" unitRef="shares" decimals="INF" id="id_1168147_B96E0376-3DC7-4105-A45B-54F2D5B85A0B_1_1">83334</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod>
  <galt:SeverancePaymentPeriod contextRef="eol_PE87402---1210-K0013_STD_28_20090228_0" id="id_1168147_B96E0376-3DC7-4105-A45B-54F2D5B85A0B_1_6">P6M</galt:SeverancePaymentPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_28_20090228_0_504051x551546" unitRef="iso4217_USD_per_shares" decimals="0" id="id_1168147_8EF2E569-5CEA-4272-B068-04058D366864_1001_1">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_28_20090228_0_504051x551546" unitRef="shares" decimals="INF" id="id_1168147_8EF2E569-5CEA-4272-B068-04058D366864_1001_0">33334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1210-K0013_STD_28_20090228_0_504051x551546" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_8EF2E569-5CEA-4272-B068-04058D366864_1001_2">0.72</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_28_20100308_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_2D9B45B1-B4AF-4E13-84D8-AD29806424BF_1_5">322000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_28_20100308_0_509379x531223_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_2D9B45B1-B4AF-4E13-84D8-AD29806424BF_1001_4">223334</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_28_20100308_0_509379x624345_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_2D9B45B1-B4AF-4E13-84D8-AD29806424BF_2001_2">55834</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_28_20100308_0_509379x624346_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_2D9B45B1-B4AF-4E13-84D8-AD29806424BF_3001_3">55834</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_28_20100308_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_2D9B45B1-B4AF-4E13-84D8-AD29806424BF_4001_0">167500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE87402---1210-K0013_STD_28_20111115_0_504051x551546" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_9299150D-565A-4A38-842D-1A84013FDAF4_1002_2">5.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodGrantDateFairValue contextRef="eol_PE87402---1210-K0013_STD_28_20111115_0_504051x551546" unitRef="iso4217_USD" decimals="0" id="id_1168147_9299150D-565A-4A38-842D-1A84013FDAF4_1002_1">113000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodGrantDateFairValue>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_29_20130329_0_506663x511390_513696x501142" unitRef="iso4217_USD" decimals="0" id="id_1168147_ECA4B083-20A9-46C0-8130-AD8E950277AB_1002_1">241000</us-gaap:DividendsPreferredStock>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_29_20100129_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_A6D1D08E-BA5E-49AB-979C-C930790E6173_1_5">308000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_29_20100129_0_509379x531223_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_A6D1D08E-BA5E-49AB-979C-C930790E6173_1001_4">216667</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_29_20100129_0_509379x624345_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_A6D1D08E-BA5E-49AB-979C-C930790E6173_2001_2">54167</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_29_20100129_0_509379x624346_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_A6D1D08E-BA5E-49AB-979C-C930790E6173_3001_3">54167</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_29_20100129_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_A6D1D08E-BA5E-49AB-979C-C930790E6173_4001_0">162500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_30_20051130_0_504051x610121" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_8D03EB75-C043-486B-ABE7-23BD2254C775_1001_1">15.66</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20051130_0_504051x610121" unitRef="shares" decimals="INF" id="id_1168147_8D03EB75-C043-486B-ABE7-23BD2254C775_1001_0">834</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1210-K0013_STD_30_20051130_0_504051x610121" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_8D03EB75-C043-486B-ABE7-23BD2254C775_1001_2">8.10</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_30_20090513_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_B95C0865-F3BB-42BD-9B7B-155EC333F480_1_5">801000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20090513_0_509379x531223_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_B95C0865-F3BB-42BD-9B7B-155EC333F480_1001_4">600000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20090513_0_509379x624345_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_B95C0865-F3BB-42BD-9B7B-155EC333F480_2001_2">150000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20090513_0_509379x624346_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_B95C0865-F3BB-42BD-9B7B-155EC333F480_3001_3">150000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_30_20090513_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_B95C0865-F3BB-42BD-9B7B-155EC333F480_4001_0">450000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20101230_0" unitRef="shares" decimals="INF" id="id_1168147_EC123E1B-D5D7-4E4D-B32D-B1D6EF5867E2_1_5">500</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_30_20101230_0_513696x501142" unitRef="iso4217_USD" decimals="0" id="id_1168147_EC123E1B-D5D7-4E4D-B32D-B1D6EF5867E2_1001_3">47000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_30_20101230_0_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_EC123E1B-D5D7-4E4D-B32D-B1D6EF5867E2_1001_0">212</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1210-K0013_STD_30_20101230_0_513696x501142" unitRef="iso4217_USD_per_shares" decimals="0" id="id_1168147_EC123E1B-D5D7-4E4D-B32D-B1D6EF5867E2_1001_1">10000</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="eol_PE87402---1210-K0013_STD_30_20101230_0_513696x501142" unitRef="iso4217_USD" decimals="0" id="id_1168147_EC123E1B-D5D7-4E4D-B32D-B1D6EF5867E2_1001_2">2120000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <galt:ProceedsFromIssuanceOfPreferredStockNetOfIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_30_20101230_0_513696x501142" unitRef="iso4217_USD" decimals="0" id="id_1168147_EC123E1B-D5D7-4E4D-B32D-B1D6EF5867E2_1001_4">2073000</galt:ProceedsFromIssuanceOfPreferredStockNetOfIssuanceCosts>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_30_20040430_0_504051x624048" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_68015234-5656-43CC-A449-633134DBD901_1001_2">30.96</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuablePerMonth contextRef="eol_PE87402---1210-K0013_STD_30_20040430_0_504051x624048" unitRef="shares" decimals="0" id="id_1168147_68015234-5656-43CC-A449-633134DBD901_1001_0">834</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuablePerMonth>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuableInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20040430_0_504051x624048_504957x514053" unitRef="shares" decimals="0" id="id_1168147_68015234-5656-43CC-A449-633134DBD901_2001_1">10000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuableInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_30_20080430_0_504051x551546" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_88F2672A-F265-4C9E-92F1-A87317AA1041_1001_1">2.64</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20080430_0_504051x551546" unitRef="shares" decimals="INF" id="id_1168147_88F2672A-F265-4C9E-92F1-A87317AA1041_1001_0">8000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1210-K0013_STD_30_20080430_0_504051x551546" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_88F2672A-F265-4C9E-92F1-A87317AA1041_1001_2">2.34</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_30_20090430_0_509379x517826" unitRef="pure" decimals="4" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_3001_7">0.0176</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1210-K0013_STD_30_20090430_0_509379x517826" unitRef="pure" decimals="2" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_3001_8">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_30_20090430_0_509379x517826" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_3001_5">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20090430_0_509379x517826" unitRef="shares" decimals="INF" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_3001_2">13334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_30_20090430_0_509379x517826" unitRef="pure" decimals="2" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_3001_6">1.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1210-K0013_STD_30_20090430_0_509379x517826" unitRef="iso4217_USD" decimals="0" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_3001_4">32000</galt:IssuanceOfWarrantsValue>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_30_20100430_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_0A901237-551F-4C99-AC9B-6F8DFD11BA79_1_5">297000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20100430_0_509379x531223_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_0A901237-551F-4C99-AC9B-6F8DFD11BA79_1001_4">206667</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20100430_0_509379x624345_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_0A901237-551F-4C99-AC9B-6F8DFD11BA79_2001_2">51667</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20100430_0_509379x624346_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_0A901237-551F-4C99-AC9B-6F8DFD11BA79_3001_3">51667</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_30_20100430_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_0A901237-551F-4C99-AC9B-6F8DFD11BA79_4001_0">155000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_30_20100510_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_4204B502-6134-49E4-B7FE-157E05A156D0_1_5">536000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20100510_0_509379x531223_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_4204B502-6134-49E4-B7FE-157E05A156D0_1001_4">380000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20100510_0_509379x624345_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_4204B502-6134-49E4-B7FE-157E05A156D0_2001_2">95000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20100510_0_509379x624346_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_4204B502-6134-49E4-B7FE-157E05A156D0_3001_3">95000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_30_20100510_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_4204B502-6134-49E4-B7FE-157E05A156D0_4001_0">285000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20030630_0_504051x610120_507189x610125" unitRef="shares" decimals="INF" id="id_1168147_7DF7FF4B-569F-45E9-BD2E-590C13CB925C_1003_0">4000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1210-K0013_STD_30_20030630_0_504051x610120_507189x610125" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_7DF7FF4B-569F-45E9-BD2E-590C13CB925C_1003_3">21.00</us-gaap:EquityIssuancePerShareAmount>
  <galt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue contextRef="eol_PE87402---1210-K0013_STD_30_20030630_0_504051x610120_507189x610125" unitRef="iso4217_USD" decimals="0" id="id_1168147_7DF7FF4B-569F-45E9-BD2E-590C13CB925C_1003_2">33000</galt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestPerMonth contextRef="eol_PE87402---1210-K0013_STD_30_20030630_0_504051x610120_507189x610125" unitRef="shares" decimals="0" id="id_1168147_7DF7FF4B-569F-45E9-BD2E-590C13CB925C_1003_1">334</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestPerMonth>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_30_20090630_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_6C8D77AD-7677-49CA-833F-5CD272602624_1_5">473000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20090630_0_509379x531223_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_6C8D77AD-7677-49CA-833F-5CD272602624_1001_4">333333</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20090630_0_509379x624345_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_6C8D77AD-7677-49CA-833F-5CD272602624_2001_2">83333</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20090630_0_509379x624346_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_6C8D77AD-7677-49CA-833F-5CD272602624_3001_3">83333</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_30_20090630_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_6C8D77AD-7677-49CA-833F-5CD272602624_4001_0">250000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:PrivatePlacementNumberOfUnitsAnnounced contextRef="eol_PE87402---1210-K0013_STD_30_20020930_0" unitRef="shares" decimals="INF" id="id_1168147_97D6DB27-14C1-4A9A-B9F1-4A3694D9CE65_1_0">1666667</galt:PrivatePlacementNumberOfUnitsAnnounced>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_30_20030930_0_504051x591663" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_0719083A-24BF-4BF3-B1B0-385512E82DCD_1002_1">24.30</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20030930_0_504051x591663" unitRef="shares" decimals="INF" id="id_1168147_0719083A-24BF-4BF3-B1B0-385512E82DCD_1002_0">16667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_30_20030930_0_504051x610122" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_1EF4646D-3D5E-4BC4-A516-F35FE0189BE5_1002_1">24.30</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20030930_0_504051x610122" unitRef="shares" decimals="INF" id="id_1168147_1EF4646D-3D5E-4BC4-A516-F35FE0189BE5_1002_0">4167</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1210-K0013_STD_30_20030930_0_504051x610122" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_1EF4646D-3D5E-4BC4-A516-F35FE0189BE5_1002_2">14.64</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE87402---1210-K0013_STD_30_20031002_0_510623x531324" unitRef="iso4217_USD" decimals="0" id="id_1168147_E5203BE0-3399-442B-B3BB-0A71791AD0DC_1001_3">4041000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_30_20031002_0_510623x531324" unitRef="iso4217_USD" decimals="0" id="id_1168147_E5203BE0-3399-442B-B3BB-0A71791AD0DC_1001_4">559000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_30_20031002_0_510623x531324" unitRef="shares" decimals="INF" id="id_1168147_E5203BE0-3399-442B-B3BB-0A71791AD0DC_1001_1">219096</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20031002_0_510623x531324" unitRef="shares" decimals="INF" id="id_1168147_E5203BE0-3399-442B-B3BB-0A71791AD0DC_1001_5">109549</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:PrivatePlacementNumberOfUnitsAnnounced contextRef="eol_PE87402---1210-K0013_STD_30_20031002_0_510623x531324" unitRef="shares" decimals="INF" id="id_1168147_E5203BE0-3399-442B-B3BB-0A71791AD0DC_1001_0">238096</galt:PrivatePlacementNumberOfUnitsAnnounced>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20031002_0_510623x547978" unitRef="shares" decimals="INF" id="id_1168147_E5203BE0-3399-442B-B3BB-0A71791AD0DC_2001_7">10955</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_30_20090930_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_9106A679-B69E-4163-8FB3-08160784E3FF_1_5">305000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20090930_0_509379x531223_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_9106A679-B69E-4163-8FB3-08160784E3FF_1001_4">216666</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20090930_0_509379x624345_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_9106A679-B69E-4163-8FB3-08160784E3FF_2001_2">54166</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_30_20090930_0_509379x624346_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_9106A679-B69E-4163-8FB3-08160784E3FF_3001_3">54166</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_30_20090930_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_9106A679-B69E-4163-8FB3-08160784E3FF_4001_0">162500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:OfferingCostsPayable contextRef="eol_PE87402---1210-K0013_STD_31_20030131_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_7A2B30FB-8F42-4D2C-A7BE-3AA3C588955B_2_3">18000</galt:OfferingCostsPayable>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_31_20030131_0_504051x537581" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_8339F3A8-908E-4AD1-9652-332A06F8A6C0_1003_1">21.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20030131_0_504051x537581" unitRef="shares" decimals="INF" id="id_1168147_8339F3A8-908E-4AD1-9652-332A06F8A6C0_1003_0">16667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1210-K0013_STD_31_20030131_0_504051x537581" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_8339F3A8-908E-4AD1-9652-332A06F8A6C0_1003_4">16.80</us-gaap:EquityIssuancePerShareAmount>
  <galt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue contextRef="eol_PE87402---1210-K0013_STD_31_20030131_0_504051x537581" unitRef="iso4217_USD" decimals="0" id="id_1168147_8339F3A8-908E-4AD1-9652-332A06F8A6C0_1003_3">156000</galt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedPercentage contextRef="eol_PE87402---1210-K0013_STD_31_20030131_0_504051x537581" unitRef="pure" decimals="4" id="id_1168147_8339F3A8-908E-4AD1-9652-332A06F8A6C0_1003_2">0.3333</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedPercentage>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE87402---1210-K0013_STD_31_20040812_0_510623x531324" unitRef="iso4217_USD" decimals="0" id="id_1168147_50DF7FFA-B3A8-4741-B478-1A281CD41D5F_1001_2">5515000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_31_20040812_0_510623x531324" unitRef="iso4217_USD" decimals="0" id="id_1168147_50DF7FFA-B3A8-4741-B478-1A281CD41D5F_1001_3">485000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_31_20040812_0_510623x531324" unitRef="shares" decimals="INF" id="id_1168147_50DF7FFA-B3A8-4741-B478-1A281CD41D5F_1001_0">333334</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20040812_0_510623x531324" unitRef="shares" decimals="INF" id="id_1168147_50DF7FFA-B3A8-4741-B478-1A281CD41D5F_1001_4">333334</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20040812_0_510623x547978" unitRef="shares" decimals="INF" id="id_1168147_50DF7FFA-B3A8-4741-B478-1A281CD41D5F_2001_5">16667</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_31_20080225_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_E00CB1DB-C74F-4132-A83E-2FB087D6F812_1_3">1044000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_31_20080225_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_E00CB1DB-C74F-4132-A83E-2FB087D6F812_1_1">369000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_31_20080225_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_E00CB1DB-C74F-4132-A83E-2FB087D6F812_1_0">3381000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_31_20080225_0" unitRef="shares" decimals="INF" id="id_1168147_06B4A6DA-1335-46D0-9255-D5E4599DC8D6_1_0">1250000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:StockIssuedIssuanceCostsWarrantsIssuedForAgentsFairValue contextRef="eol_PE87402---1210-K0013_STD_31_20080225_0" unitRef="iso4217_USD" decimals="INF" id="id_1168147_E00CB1DB-C74F-4132-A83E-2FB087D6F812_1_2">56000</galt:StockIssuedIssuanceCostsWarrantsIssuedForAgentsFairValue>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20080225_0_509379x517822" unitRef="shares" decimals="INF" id="id_1168147_06B4A6DA-1335-46D0-9255-D5E4599DC8D6_1001_3">1250000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20080225_0_509379x517822_510623x547978" unitRef="shares" decimals="INF" id="id_1168147_06B4A6DA-1335-46D0-9255-D5E4599DC8D6_2001_7">34375</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20080225_0_509379x517823" unitRef="shares" decimals="INF" id="id_1168147_06B4A6DA-1335-46D0-9255-D5E4599DC8D6_3001_5">500000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_31_20080225_0_509379x517824" unitRef="pure" decimals="4" id="id_1168147_E00CB1DB-C74F-4132-A83E-2FB087D6F812_1001_8">0.0294</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_31_20080225_0_509379x517824" unitRef="pure" decimals="2" id="id_1168147_E00CB1DB-C74F-4132-A83E-2FB087D6F812_1001_9">0.95</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsExpectedTerm contextRef="eol_PE87402---1210-K0013_STD_31_20080225_0_509379x517824" id="id_1168147_E00CB1DB-C74F-4132-A83E-2FB087D6F812_1001_6">P5Y</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_31_20080225_0_509379x517825" unitRef="pure" decimals="4" id="id_1168147_E00CB1DB-C74F-4132-A83E-2FB087D6F812_2001_12">0.0213</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_31_20080225_0_509379x517825" unitRef="pure" decimals="2" id="id_1168147_E00CB1DB-C74F-4132-A83E-2FB087D6F812_2001_13">0.95</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsExpectedTerm contextRef="eol_PE87402---1210-K0013_STD_31_20080225_0_509379x517825" id="id_1168147_E00CB1DB-C74F-4132-A83E-2FB087D6F812_2001_10">P4M</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_31_20090212_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_AFD2EEDC-169B-471F-B627-62AF28222E1C_1_5">1548000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <galt:ClassOfWarrantOrRightIssuable contextRef="eol_PE87402---1210-K0013_STD_31_20090212_0" unitRef="shares" decimals="INF" id="id_1168147_2F78167B-BF5C-4605-ACDD-6696A8DC798E_1_3">6000000</galt:ClassOfWarrantOrRightIssuable>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20090212_0_509379x531223_513696x516922" unitRef="shares" decimals="INF" id="id_1168147_AFD2EEDC-169B-471F-B627-62AF28222E1C_1001_4">1200000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20090212_0_509379x624345_513696x516922" unitRef="shares" decimals="INF" id="id_1168147_AFD2EEDC-169B-471F-B627-62AF28222E1C_2001_2">300000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20090212_0_509379x624346_513696x516922" unitRef="shares" decimals="INF" id="id_1168147_AFD2EEDC-169B-471F-B627-62AF28222E1C_3001_3">300000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:StockIssuableValue contextRef="eol_PE87402---1210-K0013_STD_31_20090212_0_513696x511225" unitRef="iso4217_USD" decimals="-5" id="id_1168147_2F78167B-BF5C-4605-ACDD-6696A8DC798E_1001_1">6000000</galt:StockIssuableValue>
  <galt:StockIssuableShares contextRef="eol_PE87402---1210-K0013_STD_31_20090212_0_513696x511225" unitRef="shares" decimals="0" id="id_1168147_2F78167B-BF5C-4605-ACDD-6696A8DC798E_1001_0">3000000</galt:StockIssuableShares>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_31_20090212_0_513696x516922" unitRef="shares" decimals="INF" id="id_1168147_AFD2EEDC-169B-471F-B627-62AF28222E1C_4001_0">900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_31_20090812_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_39C98554-DA99-49AD-8F70-911757D237B4_1_5">287000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20090812_0_509379x531223_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_39C98554-DA99-49AD-8F70-911757D237B4_1001_4">200000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20090812_0_509379x624345_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_39C98554-DA99-49AD-8F70-911757D237B4_2001_2">50000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20090812_0_509379x624346_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_39C98554-DA99-49AD-8F70-911757D237B4_3001_3">50000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_31_20090812_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_39C98554-DA99-49AD-8F70-911757D237B4_4001_0">150000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:CommonStockOptionsGrantedShares contextRef="eol_PE87402---1210-K0013_STD_31_20120531_0_504051x551546" unitRef="shares" decimals="0" id="id_1168147_8F14530E-792B-46FA-BDEE-030E67C0FE1C_1001_0">7000</galt:CommonStockOptionsGrantedShares>
  <galt:FairMarketValueOfShares contextRef="eol_PE87402---1210-K0013_STD_31_20120531_0_504051x551546" unitRef="iso4217_USD" decimals="0" id="id_1168147_8F14530E-792B-46FA-BDEE-030E67C0FE1C_1001_1">16000</galt:FairMarketValueOfShares>
  <us-gaap:LeaseAndRentalExpense contextRef="eol_PE87402---1210-K0013_STD_31_20120831_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_6E7DAA45-FFFD-47F2-977F-C61BE78D58FE_1_0">44000</us-gaap:LeaseAndRentalExpense>
  <galt:OperatingLeaseMaturityPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20120831_0" id="id_1168147_6E7DAA45-FFFD-47F2-977F-C61BE78D58FE_1_1">P1Y</galt:OperatingLeaseMaturityPeriod>
  <galt:CommonStockOptionsGrantedShares contextRef="eol_PE87402---1210-K0013_STD_31_20120831_0_504051x551546" unitRef="shares" decimals="0" id="id_1168147_00B6C043-9C52-4014-8ECB-268C8A6FFAB6_1001_0">4348</galt:CommonStockOptionsGrantedShares>
  <galt:FairMarketValueOfShares contextRef="eol_PE87402---1210-K0013_STD_31_20120831_0_504051x551546" unitRef="iso4217_USD" decimals="0" id="id_1168147_00B6C043-9C52-4014-8ECB-268C8A6FFAB6_1001_1">10000</galt:FairMarketValueOfShares>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_31_20020331_0_504051x610120_507189x610124" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_2C4093D6-7A65-4E02-952E-760F77A26761_1001_1">21.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20020331_0_504051x610120_507189x610124" unitRef="shares" decimals="INF" id="id_1168147_2C4093D6-7A65-4E02-952E-760F77A26761_1001_2">4000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1210-K0013_STD_31_20020331_0_504051x610120_507189x610124" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_2C4093D6-7A65-4E02-952E-760F77A26761_1001_5">12.96</us-gaap:EquityIssuancePerShareAmount>
  <galt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue contextRef="eol_PE87402---1210-K0013_STD_31_20020331_0_504051x610120_507189x610124" unitRef="iso4217_USD" decimals="0" id="id_1168147_2C4093D6-7A65-4E02-952E-760F77A26761_1001_4">11000</galt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantPerMonth contextRef="eol_PE87402---1210-K0013_STD_31_20020331_0_504051x610120_507189x610124" unitRef="shares" decimals="0" id="id_1168147_2C4093D6-7A65-4E02-952E-760F77A26761_1001_0">334</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantPerMonth>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestPerMonth contextRef="eol_PE87402---1210-K0013_STD_31_20020331_0_504051x610120_507189x610124" unitRef="shares" decimals="0" id="id_1168147_2C4093D6-7A65-4E02-952E-760F77A26761_1001_3">334</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestPerMonth>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_31_20040331_0_504051x624048" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_F672F132-C066-4CA5-805C-25674FACF7AB_1003_3">34.80</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestPerMonth contextRef="eol_PE87402---1210-K0013_STD_31_20040331_0_504051x624048" unitRef="shares" decimals="0" id="id_1168147_F672F132-C066-4CA5-805C-25674FACF7AB_1003_1">834</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestPerMonth>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuableInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20040331_0_504051x624048_504957x514053" unitRef="shares" decimals="0" id="id_1168147_F672F132-C066-4CA5-805C-25674FACF7AB_2003_2">16667</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuableInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20040331_0_504051x624048_508454x506554" unitRef="shares" decimals="INF" id="id_1168147_F672F132-C066-4CA5-805C-25674FACF7AB_5003_0">4167</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_31_20060331_0_504051x551546" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_E5FB5C6C-AD14-483D-8FBA-71794D43F58E_1001_2">22.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20060331_0_504051x551546" unitRef="shares" decimals="INF" id="id_1168147_E5FB5C6C-AD14-483D-8FBA-71794D43F58E_1001_0">2500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1210-K0013_STD_31_20060331_0_504051x551546" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_E5FB5C6C-AD14-483D-8FBA-71794D43F58E_1001_3">13.20</us-gaap:EquityIssuancePerShareAmount>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20060331_0_504051x551546" unitRef="shares" decimals="INF" id="id_1168147_E5FB5C6C-AD14-483D-8FBA-71794D43F58E_1001_1">834</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_31_20060331_0_504051x551546_508454x506554" unitRef="iso4217_USD" decimals="0" id="id_1168147_E5FB5C6C-AD14-483D-8FBA-71794D43F58E_2001_4">33000</us-gaap:ShareBasedCompensation>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20090331_0_504051x551546" unitRef="shares" decimals="INF" id="id_1168147_E5FB5C6C-AD14-483D-8FBA-71794D43F58E_1003_1">833</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_31_20100531_0_509379x537560_542884x531496" unitRef="pure" decimals="5" id="id_1168147_0DB338AE-9AE1-4EF3-BF05-53D6024143B6_1001_5">0.01610</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1210-K0013_STD_31_20100531_0_509379x537560_542884x531496" unitRef="pure" decimals="2" id="id_1168147_0DB338AE-9AE1-4EF3-BF05-53D6024143B6_1001_6">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_31_20100531_0_509379x537560_542884x531496" id="id_1168147_0DB338AE-9AE1-4EF3-BF05-53D6024143B6_1001_3">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_31_20100531_0_509379x537560_542884x531496" unitRef="pure" decimals="2" id="id_1168147_0DB338AE-9AE1-4EF3-BF05-53D6024143B6_1001_4">1.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1210-K0013_STD_31_20100531_0_509379x537560_542884x531496" unitRef="iso4217_USD" decimals="0" id="id_1168147_0DB338AE-9AE1-4EF3-BF05-53D6024143B6_1001_2">134000</galt:IssuanceOfWarrantsValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_31_20100531_0_509379x537560_542884x531497" unitRef="pure" decimals="5" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_3001_5">0.01610</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1210-K0013_STD_31_20100531_0_509379x537560_542884x531497" unitRef="pure" decimals="2" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_3001_6">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_31_20100531_0_509379x537560_542884x531497" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_3001_3">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_31_20100531_0_509379x537560_542884x531497" unitRef="pure" decimals="2" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_3001_4">1.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1210-K0013_STD_31_20100531_0_509379x537560_542884x531497" unitRef="iso4217_USD" decimals="0" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_3001_2">40000</galt:IssuanceOfWarrantsValue>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_31_20030531_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_BDD64628-D3F6-4CFF-A671-2A7B7D81FEC4_1_4">128000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="eol_PE87402---1210-K0013_STD_31_20030531_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_BDD64628-D3F6-4CFF-A671-2A7B7D81FEC4_1_3">4671000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_31_20030531_0" unitRef="shares" decimals="INF" id="id_1168147_BDD64628-D3F6-4CFF-A671-2A7B7D81FEC4_1_2">399917</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20030531_0" unitRef="shares" decimals="INF" id="id_1168147_BDD64628-D3F6-4CFF-A671-2A7B7D81FEC4_1_5">18269</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:PrivatePlacementNumberOfUnitsAnnounced contextRef="eol_PE87402---1210-K0013_STD_31_20030531_0" unitRef="shares" decimals="INF" id="id_1168147_BDD64628-D3F6-4CFF-A671-2A7B7D81FEC4_1_0">416667</galt:PrivatePlacementNumberOfUnitsAnnounced>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_31_20030531_0_504051x610121" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_5078883F-5052-4131-A8F5-C841B0058938_1003_1">21.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20030531_0_504051x610121" unitRef="shares" decimals="INF" id="id_1168147_5078883F-5052-4131-A8F5-C841B0058938_1003_0">1667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1210-K0013_STD_31_20030531_0_504051x610121" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_5078883F-5052-4131-A8F5-C841B0058938_1003_4">16.80</us-gaap:EquityIssuancePerShareAmount>
  <galt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue contextRef="eol_PE87402---1210-K0013_STD_31_20030531_0_504051x610121" unitRef="iso4217_USD" decimals="0" id="id_1168147_5078883F-5052-4131-A8F5-C841B0058938_1003_3">16000</galt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedPercentage contextRef="eol_PE87402---1210-K0013_STD_31_20030531_0_504051x610121" unitRef="pure" decimals="2" id="id_1168147_5078883F-5052-4131-A8F5-C841B0058938_1003_2">0.50</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedPercentage>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1210-K0013_STD_31_20080531_0_497730x551558" unitRef="iso4217_USD" decimals="0" id="id_1168147_CBE1E091-8750-45B6-B803-4A14093E336D_1001_1">3000</galt:IssuanceOfWarrantsValue>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20080531_0_497730x551558" unitRef="shares" decimals="INF" id="id_1168147_CBE1E091-8750-45B6-B803-4A14093E336D_1001_0">6500</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightExercisePeriod contextRef="eol_PE87402---1210-K0013_STD_31_20080531_0_497730x551558" id="id_1168147_CBE1E091-8750-45B6-B803-4A14093E336D_1001_3">P3Y</galt:ClassOfWarrantOrRightExercisePeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_31_20090531_0_509379x517827" unitRef="pure" decimals="4" id="id_1168147_6ED586FF-9B5C-4FA5-8556-BD5D5F1A6262_1001_7">0.0216</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1210-K0013_STD_31_20090531_0_509379x517827" unitRef="pure" decimals="2" id="id_1168147_6ED586FF-9B5C-4FA5-8556-BD5D5F1A6262_1001_8">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_31_20090531_0_509379x517827" id="id_1168147_6ED586FF-9B5C-4FA5-8556-BD5D5F1A6262_1001_5">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20090531_0_509379x517827" unitRef="shares" decimals="INF" id="id_1168147_6ED586FF-9B5C-4FA5-8556-BD5D5F1A6262_1001_2">74000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_31_20090531_0_509379x517827" unitRef="pure" decimals="2" id="id_1168147_6ED586FF-9B5C-4FA5-8556-BD5D5F1A6262_1001_6">1.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20090531_0_509379x517827" unitRef="shares" decimals="INF" id="id_1168147_6ED586FF-9B5C-4FA5-8556-BD5D5F1A6262_1001_3">21834</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1210-K0013_STD_31_20090531_0_509379x517827" unitRef="iso4217_USD" decimals="0" id="id_1168147_6ED586FF-9B5C-4FA5-8556-BD5D5F1A6262_1001_4">232000</galt:IssuanceOfWarrantsValue>
  <us-gaap:PreferredStockDividendRatePercentage contextRef="eol_PE87402---1210-K0013_STD_31_20110731_0" unitRef="pure" decimals="2" id="id_1168147_A36FCC98-7271-4BB3-9642-D1F0BAE37C78_1_3">0.06</us-gaap:PreferredStockDividendRatePercentage>
  <galt:DividendEquivalentRights contextRef="eol_PE87402---1210-K0013_STD_31_20110731_0" unitRef="shares" decimals="INF" id="id_1168147_A36FCC98-7271-4BB3-9642-D1F0BAE37C78_1_2">5</galt:DividendEquivalentRights>
  <galt:LeaseExtensionPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20110731_0" id="id_1168147_187E5E2E-021D-4DBC-AB2C-D9A977264A15_1_1">P1Y</galt:LeaseExtensionPeriod>
  <galt:LeaseAgreementExpirationDate contextRef="eol_PE87402---1210-K0013_STD_31_20110731_0" id="id_1168147_187E5E2E-021D-4DBC-AB2C-D9A977264A15_1_0">2012-09-30</galt:LeaseAgreementExpirationDate>
  <us-gaap:ConversionOfStockSharesIssued1 contextRef="eol_PE87402---1210-K0013_STD_31_20110731_0_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_FA147729-9C67-470F-B826-B0E2FA20D303_1001_1">8334</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:ConversionOfStockSharesConverted1 contextRef="eol_PE87402---1210-K0013_STD_31_20110731_0_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_FA147729-9C67-470F-B826-B0E2FA20D303_1001_0">5</us-gaap:ConversionOfStockSharesConverted1>
  <galt:PostConversionDividendRightsIssued contextRef="eol_PE87402---1210-K0013_STD_31_20110731_0_513696x501142" unitRef="shares" decimals="0" id="id_1168147_FA147729-9C67-470F-B826-B0E2FA20D303_1001_2">5</galt:PostConversionDividendRightsIssued>
  <us-gaap:ConversionOfStockSharesIssued1 contextRef="eol_PE87402---1210-K0013_STD_31_20110731_0_513696x501348" unitRef="shares" decimals="INF" id="id_1168147_A36FCC98-7271-4BB3-9642-D1F0BAE37C78_2001_1">8334</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="eol_PE87402---1210-K0013_STD_31_20010831_0" unitRef="shares" decimals="INF" id="id_1168147_A81E0F6C-9C6E-4EB4-86A8-78534CA58FEE_1_2">99705</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
  <us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 contextRef="eol_PE87402---1210-K0013_STD_31_20010831_0" unitRef="shares" decimals="INF" id="id_1168147_A81E0F6C-9C6E-4EB4-86A8-78534CA58FEE_1_3">93801</us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE87402---1210-K0013_STD_31_20011031_0_498429x610126" id="id_1168147_D25B9929-1B80-4EC9-8E55-9690ADD6F9E4_1002_1">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationTerm contextRef="eol_PE87402---1210-K0013_STD_31_20011031_0_498429x610126_504957x513639" id="id_1168147_D25B9929-1B80-4EC9-8E55-9690ADD6F9E4_2002_2">P3Y</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationTerm>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationTerm contextRef="eol_PE87402---1210-K0013_STD_31_20011031_0_498429x610126_504957x514053" id="id_1168147_D25B9929-1B80-4EC9-8E55-9690ADD6F9E4_3002_3">P10Y</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationTerm>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_31_20031031_0_504051x591663" unitRef="iso4217_USD" decimals="0" id="id_1168147_0719083A-24BF-4BF3-B1B0-385512E82DCD_1003_3">40000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_31_20031031_0_504051x591663" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_0719083A-24BF-4BF3-B1B0-385512E82DCD_1003_5">17.82</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ConversionOfStockSharesIssued1 contextRef="eol_PE87402---1210-K0013_STD_31_20031031_0_504051x591663" unitRef="shares" decimals="INF" id="id_1168147_0719083A-24BF-4BF3-B1B0-385512E82DCD_1003_6">2772</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE87402---1210-K0013_STD_31_20031031_0_504051x591663_507189x534240" unitRef="shares" decimals="INF" id="id_1168147_0719083A-24BF-4BF3-B1B0-385512E82DCD_2003_4">8334</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1210-K0013_STD_31_20031031_0_504051x591663_508454x506554" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_0719083A-24BF-4BF3-B1B0-385512E82DCD_3003_2">26.70</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_31_20101031_0_509379x537561" unitRef="pure" decimals="5" id="id_1168147_CF0E523E-E16B-4ABB-97BA-033347B4095C_1001_7">0.01705</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1210-K0013_STD_31_20101031_0_509379x537561" unitRef="pure" decimals="2" id="id_1168147_CF0E523E-E16B-4ABB-97BA-033347B4095C_1001_8">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_31_20101031_0_509379x537561" id="id_1168147_CF0E523E-E16B-4ABB-97BA-033347B4095C_1001_5">P4Y3M11D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20101031_0_509379x537561" unitRef="shares" decimals="INF" id="id_1168147_CF0E523E-E16B-4ABB-97BA-033347B4095C_1001_2">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_31_20101031_0_509379x537561" unitRef="pure" decimals="2" id="id_1168147_CF0E523E-E16B-4ABB-97BA-033347B4095C_1001_6">1.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <galt:LawsuitDamageClaim contextRef="eol_PE87402---1210-K0013_STD_31_20121031_0" unitRef="iso4217_USD" decimals="-5" id="id_1168147_7F5181FA-E707-4765-9B1B-AE6797B942C5_1_0">1000000</galt:LawsuitDamageClaim>
  <galt:OrganizationalAndSeparationRelatedCharges contextRef="eol_PE87402---1210-K0013_STD_31_20121031_0" unitRef="iso4217_USD" decimals="-5" id="id_1168147_DAE05C43-9226-43DF-BD06-EDD059A3C3CB_1_0">1000000</galt:OrganizationalAndSeparationRelatedCharges>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_31_20030114_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_97D6DB27-14C1-4A9A-B9F1-4A3694D9CE65_3_4">18000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="eol_PE87402---1210-K0013_STD_31_20030114_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_97D6DB27-14C1-4A9A-B9F1-4A3694D9CE65_3_3">1070000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_31_20030114_0" unitRef="shares" decimals="INF" id="id_1168147_97D6DB27-14C1-4A9A-B9F1-4A3694D9CE65_3_2">181334</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="eol_PE87402---1210-K0013_STD_31_20030114_0_504296x533527" unitRef="iso4217_USD" decimals="INF" id="id_1168147_35EFCD9A-0255-4802-96BD-B42D0201D705_1003_2">27000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_31_20030114_0_504296x624055" unitRef="iso4217_USD" decimals="0" id="id_1168147_DA2F657E-1733-4A38-A479-6445B98C7217_1002_2">3000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_31_20071231_0_504051x551546" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_AA68E613-5A56-4724-BE30-311E7867F3AD_1001_1">3.78</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_31_20071231_0_504051x551546" unitRef="shares" decimals="INF" id="id_1168147_AA68E613-5A56-4724-BE30-311E7867F3AD_1001_0">834</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1210-K0013_STD_31_20071231_0_504051x551546" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_AA68E613-5A56-4724-BE30-311E7867F3AD_1001_2">2.76</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_31_20101231_0_509379x588296_542884x531496" unitRef="pure" decimals="3" id="id_1168147_7FA0AC05-137E-41EC-BF5E-DC2401FC30A5_1001_5">0.019</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1210-K0013_STD_31_20101231_0_509379x588296_542884x531496" unitRef="pure" decimals="2" id="id_1168147_7FA0AC05-137E-41EC-BF5E-DC2401FC30A5_1001_6">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_31_20101231_0_509379x588296_542884x531496" id="id_1168147_7FA0AC05-137E-41EC-BF5E-DC2401FC30A5_1001_3">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_31_20101231_0_509379x588296_542884x531496" unitRef="pure" decimals="2" id="id_1168147_7FA0AC05-137E-41EC-BF5E-DC2401FC30A5_1001_4">1.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1210-K0013_STD_31_20101231_0_509379x588296_542884x531496" unitRef="iso4217_USD" decimals="0" id="id_1168147_7FA0AC05-137E-41EC-BF5E-DC2401FC30A5_1001_2">112000</galt:IssuanceOfWarrantsValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_31_20101231_0_509379x588296_542884x531497" unitRef="pure" decimals="4" id="id_1168147_952DBBC3-4DBA-40F1-BDD3-B9F631CF015D_1001_5">0.0206</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1210-K0013_STD_31_20101231_0_509379x588296_542884x531497" unitRef="pure" decimals="2" id="id_1168147_952DBBC3-4DBA-40F1-BDD3-B9F631CF015D_1001_6">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_31_20101231_0_509379x588296_542884x531497" id="id_1168147_952DBBC3-4DBA-40F1-BDD3-B9F631CF015D_1001_3">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_31_20101231_0_509379x588296_542884x531497" unitRef="pure" decimals="2" id="id_1168147_952DBBC3-4DBA-40F1-BDD3-B9F631CF015D_1001_4">1.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1210-K0013_STD_31_20101231_0_509379x588296_542884x531497" unitRef="iso4217_USD" decimals="0" id="id_1168147_952DBBC3-4DBA-40F1-BDD3-B9F631CF015D_1001_2">2000</galt:IssuanceOfWarrantsValue>
  <us-gaap:ConversionOfStockSharesIssued1 contextRef="eol_PE87402---1210-K0013_STD_31_20130131_0_506663x511390_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_FA147729-9C67-470F-B826-B0E2FA20D303_1002_1">8334</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:ConversionOfStockSharesConverted1 contextRef="eol_PE87402---1210-K0013_STD_31_20130131_0_506663x511390_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_FA147729-9C67-470F-B826-B0E2FA20D303_1002_0">5</us-gaap:ConversionOfStockSharesConverted1>
  <galt:PostConversionDividendRightsIssued contextRef="eol_PE87402---1210-K0013_STD_31_20130131_0_506663x511390_513696x501142" unitRef="shares" decimals="0" id="id_1168147_FA147729-9C67-470F-B826-B0E2FA20D303_1002_2">5</galt:PostConversionDividendRightsIssued>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1210-K0013_STD_32_20080702_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_03139DDB-C281-48DE-AEFE-F5D7E2AC3029_1_4">20000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="eol_PE87402---1210-K0013_STD_32_20080702_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_03139DDB-C281-48DE-AEFE-F5D7E2AC3029_1_1">20000</us-gaap:ProceedsFromIssuanceOfWarrants>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_32_20080702_0" unitRef="shares" decimals="INF" id="id_1168147_03139DDB-C281-48DE-AEFE-F5D7E2AC3029_1_0">50000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_34_20091208_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_388B2B43-4C03-404C-A6C7-AF780089BD36_1_5">310000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_34_20091208_0_509379x531223_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_388B2B43-4C03-404C-A6C7-AF780089BD36_1001_4">216667</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_34_20091208_0_509379x624345_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_388B2B43-4C03-404C-A6C7-AF780089BD36_2001_2">54167</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_34_20091208_0_509379x624346_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_388B2B43-4C03-404C-A6C7-AF780089BD36_3001_3">54167</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_34_20091208_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_388B2B43-4C03-404C-A6C7-AF780089BD36_4001_0">162500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_35_20080204_0" unitRef="pure" decimals="4" id="id_1168147_1DFED9B8-9083-4FA3-AA98-28025451C0A0_3_9">0.0251</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_35_20080204_0" unitRef="pure" decimals="2" id="id_1168147_1DFED9B8-9083-4FA3-AA98-28025451C0A0_3_10">0.95</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_35_20080204_0" unitRef="shares" decimals="INF" id="id_1168147_1DFED9B8-9083-4FA3-AA98-28025451C0A0_3_6">1400</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClosingStockPriceOfCommonStock contextRef="eol_PE87402---1210-K0013_STD_35_20080204_0_504957x513639_513696x498640" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_F4E3F57A-F250-4D3C-9FEC-E08C3A924BBC_1001_1">18.00</galt:ClosingStockPriceOfCommonStock>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1210-K0013_STD_35_20080204_0_507189x517783_513696x498640" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_788AD345-0F59-42B7-A37E-DBFD3D632D69_1001_4">9.00</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1210-K0013_STD_35_20080204_0_507189x517784_513696x498640" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_788AD345-0F59-42B7-A37E-DBFD3D632D69_2001_5">12.00</us-gaap:EquityIssuancePerShareAmount>
  <galt:DividendPaymentDateDayAndMonth contextRef="eol_PE87402---1210-K0013_STD_35_20080204_0_507189x538000_513696x498640" id="id_1168147_788AD345-0F59-42B7-A37E-DBFD3D632D69_3001_10">--09-30</galt:DividendPaymentDateDayAndMonth>
  <galt:DividendPaymentDateDayAndMonth contextRef="eol_PE87402---1210-K0013_STD_35_20080204_0_507189x538001_513696x498640" id="id_1168147_788AD345-0F59-42B7-A37E-DBFD3D632D69_4001_9">--03-30</galt:DividendPaymentDateDayAndMonth>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_35_20080204_0_509379x507958" unitRef="iso4217_USD" decimals="0" id="id_1168147_1DFED9B8-9083-4FA3-AA98-28025451C0A0_3003_5">3000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:PreferredStockDividendRatePercentage contextRef="eol_PE87402---1210-K0013_STD_35_20080204_0_513696x498640" unitRef="pure" decimals="2" id="id_1168147_788AD345-0F59-42B7-A37E-DBFD3D632D69_5001_0">0.12</us-gaap:PreferredStockDividendRatePercentage>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_35_20080204_0_513696x498640" unitRef="iso4217_USD" decimals="0" id="id_1168147_1DFED9B8-9083-4FA3-AA98-28025451C0A0_4003_3">52000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_35_20080204_0_513696x498640" unitRef="iso4217_USD" decimals="0" id="id_1168147_1DFED9B8-9083-4FA3-AA98-28025451C0A0_4003_4">1691000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1210-K0013_STD_35_20080204_0_513696x498640" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_788AD345-0F59-42B7-A37E-DBFD3D632D69_5001_1">6.00</us-gaap:EquityIssuancePerShareAmount>
  <galt:NumberOfSharesInEachUnit contextRef="eol_PE87402---1210-K0013_STD_35_20080204_0_513696x498640" unitRef="shares" decimals="0" id="id_1168147_788AD345-0F59-42B7-A37E-DBFD3D632D69_5001_2">1</galt:NumberOfSharesInEachUnit>
  <galt:NumberOfWarrantsInEachUnit contextRef="eol_PE87402---1210-K0013_STD_35_20080204_0_513696x498640" unitRef="shares" decimals="0" id="id_1168147_788AD345-0F59-42B7-A37E-DBFD3D632D69_5001_3">1</galt:NumberOfWarrantsInEachUnit>
  <galt:PercentageOfWeightedAverageStockPriceForDividendsPriorToPaymentDate contextRef="eol_PE87402---1210-K0013_STD_35_20080204_0_513696x498640" unitRef="pure" decimals="2" id="id_1168147_788AD345-0F59-42B7-A37E-DBFD3D632D69_5001_7">1.00</galt:PercentageOfWeightedAverageStockPriceForDividendsPriorToPaymentDate>
  <galt:ShareConversionRatio contextRef="eol_PE87402---1210-K0013_STD_35_20080204_0_513696x498640" unitRef="pure" decimals="4" id="id_1168147_F4E3F57A-F250-4D3C-9FEC-E08C3A924BBC_2001_0">0.1667</galt:ShareConversionRatio>
  <galt:NumberOfConsecutiveTradingDaysForConversionOfPreferredStock contextRef="eol_PE87402---1210-K0013_STD_35_20080204_0_513696x498640" id="id_1168147_F4E3F57A-F250-4D3C-9FEC-E08C3A924BBC_2001_2">P15D</galt:NumberOfConsecutiveTradingDaysForConversionOfPreferredStock>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_35_20091104_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_F7A01913-F2CB-4C70-85B5-28AEB5496597_1_5">296000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_35_20091104_0_509379x531223_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_F7A01913-F2CB-4C70-85B5-28AEB5496597_1001_4">206666</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_35_20091104_0_509379x624345_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_F7A01913-F2CB-4C70-85B5-28AEB5496597_2001_2">51666</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_35_20091104_0_509379x624346_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_F7A01913-F2CB-4C70-85B5-28AEB5496597_3001_3">51666</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_35_20091104_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_F7A01913-F2CB-4C70-85B5-28AEB5496597_4001_0">155000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_35_20080331_0_504051x551546" unitRef="shares" decimals="INF" id="id_1168147_E5FB5C6C-AD14-483D-8FBA-71794D43F58E_1002_1">833</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_365_20011231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_E2B0A2E5-4879-4958-82A2-6685DFDC2EB3_1_2">17000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="eol_PE87402---1210-K0013_STD_365_20011231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_E2B0A2E5-4879-4958-82A2-6685DFDC2EB3_1_1">2221000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_365_20011231_0" unitRef="shares" decimals="INF" id="id_1168147_E2B0A2E5-4879-4958-82A2-6685DFDC2EB3_1_0">114884</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20011231_0_504051x610120_508454x506554_575189x610123" unitRef="iso4217_USD" decimals="0" id="id_1168147_34A26872-1178-4D13-9D23-E91DA4F0BEF9_1003_4">147000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_365_20011231_0_504051x610120_575189x610123" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_34A26872-1178-4D13-9D23-E91DA4F0BEF9_2003_1">21.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20011231_0_504051x610120_575189x610123" unitRef="iso4217_USD" decimals="0" id="id_1168147_34A26872-1178-4D13-9D23-E91DA4F0BEF9_2003_2">239000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20011231_0_504051x610120_575189x610123" unitRef="shares" decimals="INF" id="id_1168147_34A26872-1178-4D13-9D23-E91DA4F0BEF9_2003_0">33334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE87402---1210-K0013_STD_365_20011231_0_504051x610120_575189x610123" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_34A26872-1178-4D13-9D23-E91DA4F0BEF9_2003_3">13.68</us-gaap:EquityIssuancePerShareAmount>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20011231_0_509379x517820" unitRef="shares" decimals="INF" id="id_1168147_E2B0A2E5-4879-4958-82A2-6685DFDC2EB3_1001_3">56534</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20011231_0_509379x517821" unitRef="shares" decimals="INF" id="id_1168147_E2B0A2E5-4879-4958-82A2-6685DFDC2EB3_2001_4">58350</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_365_20021231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_97D6DB27-14C1-4A9A-B9F1-4A3694D9CE65_2_4">212000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="eol_PE87402---1210-K0013_STD_365_20021231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_97D6DB27-14C1-4A9A-B9F1-4A3694D9CE65_2_3">2861000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_365_20021231_0" unitRef="shares" decimals="INF" id="id_1168147_97D6DB27-14C1-4A9A-B9F1-4A3694D9CE65_2_2">537227</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20021231_0" unitRef="shares" decimals="INF" id="id_1168147_A031F127-3B2B-4069-A99E-61FC9FFBCA32_1_0">18334</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20021231_0_504051x610120_507189x610124" unitRef="shares" decimals="INF" id="id_1168147_2C4093D6-7A65-4E02-952E-760F77A26761_1002_7">3334</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20021231_0_504051x610120_507189x610124_508454x506554" unitRef="iso4217_USD" decimals="0" id="id_1168147_2C4093D6-7A65-4E02-952E-760F77A26761_2002_6">41000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20021231_0_504051x610120_508454x506554_575189x610123" unitRef="iso4217_USD" decimals="0" id="id_1168147_34A26872-1178-4D13-9D23-E91DA4F0BEF9_1002_4">64000</us-gaap:ShareBasedCompensation>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE87402---1210-K0013_STD_365_20021231_0_512768x531939" unitRef="iso4217_USD" decimals="0" id="id_1168147_BF863662-0B06-4CD8-953A-B2392714FC4F_1002_2">602000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_365_20021231_0_512768x531939" unitRef="iso4217_USD" decimals="0" id="id_1168147_BF863662-0B06-4CD8-953A-B2392714FC4F_1002_3">49000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_365_20021231_0_512768x531939" unitRef="shares" decimals="INF" id="id_1168147_BF863662-0B06-4CD8-953A-B2392714FC4F_1002_1">31000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments contextRef="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x537581" unitRef="iso4217_USD" decimals="0" id="id_1168147_8339F3A8-908E-4AD1-9652-332A06F8A6C0_1002_5">82000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x537581_508454x506554" unitRef="iso4217_USD" decimals="0" id="id_1168147_8339F3A8-908E-4AD1-9652-332A06F8A6C0_2002_6">193000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x591663" unitRef="iso4217_USD" decimals="0" id="id_1168147_0719083A-24BF-4BF3-B1B0-385512E82DCD_1001_3">74000</us-gaap:ShareBasedCompensation>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments contextRef="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x610120_507189x610125" unitRef="iso4217_USD" decimals="0" id="id_1168147_7DF7FF4B-569F-45E9-BD2E-590C13CB925C_1002_4">21000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x610120_507189x610125_508454x514283" unitRef="iso4217_USD" decimals="0" id="id_1168147_7DF7FF4B-569F-45E9-BD2E-590C13CB925C_2002_5">40000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x610120_508454x506554_575189x610123" unitRef="iso4217_USD" decimals="0" id="id_1168147_34A26872-1178-4D13-9D23-E91DA4F0BEF9_1001_4">71000</us-gaap:ShareBasedCompensation>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments contextRef="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x610121" unitRef="iso4217_USD" decimals="0" id="id_1168147_5078883F-5052-4131-A8F5-C841B0058938_1002_5">6000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x610121_508454x506554" unitRef="iso4217_USD" decimals="0" id="id_1168147_5078883F-5052-4131-A8F5-C841B0058938_2002_6">13000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x610122_508454x506554" unitRef="iso4217_USD" decimals="0" id="id_1168147_1EF4646D-3D5E-4BC4-A516-F35FE0189BE5_2001_3">122000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x624048_507189x624046_508454x506554" unitRef="iso4217_USD" decimals="0" id="id_1168147_F672F132-C066-4CA5-805C-25674FACF7AB_3002_4">29000</us-gaap:ShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="eol_PE87402---1210-K0013_STD_365_20031231_0_504296x533527" unitRef="shares" decimals="INF" id="id_1168147_35EFCD9A-0255-4802-96BD-B42D0201D705_1002_1">350</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="eol_PE87402---1210-K0013_STD_365_20031231_0_504296x533527" unitRef="iso4217_USD" decimals="INF" id="id_1168147_35EFCD9A-0255-4802-96BD-B42D0201D705_1002_2">6000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="eol_PE87402---1210-K0013_STD_365_20031231_0_504296x624057" unitRef="shares" decimals="INF" id="id_1168147_20C940DC-96D2-4CCF-A3D8-818DEECA181B_1002_1">4226</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20031231_0_508454x506554" unitRef="shares" decimals="INF" id="id_1168147_F672F132-C066-4CA5-805C-25674FACF7AB_6002_6">2500</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20051231_0_504051x610121_508454x506554" unitRef="iso4217_USD" decimals="0" id="id_1168147_8D03EB75-C043-486B-ABE7-23BD2254C775_2002_3">7000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20051231_0_504051x624048" unitRef="iso4217_USD" decimals="0" id="id_1168147_68015234-5656-43CC-A449-633134DBD901_1003_5">14000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20051231_0_504051x624048" unitRef="shares" decimals="INF" id="id_1168147_68015234-5656-43CC-A449-633134DBD901_1003_4">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20051231_0_504051x624048" unitRef="shares" decimals="INF" id="id_1168147_68015234-5656-43CC-A449-633134DBD901_1003_3">2500</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20071231_0_504051x551546_508454x506554" unitRef="iso4217_USD" decimals="0" id="id_1168147_AA68E613-5A56-4724-BE30-311E7867F3AD_2002_3">2000</us-gaap:ShareBasedCompensation>
  <galt:ProceedsFromSubscriptionAdvances contextRef="eol_PE87402---1210-K0013_STD_365_20071231_0_507189x517065_513696x498640" unitRef="iso4217_USD" decimals="INF" id="id_1168147_1DFED9B8-9083-4FA3-AA98-28025451C0A0_1001_0">1667500</galt:ProceedsFromSubscriptionAdvances>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20091231_0_504051x537581" unitRef="shares" decimals="INF" id="id_1168147_B6046651-3CD4-4826-9111-AB646796397B_1001_0">416670</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE87402---1210-K0013_STD_365_20091231_0_504051x537581" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_B6046651-3CD4-4826-9111-AB646796397B_1001_3">1.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodGrantDateFairValue contextRef="eol_PE87402---1210-K0013_STD_365_20091231_0_504051x537581" unitRef="iso4217_USD" decimals="0" id="id_1168147_B6046651-3CD4-4826-9111-AB646796397B_1001_2">450000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodGrantDateFairValue>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20091231_0_504051x551546_508454x506554" unitRef="iso4217_USD" decimals="0" id="id_1168147_8EF2E569-5CEA-4272-B068-04058D366864_2002_3">24000</us-gaap:ShareBasedCompensation>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_365_20091231_0_504957x513639_513696x516923" unitRef="pure" decimals="4" id="id_1168147_639297F8-479A-4F09-899B-F2FB629F7A96_1002_4">0.0198</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_365_20091231_0_504957x513639_513696x516923" unitRef="pure" decimals="2" id="id_1168147_639297F8-479A-4F09-899B-F2FB629F7A96_1002_2">1.24</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_365_20091231_0_504957x514053_513696x516923" unitRef="pure" decimals="4" id="id_1168147_639297F8-479A-4F09-899B-F2FB629F7A96_2002_5">0.0270</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_365_20091231_0_504957x514053_513696x516923" unitRef="pure" decimals="2" id="id_1168147_639297F8-479A-4F09-899B-F2FB629F7A96_2002_3">1.27</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_365_20091231_0_505872x508619_513696x516923" unitRef="iso4217_USD" decimals="0" id="id_1168147_639297F8-479A-4F09-899B-F2FB629F7A96_3002_7">1732000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_365_20091231_0_505872x531897_513696x516923" unitRef="iso4217_USD" decimals="0" id="id_1168147_EF1E9DD3-2507-4271-B539-8CD4475A279C_1002_0">628000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_365_20091231_0_513696x516922" unitRef="iso4217_USD" decimals="0" id="id_1168147_6C2DD29A-4746-424F-AD9E-E6723EC9B859_1003_6">1548000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_365_20091231_0_513696x516922" unitRef="shares" decimals="INF" id="id_1168147_6C2DD29A-4746-424F-AD9E-E6723EC9B859_1003_7">900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1210-K0013_STD_365_20091231_0_513696x516923" unitRef="pure" decimals="2" id="id_1168147_639297F8-479A-4F09-899B-F2FB629F7A96_4002_6">0.00</us-gaap:FairValueAssumptionsExpectedDividendRate>
  <us-gaap:FairValueAssumptionsExpectedTerm contextRef="eol_PE87402---1210-K0013_STD_365_20091231_0_513696x516923" id="id_1168147_639297F8-479A-4F09-899B-F2FB629F7A96_4002_1">P5Y</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_365_20091231_0_513696x516923" unitRef="iso4217_USD" decimals="0" id="id_1168147_6C2DD29A-4746-424F-AD9E-E6723EC9B859_2003_4">2472000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_365_20091231_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_6C2DD29A-4746-424F-AD9E-E6723EC9B859_2003_5">1330000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromGrantors contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_EE087CD3-D31B-4C07-A37A-254A842E17EE_1_1">255000</us-gaap:ProceedsFromGrantors>
  <us-gaap:OtherNonoperatingIncome contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_EE087CD3-D31B-4C07-A37A-254A842E17EE_1_0">489000</us-gaap:OtherNonoperatingIncome>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_504051x537581" unitRef="shares" decimals="INF" id="id_1168147_B6046651-3CD4-4826-9111-AB646796397B_1002_1">26042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_504957x513639_509379x537560_542884x531497" unitRef="pure" decimals="4" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_1003_14">0.0051</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_504957x513639_509379x537560_542884x531497" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_1003_10">P3Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_504957x513639_509379x537560_542884x531497" unitRef="pure" decimals="2" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_1003_12">1.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_504957x513639_513696x516923" unitRef="pure" decimals="4" id="id_1168147_639297F8-479A-4F09-899B-F2FB629F7A96_1001_4">0.0227</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_504957x513639_513696x516923" unitRef="pure" decimals="2" id="id_1168147_639297F8-479A-4F09-899B-F2FB629F7A96_1001_2">1.26</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_504957x514053_509379x537560_542884x531497" unitRef="pure" decimals="4" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_2003_15">0.0168</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_504957x514053_509379x537560_542884x531497" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_2003_11">P3Y11M27D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_504957x514053_509379x537560_542884x531497" unitRef="pure" decimals="2" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_2003_13">1.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_504957x514053_513696x516923" unitRef="pure" decimals="4" id="id_1168147_639297F8-479A-4F09-899B-F2FB629F7A96_2001_5">0.0243</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_504957x514053_513696x516923" unitRef="pure" decimals="2" id="id_1168147_639297F8-479A-4F09-899B-F2FB629F7A96_2001_3">1.29</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_505872x508619_513696x516923" unitRef="iso4217_USD" decimals="0" id="id_1168147_639297F8-479A-4F09-899B-F2FB629F7A96_3001_7">1028000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_505872x531897_513696x516923" unitRef="iso4217_USD" decimals="0" id="id_1168147_EF1E9DD3-2507-4271-B539-8CD4475A279C_1001_0">388000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_507189x599318_509379x517826" unitRef="pure" decimals="4" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_1002_13">0.0169</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_507189x599318_509379x517826" unitRef="pure" decimals="2" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_1002_14">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_507189x599318_509379x517826" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_1002_11">P3Y22D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_507189x599318_509379x517826" unitRef="shares" decimals="INF" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_1002_9">8334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_507189x599318_509379x517826" unitRef="pure" decimals="2" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_1002_12">1.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_507189x599318_509379x517826" unitRef="iso4217_USD" decimals="0" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_1002_10">16000</galt:IssuanceOfWarrantsValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_507189x599319_509379x517826" unitRef="pure" decimals="4" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_2002_19">0.0061</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_507189x599319_509379x517826" unitRef="pure" decimals="2" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_2002_20">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_507189x599319_509379x517826" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_2002_17">P2Y3M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_507189x599319_509379x517826" unitRef="pure" decimals="2" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_2002_18">1.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_507189x599319_509379x517826" unitRef="iso4217_USD" decimals="0" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_2002_16">124000</galt:IssuanceOfWarrantsValue>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_509379x517826" unitRef="iso4217_USD" decimals="0" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_3002_26">111000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_509379x517827" unitRef="iso4217_USD" decimals="0" id="id_1168147_6ED586FF-9B5C-4FA5-8556-BD5D5F1A6262_1002_9">53000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_509379x517827" unitRef="shares" decimals="INF" id="id_1168147_6ED586FF-9B5C-4FA5-8556-BD5D5F1A6262_1002_10">74000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_509379x517827" unitRef="shares" decimals="INF" id="id_1168147_6ED586FF-9B5C-4FA5-8556-BD5D5F1A6262_1002_11">21834</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_509379x537560_542884x531496" unitRef="iso4217_USD" decimals="0" id="id_1168147_0DB338AE-9AE1-4EF3-BF05-53D6024143B6_1002_7">134000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_509379x537560_542884x531497" unitRef="pure" decimals="2" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_3003_16">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_509379x537560_542884x531497" unitRef="iso4217_USD" decimals="0" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_3003_17">15000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_509379x537561" unitRef="iso4217_USD" decimals="0" id="id_1168147_CF0E523E-E16B-4ABB-97BA-033347B4095C_1003_9">219000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_509379x588296_542884x531496" unitRef="iso4217_USD" decimals="0" id="id_1168147_7FA0AC05-137E-41EC-BF5E-DC2401FC30A5_1002_7">112000</us-gaap:ShareBasedCompensation>
  <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_513696x516923" unitRef="pure" decimals="2" id="id_1168147_639297F8-479A-4F09-899B-F2FB629F7A96_4001_6">0.00</us-gaap:FairValueAssumptionsExpectedDividendRate>
  <us-gaap:FairValueAssumptionsExpectedTerm contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_513696x516923" id="id_1168147_639297F8-479A-4F09-899B-F2FB629F7A96_4001_1">P5Y</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_513696x516923" unitRef="iso4217_USD" decimals="0" id="id_1168147_6C2DD29A-4746-424F-AD9E-E6723EC9B859_2002_4">1463000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_365_20101231_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_6C2DD29A-4746-424F-AD9E-E6723EC9B859_2002_5">770000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="pure" decimals="4" id="id_1168147_E83B26F4-E3A6-4973-A21B-1379180C02C0_2_0">0.0190</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_1BB73C8E-496F-4888-A849-1C50DCD0B7CA_2_5">1174000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_2_4">-10409000</us-gaap:OperatingIncomeLoss>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_4013_1600003">54000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_4013_1600018">3245000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="pure" decimals="2" id="id_1168147_E83B26F4-E3A6-4973-A21B-1379180C02C0_2_3">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_2_4">3245000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_DD7E11D3-E508-4A68-939D-30C68D6D67C1_4001_3">7.02</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_1168147_978BDCCB-1131-4951-BEF4-C79D4419A824_2_4">0.034</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_DD7E11D3-E508-4A68-939D-30C68D6D67C1_4001_4">8.93</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_2_12">1273000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInRestrictedCash contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_2_17">10000</us-gaap:IncreaseDecreaseInRestrictedCash>
  <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_2_13">-12000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_2_16">-1.06</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_1BB73C8E-496F-4888-A849-1C50DCD0B7CA_2_0">216443</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_2_3">9000</us-gaap:DepreciationAndAmortization>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="pure" decimals="2" id="id_1168147_978BDCCB-1131-4951-BEF4-C79D4419A824_2_6">0.00</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" id="id_1168147_E83B26F4-E3A6-4973-A21B-1379180C02C0_2_1">P5Y1M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ProceedsFromStockOptionsExercised contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_1BB73C8E-496F-4888-A849-1C50DCD0B7CA_2_2">234000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_2_14">-5676000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_2_19">-15000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_2_6">18000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_DD7E11D3-E508-4A68-939D-30C68D6D67C1_4001_5">1.21</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_1168147_978BDCCB-1131-4951-BEF4-C79D4419A824_2_1">-0.053</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_2_16">5000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_2_31">506000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_2_2">6857000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:ProceedsFromGrantors contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_EE087CD3-D31B-4C07-A37A-254A842E17EE_2_1">234000</us-gaap:ProceedsFromGrantors>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_2_11">34000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_EF3241BF-3468-4E6A-8B5F-2F8915F3B83C_4001_3">1676712</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_4013_1600015">234000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:ConversionOfStockSharesIssued1 contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_1BB73C8E-496F-4888-A849-1C50DCD0B7CA_2_4">64273</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_2_1">3552000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_1168147_978BDCCB-1131-4951-BEF4-C79D4419A824_2_2">-0.010</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_2_30">6197000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_EF3241BF-3468-4E6A-8B5F-2F8915F3B83C_4001_4">334543</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:OperatingExpenses contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_2_3">10409000</us-gaap:OperatingExpenses>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="pure" decimals="2" id="id_1168147_E83B26F4-E3A6-4973-A21B-1379180C02C0_2_2">1.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="pure" decimals="2" id="id_1168147_978BDCCB-1131-4951-BEF4-C79D4419A824_2_0">-0.34</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_1168147_978BDCCB-1131-4951-BEF4-C79D4419A824_2_5">0.334</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:Depreciation contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_A273B911-C806-4E8D-A439-0FAB037F8A4F_2_0">6000</us-gaap:Depreciation>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="shares" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_2_17">11986000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:PreferredStockDividendsIncomeStatementImpact contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_2_13">1568000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_FCF2A95D-045B-4B70-BD2B-18AF7103A1F1_2_3">12391989</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:NetIncomeLoss contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_2_12">-10915000</us-gaap:NetIncomeLoss>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_2_11">-506000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_2_14">230000</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
  <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_2_10">-234000</us-gaap:IncreaseDecreaseInOtherReceivables>
  <us-gaap:LeaseAndRentalExpense contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_5B3A8141-EB22-46AB-B25C-ECCCD233AE81_2_0">293000</us-gaap:LeaseAndRentalExpense>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_8E660CB7-3554-4F03-916E-70B93451CC88_2_1">2153000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_2_15">-12713000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:AmortizationOfIntangibleAssets contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_5DF9B4B9-8DED-4016-8955-BF0CF2506A9A_2_1">3000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_D38119FE-C309-44C9-B627-B9E50FDE3850_4001_400004">141084</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_9B5DC16D-9A0A-45B4-843D-87D967EF0B53_2_0">6.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <galt:ProceedsFromStockOptionAndWarrantExercises contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_2_28">6067000</galt:ProceedsFromStockOptionAndWarrantExercises>
  <galt:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_4013_1600014">7218000</galt:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <galt:SupplementalDividendsOnConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_2_41">1536000</galt:SupplementalDividendsOnConvertiblePreferredStock>
  <galt:ChangeInFairValueOfWarrant contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_2_9">-524000</galt:ChangeInFairValueOfWarrant>
  <galt:ChangeInFairValueOfWarrantLiabilities contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A5D7EC06-14B3-4865-AF3B-46A58A7CC002_5001_2">524000</galt:ChangeInFairValueOfWarrantLiabilities>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_D38119FE-C309-44C9-B627-B9E50FDE3850_4001_400005">1771383</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriod>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="shares" decimals="INF" id="id_1168147_8E660CB7-3554-4F03-916E-70B93451CC88_2_0">380391</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod>
  <galt:EffectiveIncomeTaxRateReconciliationPermanentDifferences contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_1168147_978BDCCB-1131-4951-BEF4-C79D4419A824_2_3">0.035</galt:EffectiveIncomeTaxRateReconciliationPermanentDifferences>
  <galt:CashlessExerciseOfStockOptionsAndWarrants contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_2_38">341000</galt:CashlessExerciseOfStockOptionsAndWarrants>
  <galt:AdditionalShareBasedCompensationExpenseRelatedToModifiedStockOptions contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_0614232D-083F-47F6-92A9-1016025BDF3A_2_2">63000</galt:AdditionalShareBasedCompensationExpenseRelatedToModifiedStockOptions>
  <galt:StockIssuedDuringPeriodSharesStockOptionsExercisedAmount contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_1BB73C8E-496F-4888-A849-1C50DCD0B7CA_2_1">253000</galt:StockIssuedDuringPeriodSharesStockOptionsExercisedAmount>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_498752x506779" unitRef="iso4217_USD" decimals="-3" id="id_1168147_02BAABA8-2F08-4E1C-A1AF-8DCF2C1BC2C7_1002_0">1558000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_498752x510320" unitRef="iso4217_USD" decimals="-3" id="id_1168147_02BAABA8-2F08-4E1C-A1AF-8DCF2C1BC2C7_2002_1">1687000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_504051x537581" unitRef="shares" decimals="INF" id="id_1168147_B6046651-3CD4-4826-9111-AB646796397B_1003_1">390628</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_504051x537581_508454x512177" unitRef="iso4217_USD" decimals="0" id="id_1168147_B6046651-3CD4-4826-9111-AB646796397B_2003_4">18000</us-gaap:ShareBasedCompensation>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_504051x551546" unitRef="shares" decimals="INF" id="id_1168147_9299150D-565A-4A38-842D-1A84013FDAF4_1001_0">20834</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_504051x551546_507189x517784_508454x512177" unitRef="iso4217_USD" decimals="0" id="id_1168147_9299150D-565A-4A38-842D-1A84013FDAF4_2001_3">110000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_504957x513639_509379x537560_542884x531497" unitRef="pure" decimals="4" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_1002_14">0.0079</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_504957x513639_509379x537560_542884x531497" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_1002_10">P2Y11M27D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_504957x513639_509379x537560_542884x531497" unitRef="pure" decimals="2" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_1002_12">1.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <galt:ClosingStockPriceOfCommonStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_504957x513639_513696x501142" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_D20401C2-1EB8-436D-9E97-01CCEE795FC6_1001_0">18.00</galt:ClosingStockPriceOfCommonStock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_504957x514053_509379x537560_542884x531497" unitRef="pure" decimals="4" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_2002_15">0.0129</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_504957x514053_509379x537560_542884x531497" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_2002_11">P3Y3M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_504957x514053_509379x537560_542884x531497" unitRef="pure" decimals="2" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_2002_13">1.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_504957x514053_513696x501142" unitRef="iso4217_USD" decimals="0" id="id_1168147_07385DE2-AED0-46BF-98CB-CEA0F7D5F79D_1001_3">100000</us-gaap:DividendsPreferredStock>
  <galt:RedemptionPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_504957x514053_513696x501142" id="id_1168147_D92F9120-6428-4713-98E2-4F4FD3512C51_1001_0">P30D</galt:RedemptionPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x498640_513696x498640" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_5007_1000016">-30000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x498640_513696x498640" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_5007_1100016">-12000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x500343" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_4012_1500003">54000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:NetIncomeLoss contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x500343" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_4012_1500019">-10915000</us-gaap:NetIncomeLoss>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x500343_513696x498640" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_5012_1500006">179000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x500343_513696x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_6012_1500012">130000</us-gaap:DividendsPreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x500343_513696x511225" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_7012_1500002">176000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x500343_513696x516922" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_8012_1500008">378000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x500343_513696x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_9012_1500010">881000</us-gaap:DividendsPreferredStock>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501142_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_6005_800017">-5</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501142_513696x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_6005_900004">130000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501142_513696x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_6005_900017">-49000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501142_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_6005_800004">13</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_4009_1200015">216440</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_4009_1200013">20834</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <galt:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501348" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_4009_1300014">2000</galt:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <galt:StockIssuedDuringPeriodSharesStockWarrantsExercised contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_4009_1200014">1771383</galt:StockIssuedDuringPeriodSharesStockWarrantsExercised>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501348_513696x498640" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_5009_1200005">30321</us-gaap:PreferredStockDividendsShares>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501348_513696x498640" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_5009_1200016">5000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501348_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_6009_1200011">17066</us-gaap:PreferredStockDividendsShares>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501348_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_6009_1200017">8334</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501348_513696x516922" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_8009_1200007">59588</us-gaap:PreferredStockDividendsShares>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501348_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_9009_1200009">139037</us-gaap:PreferredStockDividendsShares>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_4011_1400018">3245000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_4011_1400015">234000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <galt:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_4011_1400014">7216000</galt:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x508619_513696x498640" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_5011_1400016">12000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x508619_513696x498640" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_5011_1400006">-180000</us-gaap:DividendsPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x508619_513696x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_6011_1400017">49000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x508619_513696x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_6011_1400012">-97000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x508619_513696x516922" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_8011_1400008">-378000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x508619_513696x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_9011_1400010">-881000</us-gaap:DividendsPreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x516922_513696x511225" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_7001_500002">-17000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_4003_700003">-54000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x516923_513696x511225" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_7003_700002">-159000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:DividendAsPercentageOfNetSales contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_507189x517594_513696x501142" unitRef="pure" decimals="3" id="id_1168147_07385DE2-AED0-46BF-98CB-CEA0F7D5F79D_2001_1">0.025</galt:DividendAsPercentageOfNetSales>
  <galt:DividendAsPercentageOfNetSales contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_507189x517595_513696x501142" unitRef="pure" decimals="4" id="id_1168147_07385DE2-AED0-46BF-98CB-CEA0F7D5F79D_3001_2">0.0125</galt:DividendAsPercentageOfNetSales>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_507189x517783" unitRef="iso4217_USD" decimals="-9" id="id_1168147_6F174B77-3A8B-4CA7-8F01-94E78DFA58DE_1001_2">5000000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_507189x517784" unitRef="iso4217_USD" decimals="-9" id="id_1168147_6F174B77-3A8B-4CA7-8F01-94E78DFA58DE_2001_4">10000000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_507189x534240" unitRef="shares" decimals="INF" id="id_1168147_1BB73C8E-496F-4888-A849-1C50DCD0B7CA_1002_3">83334</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <galt:DividendPaymentDateDayAndMonth contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_507189x538000_513696x501142" id="id_1168147_F3A23398-78AF-4164-827C-9C9A12FB50DB_1001_1">--09-30</galt:DividendPaymentDateDayAndMonth>
  <galt:DividendPaymentDateDayAndMonth contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_507189x538001_513696x501142" id="id_1168147_F3A23398-78AF-4164-827C-9C9A12FB50DB_2001_0">--03-31</galt:DividendPaymentDateDayAndMonth>
  <galt:ExtensionOfExercisePeriod contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_508454x506554" id="id_1168147_0614232D-083F-47F6-92A9-1016025BDF3A_1002_0">P90D</galt:ExtensionOfExercisePeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_508454x512177" unitRef="shares" decimals="INF" id="id_1168147_A92B2F3F-3537-40A0-86AD-D5CDAF8F3C66_5001_4">46876</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_508454x512177" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_508AFD0E-A3FF-4563-A319-3D7E002FE501_5001_4">4.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_508454x512177" unitRef="shares" decimals="INF" id="id_1168147_A92B2F3F-3537-40A0-86AD-D5CDAF8F3C66_5001_3">20834</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_508454x512177" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_508AFD0E-A3FF-4563-A319-3D7E002FE501_5001_3">8.04</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_509379x517826" unitRef="pure" decimals="4" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_3003_24">0.0012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_509379x517826" unitRef="pure" decimals="2" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_3003_25">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_509379x517826" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_3003_22">P1Y3M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_509379x517826" unitRef="pure" decimals="2" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_3003_23">0.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <galt:IssuanceOfWarrantsValue contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_509379x517826" unitRef="iso4217_USD" decimals="0" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_3003_21">104000</galt:IssuanceOfWarrantsValue>
  <galt:ReversalOfSharebasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_509379x517826" unitRef="iso4217_USD" decimals="0" id="id_1168147_936560DE-6C5A-4BED-AFFC-F3F65E878091_3003_27">13000</galt:ReversalOfSharebasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_509379x537560_542884x531497" unitRef="pure" decimals="2" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_3002_16">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_509379x537560_542884x531497" unitRef="iso4217_USD" decimals="0" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_3002_17">12000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_509379x537560_542884x531497" unitRef="shares" decimals="INF" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_3002_8">7500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_509379x537560_542884x531497" unitRef="shares" decimals="INF" id="id_1168147_A1033CA2-8879-4E44-A06A-AF8007BDD9B8_3002_9">4500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_509379x537561" unitRef="iso4217_USD" decimals="0" id="id_1168147_CF0E523E-E16B-4ABB-97BA-033347B4095C_1002_9">340000</us-gaap:ShareBasedCompensation>
  <us-gaap:PreferredStockDividendRatePercentage contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x498640" unitRef="pure" decimals="2" id="id_1168147_2D46428A-3E53-4790-8D57-0C8C17138C00_1001_1">0.12</us-gaap:PreferredStockDividendRatePercentage>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x498640" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_5013_1600006">-1000</us-gaap:DividendsPreferredStock>
  <us-gaap:PreferredStockDividendRatePercentage contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142" unitRef="pure" decimals="2" id="id_1168147_07385DE2-AED0-46BF-98CB-CEA0F7D5F79D_4001_0">0.06</us-gaap:PreferredStockDividendRatePercentage>
  <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_2002_25">130000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_6013_1600017">49000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:ConversionOfStockSharesIssued1 contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_6D21A9F9-4917-4A3E-B2AA-47B51188D00C_1001_3">366676</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_6013_1600012">33000</us-gaap:DividendsPreferredStock>
  <us-gaap:ConversionOfStockSharesConverted1 contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_6D21A9F9-4917-4A3E-B2AA-47B51188D00C_1001_2">220</us-gaap:ConversionOfStockSharesConverted1>
  <galt:PostConversionRedemptionRightReturnOnInvestmentMultiplierAmount contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142" unitRef="shares" decimals="0" id="id_1168147_D92F9120-6428-4713-98E2-4F4FD3512C51_2001_1">10000</galt:PostConversionRedemptionRightReturnOnInvestmentMultiplierAmount>
  <galt:NumberOfDaysForRedemptions contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142" id="id_1168147_D92F9120-6428-4713-98E2-4F4FD3512C51_2001_3">P10D</galt:NumberOfDaysForRedemptions>
  <galt:NumberOfConsecutiveTradingDaysForConversionOfPreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142" id="id_1168147_D20401C2-1EB8-436D-9E97-01CCEE795FC6_2001_1">P15D</galt:NumberOfConsecutiveTradingDaysForConversionOfPreferredStock>
  <galt:PercentageOfReturnOnInvestment contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517065" unitRef="pure" decimals="2" id="id_1168147_EC1619C2-9353-4639-B86C-D327C0523565_1001_1">2.00</galt:PercentageOfReturnOnInvestment>
  <galt:RedemptionDateDescription contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517065" id="id_1168147_EC1619C2-9353-4639-B86C-D327C0523565_1001_2">before the second anniversary of the date of issuance;</galt:RedemptionDateDescription>
  <galt:PercentageOfReturnOnInvestment contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517066" unitRef="pure" decimals="2" id="id_1168147_EC1619C2-9353-4639-B86C-D327C0523565_1002_1">2.50</galt:PercentageOfReturnOnInvestment>
  <galt:RedemptionDateDescription contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517066" id="id_1168147_EC1619C2-9353-4639-B86C-D327C0523565_1002_2">on or after the second anniversary of the date of issuance, but before the third anniversary of the date of issuance;</galt:RedemptionDateDescription>
  <galt:PercentageOfReturnOnInvestment contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517067" unitRef="pure" decimals="2" id="id_1168147_EC1619C2-9353-4639-B86C-D327C0523565_1006_1">4.50</galt:PercentageOfReturnOnInvestment>
  <galt:RedemptionDateDescription contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517067" id="id_1168147_EC1619C2-9353-4639-B86C-D327C0523565_1006_2">on or after the sixth anniversary of the date of issuance, but before the seventh anniversary of the date of issuance;</galt:RedemptionDateDescription>
  <galt:PercentageOfReturnOnInvestment contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517068" unitRef="pure" decimals="2" id="id_1168147_EC1619C2-9353-4639-B86C-D327C0523565_1005_1">4.00</galt:PercentageOfReturnOnInvestment>
  <galt:RedemptionDateDescription contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517068" id="id_1168147_EC1619C2-9353-4639-B86C-D327C0523565_1005_2">on or after the fifth anniversary of the date of issuance, but before the sixth anniversary of the date of issuance;</galt:RedemptionDateDescription>
  <galt:PercentageOfReturnOnInvestment contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517069" unitRef="pure" decimals="2" id="id_1168147_EC1619C2-9353-4639-B86C-D327C0523565_1004_1">3.50</galt:PercentageOfReturnOnInvestment>
  <galt:RedemptionDateDescription contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517069" id="id_1168147_EC1619C2-9353-4639-B86C-D327C0523565_1004_2">on or after the fourth anniversary of the date of issuance, but before the fifth anniversary of the date of issuance;</galt:RedemptionDateDescription>
  <galt:PercentageOfReturnOnInvestment contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517070" unitRef="pure" decimals="2" id="id_1168147_EC1619C2-9353-4639-B86C-D327C0523565_1003_1">3.00</galt:PercentageOfReturnOnInvestment>
  <galt:RedemptionDateDescription contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517070" id="id_1168147_EC1619C2-9353-4639-B86C-D327C0523565_1003_2">on or after the third anniversary of the date of issuance, but before the fourth anniversary of the date of issuance;</galt:RedemptionDateDescription>
  <galt:PercentageOfReturnOnInvestment contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517741" unitRef="pure" decimals="2" id="id_1168147_EC1619C2-9353-4639-B86C-D327C0523565_1007_1">5.00</galt:PercentageOfReturnOnInvestment>
  <galt:RedemptionDateDescription contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517741" id="id_1168147_EC1619C2-9353-4639-B86C-D327C0523565_1007_2">on or after the seventh anniversary of the date of issuance, but before the eighth anniversary of the date of issuance; and</galt:RedemptionDateDescription>
  <galt:PercentageOfReturnOnInvestment contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517742" unitRef="pure" decimals="2" id="id_1168147_EC1619C2-9353-4639-B86C-D327C0523565_1008_1">5.50</galt:PercentageOfReturnOnInvestment>
  <galt:RedemptionDateDescription contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517742" id="id_1168147_EC1619C2-9353-4639-B86C-D327C0523565_1008_2">on or after the eighth anniversary of the date of issuance, but before the ninth anniversary of the date of issuance.</galt:RedemptionDateDescription>
  <us-gaap:PreferredStockDividendRatePercentage contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x511225" unitRef="pure" decimals="2" id="id_1168147_04843158-7341-46D0-B87B-BB4F3671419B_1001_0">0.12</us-gaap:PreferredStockDividendRatePercentage>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x511225" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_7013_1600002">176000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:PercentageOfWeightedAverageStockPriceForDividendsPriorToPaymentDate contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x511225" unitRef="pure" decimals="2" id="id_1168147_04843158-7341-46D0-B87B-BB4F3671419B_1001_1">1.00</galt:PercentageOfWeightedAverageStockPriceForDividendsPriorToPaymentDate>
  <galt:DividendAccrualRateOnInvestmentsInAffiliates contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x511225" unitRef="pure" decimals="2" id="id_1168147_04843158-7341-46D0-B87B-BB4F3671419B_1001_3">0.15</galt:DividendAccrualRateOnInvestmentsInAffiliates>
  <galt:ShareConversionRatio contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x511225" unitRef="pure" decimals="3" id="id_1168147_83596DD3-C73B-4F1E-AA75-BC5D0F7C6A45_1001_0">0.667</galt:ShareConversionRatio>
  <galt:NoticePeriod contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x511225" id="id_1168147_83596DD3-C73B-4F1E-AA75-BC5D0F7C6A45_1001_2">P10D</galt:NoticePeriod>
  <galt:NumberOfConsecutiveTradingDaysForConversionOfPreferredStock contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x511225" id="id_1168147_83596DD3-C73B-4F1E-AA75-BC5D0F7C6A45_1001_4">P15D</galt:NumberOfConsecutiveTradingDaysForConversionOfPreferredStock>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_514791x507534" unitRef="shares" decimals="INF" id="id_1168147_FCF2A95D-045B-4B70-BD2B-18AF7103A1F1_1002_2">2627110</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_514791x507958" unitRef="shares" decimals="INF" id="id_1168147_FCF2A95D-045B-4B70-BD2B-18AF7103A1F1_2002_0">6673405</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_514791x514283" unitRef="shares" decimals="INF" id="id_1168147_FCF2A95D-045B-4B70-BD2B-18AF7103A1F1_3002_1">3091474</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_557712x580425" unitRef="pure" decimals="3" id="id_1168147_6F174B77-3A8B-4CA7-8F01-94E78DFA58DE_3001_8">0.035</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_557712x580425" id="id_1168147_6F174B77-3A8B-4CA7-8F01-94E78DFA58DE_3001_9">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_557712x580425" id="id_1168147_6F174B77-3A8B-4CA7-8F01-94E78DFA58DE_3001_6">P5Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_365_20111231_0_557712x580425" unitRef="pure" decimals="2" id="id_1168147_6F174B77-3A8B-4CA7-8F01-94E78DFA58DE_3001_7">1.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments contextRef="eol_PE87402---1210-K0013_STD_366_20041231_0_504051x537581" unitRef="iso4217_USD" decimals="0" id="id_1168147_8339F3A8-908E-4AD1-9652-332A06F8A6C0_1001_5">4000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_366_20041231_0_504051x537581_508454x506554" unitRef="iso4217_USD" decimals="0" id="id_1168147_8339F3A8-908E-4AD1-9652-332A06F8A6C0_2001_6">51000</us-gaap:ShareBasedCompensation>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments contextRef="eol_PE87402---1210-K0013_STD_366_20041231_0_504051x610120_507189x610125" unitRef="iso4217_USD" decimals="0" id="id_1168147_7DF7FF4B-569F-45E9-BD2E-590C13CB925C_1001_4">-2000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_366_20041231_0_504051x610120_507189x610125_508454x514283" unitRef="iso4217_USD" decimals="0" id="id_1168147_7DF7FF4B-569F-45E9-BD2E-590C13CB925C_2001_5">17000</us-gaap:ShareBasedCompensation>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments contextRef="eol_PE87402---1210-K0013_STD_366_20041231_0_504051x610121" unitRef="iso4217_USD" decimals="0" id="id_1168147_5078883F-5052-4131-A8F5-C841B0058938_1001_5">2000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedFairValueAdjustments>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_366_20041231_0_504051x610121_508454x506554" unitRef="iso4217_USD" decimals="0" id="id_1168147_5078883F-5052-4131-A8F5-C841B0058938_2001_6">5000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_366_20041231_0_504051x624048" unitRef="iso4217_USD" decimals="0" id="id_1168147_68015234-5656-43CC-A449-633134DBD901_1002_5">67000</us-gaap:ShareBasedCompensation>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_366_20041231_0_504051x624048" unitRef="shares" decimals="INF" id="id_1168147_68015234-5656-43CC-A449-633134DBD901_1002_3">7500</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_366_20041231_0_504051x624048_507189x624047_508454x506554" unitRef="iso4217_USD" decimals="0" id="id_1168147_F672F132-C066-4CA5-805C-25674FACF7AB_4001_5">23000</us-gaap:ShareBasedCompensation>
  <galt:IncreaseDecreaseInWarrants contextRef="eol_PE87402---1210-K0013_STD_366_20081231_0_499506x536060" unitRef="iso4217_USD" decimals="0" id="id_1168147_49322142-3A8C-4549-B803-B8F29CC608F5_1002_2">204000</galt:IncreaseDecreaseInWarrants>
  <galt:DecreaseInAdditionalPaidInCapital contextRef="eol_PE87402---1210-K0013_STD_366_20081231_0_499506x536060" unitRef="iso4217_USD" decimals="0" id="id_1168147_49322142-3A8C-4549-B803-B8F29CC608F5_1002_1">458000</galt:DecreaseInAdditionalPaidInCapital>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_366_20081231_0_504051x551546_508454x506554" unitRef="iso4217_USD" decimals="0" id="id_1168147_88F2672A-F265-4C9E-92F1-A87317AA1041_2002_3">15000</us-gaap:ShareBasedCompensation>
  <galt:ProceedsFromSubscriptionAdvances contextRef="eol_PE87402---1210-K0013_STD_366_20081231_0_507189x517066_513696x498640" unitRef="iso4217_USD" decimals="INF" id="id_1168147_1DFED9B8-9083-4FA3-AA98-28025451C0A0_2002_1">75000</galt:ProceedsFromSubscriptionAdvances>
  <galt:ProceedsFromSubscriptionAdvances contextRef="eol_PE87402---1210-K0013_STD_366_20081231_0_513696x498640" unitRef="iso4217_USD" decimals="INF" id="id_1168147_1DFED9B8-9083-4FA3-AA98-28025451C0A0_4002_2">1742500</galt:ProceedsFromSubscriptionAdvances>
  <dei:TradingSymbol contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_74A16C2A-DCB4-4A42-BF0A-D0CFB9A0FDE8_1_400000">GALT</dei:TradingSymbol>
  <dei:EntityRegistrantName contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_74A16C2A-DCB4-4A42-BF0A-D0CFB9A0FDE8_1_400001">GALECTIN THERAPEUTICS INC</dei:EntityRegistrantName>
  <dei:EntityCurrentReportingStatus contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_74A16C2A-DCB4-4A42-BF0A-D0CFB9A0FDE8_1_400005">Yes</dei:EntityCurrentReportingStatus>
  <dei:AmendmentFlag contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_7424302F-AC4B-4228-ADDE-C44E782B49D8_1_1">false</dei:AmendmentFlag>
  <dei:EntityFilerCategory contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_74A16C2A-DCB4-4A42-BF0A-D0CFB9A0FDE8_1_400007">Smaller Reporting Company</dei:EntityFilerCategory>
  <dei:DocumentFiscalPeriodFocus contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_7424302F-AC4B-4228-ADDE-C44E782B49D8_1_4">FY</dei:DocumentFiscalPeriodFocus>
  <dei:EntityVoluntaryFilers contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_74A16C2A-DCB4-4A42-BF0A-D0CFB9A0FDE8_1_400006">No</dei:EntityVoluntaryFilers>
  <dei:DocumentFiscalYearFocus contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_7424302F-AC4B-4228-ADDE-C44E782B49D8_1_3">2012</dei:DocumentFiscalYearFocus>
  <dei:DocumentType contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_7424302F-AC4B-4228-ADDE-C44E782B49D8_1_0">10-K</dei:DocumentType>
  <dei:DocumentPeriodEndDate contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_7424302F-AC4B-4228-ADDE-C44E782B49D8_1_2">2012-12-31</dei:DocumentPeriodEndDate>
  <dei:EntityCentralIndexKey contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_74A16C2A-DCB4-4A42-BF0A-D0CFB9A0FDE8_1_400002">0001133416</dei:EntityCentralIndexKey>
  <dei:EntityWellKnownSeasonedIssuer contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_74A16C2A-DCB4-4A42-BF0A-D0CFB9A0FDE8_1_400004">No</dei:EntityWellKnownSeasonedIssuer>
  <dei:CurrentFiscalYearEndDate contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_74A16C2A-DCB4-4A42-BF0A-D0CFB9A0FDE8_1_400003">--12-31</dei:CurrentFiscalYearEndDate>
  <us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_EA03BE84-0B98-4BB5-BDFA-C48805CDAED0_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Future minimum
payments under this lease as of December&amp;#xA0;31, 2012 are as
follows (in thousands):&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="84%" align="center"&gt;
&lt;tr&gt;
&lt;td width="93%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;
&lt;p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 88pt"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year ended
December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2013&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;49&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2014&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;36&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total lease
payments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;85&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="pure" decimals="4" id="id_1168147_E83B26F4-E3A6-4973-A21B-1379180C02C0_1_0">0.0090</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_1AADBB1F-4FDD-48FE-A8F6-7F432F7547DC_1_0">&lt;div&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;The primary
factors affecting the Company&amp;#x2019;s income tax rates were as
follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="84%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
&lt;tr&gt;
&lt;td width="85%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Tax benefit at U.S.
statutory rates&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(34&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(34&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;State tax benefit&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(5.3&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(5.3&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Credit&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(0.2&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(1.0&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Permanent
differences&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1.4&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.5&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Expiring state
NOL&amp;#x2019;s&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.3&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.4&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Changes in valuation
allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;34.8&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;33.4&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_C6F52BD1-6FD1-49DA-A8C5-7F568D8438ED_1_0">&lt;div&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr&gt;
&lt;td valign="top" width="4%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;6.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Stockholders&amp;#x2019;
Deficit&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;At
December&amp;#xA0;31, 2012, the Company had 50,000,000 shares of common
stock and 20,000,000 undesignated shares authorized. As of
December&amp;#xA0;31, 2012, 5,000,000 shares have been designated for
Series A 12% Convertible Preferred Stock, 900,000 shares have been
designated for Series B-1 Convertible Preferred Stock, 2,100,000
shares have been designated for Series B-2 Convertible Preferred
Stock, 1,000 shares have been designated for Series C Super
Dividend Convertible Preferred Stock and 11,999,000 remain
undesignated.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company has
raised capital through a number of debt and equity financing
transactions. The following provides a description of the
Company&amp;#x2019;s equity financings and certain warrants issued in
connection with such equity financings.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;2001
Private Placement&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;During 2001,
the Company sold a total of 114,884 shares of common stock for
proceeds of $2,221,000, net of $17,000 of issuance costs through a
private placement of securities. In connection with this issuance,
the Company issued 56,534 and 58,350 warrants to purchase common
stock at $39.00 and $30.00 per share, respectively. The Company
valued the warrants at $886,000, based on a fair market value of
the Company&amp;#x2019;s common stock of $13.68 per share. These
warrants expired unexercised in 2005.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In August 2001,
the Company offered warrants to holders of its outstanding
convertible notes as an inducement to convert prior to the maturity
of the notes. Holders representing $1,126,000 of the outstanding
principal and accrued interest chose to convert at a conversion
price of $12.00 per share and received 99,705 common shares and
93,801 warrants. These warrants have an exercise price of $39.00
per share and were immediately exercisable. The Company valued the
warrants at $503,000 based on a fair market value of the
Company&amp;#x2019;s common stock of $13.68 per share. The value of the
warrants has been recorded as a debt conversion expense. These
warrants expired unexercised in 2005.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In 2002, the
Company issued 18,334 warrants to the agents in connection with the
2001 offering. The warrants were exercisable immediately at an
exercise price of $21.00 per share and have a 10 year life. The
Company valued these warrants at $236,000 based on a deemed fair
value of the Company&amp;#x2019;s common stock of $21.00 per share and
recorded such value as interest expense in the statement of
operations for the year ended December&amp;#xA0;31, 2002. These
warrants expired unexercised in 2012.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Public
Offering&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
December&amp;#xA0;13, 2001, the Company commenced a public offering of
common stock, at a price to the public of $21.00 per share. The
Company concluded the offering on June&amp;#xA0;30, 2002. During 2002,
the Company sold 31,000 shares of common stock in this offering for
proceeds of $602,000, net of $49,000 of issuance costs.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;2002
Private Placement&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In September
2002, the Company began a private placement (the &amp;#x201C;2002
Private Placement&amp;#x201D;) of up to 1,666,667 shares of common stock
at $6.00 per share. As of December&amp;#xA0;31, 2002, the Company had
sold 537,227 shares for proceeds of $2,861,000, net of issuance
costs of $212,000 and stock subscription receivable of $150,000,
which related to shares purchased but for which payment had not
been received as of December&amp;#xA0;31, 2002. This offering was
closed on January&amp;#xA0;14, 2003, although subsequent to year end
the Company sold an additional 181,334 shares for additional
proceeds of $1,070,000, net of $18,000 of offering
costs.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
compensated a registered investment adviser with respect to shares
purchased by its clients. As of December&amp;#xA0;31, 2002, the adviser
was entitled to receive 28,917 shares of common stock. The Company
also agreed to compensate a finder registered under applicable law,
and such finder&amp;#x2019;s agents, for identifying qualified
investors. As of December&amp;#xA0;31, 2002, one of the finder&amp;#x2019;s
agents was entitled to receive 125 shares of common stock. On
January&amp;#xA0;14, 2003, the Company closed the 2002 Private
Placement, at which point the Company agreed to issue the adviser
an additional 417 shares, and the finder and its other agent an
aggregate of 1,625 additional shares and $3,000 in cash in
connection with the shares sold subsequent to December&amp;#xA0;31,
2002 and through the closing date.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Shares placed
by such registered adviser, finder and finder&amp;#x2019;s agent were
accounted for as offering costs and valued at $6.00 per share,
consistent with the price paid for the shares placed in the
offering. Such offering costs were netted against the proceeds of
the 2002 Private Placement. Since none of the 29,042 shares had
been issued as of December&amp;#xA0;31, 2002, the Company recorded the
obligation to issue such shares as offering costs payable. The
additional 2,042 shares issued in January 2003 were also valued at
$6.00 per share and included in the $18,000 offering costs recorded
at the closing. These shares were subsequently issued in
2003.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;During 2002,
the Company also agreed to issue 350 shares of common stock to an
employee for finding investors in connection with the 2002 Private
Placement. None of the shares had been issued as of
December&amp;#xA0;31, 2002. These shares were subsequently issued in
2003. Accordingly, the Company recorded the obligation to general
and administrative expenses in the statement of operations in the
amount of $6,000. On January&amp;#xA0;14, 2003, the Company closed the
2002 Private Placement, at which point the Company agreed to issue
such employee an additional 1,167 shares in connection with shares
sold subsequent to December&amp;#xA0;31, 2002 and through the closing
date. The Company recorded an additional obligation of $27,000 to
general and administrative expenses in 2003 representing the fair
value of the additional 1,167 shares.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;2002
Related Party Transaction&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
agreed to issue 4,226 shares of common stock as payment for 2002
scientific advisory services. These shares were issued in
2003.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;May 2003
Private Placement&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In May 2003,
the Company began a private placement of up to 416,667 shares of
common stock at $12.00 per share. As of the closing on
July&amp;#xA0;15, 2003, the Company had sold 399,917 shares of common
stock for proceeds of $4,671,000, net of issuance costs of
$128,000. In connection with this offering the Company issued
18,269 common stock warrants (exercisable at $32.40 per share) to
its placement agents. The Company valued the warrants at $261,000
using the Black-Scholes pricing model and recorded the warrant
value as offering costs with a corresponding increase to additional
paid-in capital. These warrants expired unexercised in
2006.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;October
2003 &amp;#x201C;PIPE&amp;#x201D; Transaction&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
October&amp;#xA0;2, 2003 the Company closed a private offering,
structured as a Private Investment, Public Equity
(&amp;#x201C;PIPE&amp;#x201D;), exempt from registration under
Section&amp;#xA0;4(2) of the Securities Act of 1933, in which it sold
to institutional investors 219,096 of the 238,096 offered shares of
common stock at $21.00 per share for proceeds of $4,041,000, net of
issuance costs of $559,000. In connection with this offering, the
Company issued 109,549 warrants with an initial exercise price of
$31.74 per share to the investors and 10,955 warrants with an
initial exercise price of $41.16 per share to its placement agent.
The exercise price of the warrants was subject to adjustment
pursuant to anti-dilution and other provisions. The investor
warrants and placement agent Warrants were valued at $2,531,000 and
$191,000, respectively, using the relative fair value, and
allocated to additional paid-in-capital. The Company used the
Black-Scholes pricing model to value these warrants. The warrants
were originally accounted for as freestanding derivative
instruments. The investor warrants expired unexercised in 2008 and
the placement agent warrants expired unexercised in
2007.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;April
2004 &amp;#x201C;PIPE&amp;#x201D; Transaction&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
April&amp;#xA0;7, 2004, the Company closed a private equity offering,
structured as a &amp;#x201C;PIPE&amp;#x201D; in which it sold to certain
institutional investors 206,019 shares of common stock at $21.60
per share for proceeds of $3,983,000, net of cash issuance costs of
$466,000. In connection with this offering, the Company issued
103,010 warrants to investors and 10,301 warrants to a placement
agent with an initial exercise price of $31.80 per share. The
exercise price of the warrants was subject to adjustment pursuant
to anti-dilution and other provisions. The investor warrants and
the placement agent warrants were valued at $1,931,000 and
$154,000, respectively, using the relative fair value, and
allocated to additional paid-in-capital. The Company used the
Black-Scholes pricing model to value these warrants. The warrants
were originally accounted for as freestanding derivative
instruments. The investor warrants expired unexercised in 2009 and
the placement agent warrants expired unexercised in
2007.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;August
2004 &amp;#x201C;PIPE&amp;#x201D; Transaction&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
August&amp;#xA0;12, 2004, the Company closed a private offering,
structured as a &amp;#x201C;PIPE&amp;#x201D; in which it sold to certain
institutional investors 333,334 shares of common stock at $18.00
per share for proceeds of $5,515,000, net of cash issuance costs of
$485,000. In connection with this offering the Company issued
333,334 warrants to the investors and 16,667 warrants to the
placement agent with an exercise price of $4.20 per share. The
exercise price of the warrants was subject to adjustment solely as
a result of stock splits, recapitalizations and similar events. The
investor warrants and placement agent warrants were valued at
$4,786,000 and $239,000, respectively, and allocated to additional
paid-in-capital. The Company used the Black-Scholes pricing model
to value these warrants. The warrants were originally accounted for
as freestanding derivative instruments. These warrants expired
unexercised in 2009.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;February&amp;#xA0;25, 2008 Offering&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
February&amp;#xA0;25, 2008, the Company closed an offering in which it
sold to investors (i)&amp;#xA0;an aggregate of 1,250,000 shares of the
Company&amp;#x2019;s common stock at $3.00 per share,
(ii)&amp;#xA0;warrants, which expire on August&amp;#xA0;25, 2013, to
purchase an aggregate of 1,250,000 share of the Company&amp;#x2019;s
common stock at an exercise price of $3.50 per share, and
(iii)&amp;#xA0;warrants, which expired on December&amp;#xA0;26, 2008, to
purchase an aggregate of 500,000 shares of the Company&amp;#x2019;s
common stock at an exercise price of $3.78 per share. In addition,
the Company issued to a placement agent warrants, which expire on
August&amp;#xA0;25, 2013, to purchase 34,375 shares of the
Company&amp;#x2019;s common stock at an exercise price of $4.20 per
share. The warrants are exercisable beginning on August&amp;#xA0;25,
2008. The warrants provide for cashless exercise if at any time
during the term of the warrants if there is no effective
registration statement for the issuance or resale of the underlying
warrant shares. The exercise price of each warrant is adjustable in
the event of a stock split or stock combination, capital
reorganization, merger or similar event.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
received proceeds of $3,381,000, net of cash transaction costs of
$369,000. In addition the Company incurred $56,000 of costs for
warrants issued to a placement agent. Proceeds of $1,044,000 were
allocated to common stock and $2,281,000 were allocated to investor
warrants using the Black-Scholes method with a fair market value of
the Company&amp;#x2019;s common stock of $2.40 and the following
assumptions as of February&amp;#xA0;25, 2008: for the 5 year warrants
exercisable at $4.20 per share, a risk-free interest rate of 2.94%
and volatility of 95% and for the 4 month warrants exercisable at
$3.78 per share, a risk-free interest rate of 2.13% and volatility
of 95%. The warrants were determined to have the characteristics of
derivative liabilities and were originally accounted for as
liabilities prior to the Company increasing the authorized number
of shares. Changes in fair value were recognized as either a gain
or loss in the consolidated statement of operations. In the second
quarter of 2008 the warrants were reclassified to equity. Through
May&amp;#xA0;21, 2008, these warrants were marked to market resulting
in a reduction in warrant liabilities in the balance sheet and an
offsetting credit to change in fair value of warrant liabilities in
the statement of operations in the amount of $356,000. The
remaining fair value of $2,160,000 was credited to additional
paid-in capital in the balance sheet. On December&amp;#xA0;26, 2008 the
500,000 warrants exercisable at $3.78 expired unexercised. If the
Company pays a stock dividend or makes a distribution or combines
shares of its common stock, then the number of shares issuable upon
exercise of this warrant shall be proportionately adjusted such
that the aggregate exercise price of this warrant remains
unchanged.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Cork
Investments&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On July&amp;#xA0;2,
2008, the Company issued 50,000 warrants to Cork Investments in
exchange for $20,000. The warrants were exercisable for common
stock at $6.00 per share for a period of three years and expired
unexercised in 2011. The $20,000 was credited to additional paid in
capital.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;2012
Offering of Units&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
March&amp;#xA0;22, 2012, the Company entered into an underwriting
agreement, relating to the offer and sale of 1,159,445 units (the
&amp;#x201C;Units&amp;#x201D;) of the Company, each unit consisted of two
shares of Common Stock and one warrant to purchase one share of
Common Stock. Pursuant to the underwriting agreement, the Company
granted the underwriters a 45-day option to purchase up to an
additional 173,916 Units to cover over-allotments, which they
exercised on March&amp;#xA0;26, 2012. The public offering price for
each Unit was $9.00. Each warrant has an initial exercise price of
$5.63 per share, is exercisable upon separation of the Units and
expires on March&amp;#xA0;28, 2017.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
March&amp;#xA0;28, 2012, the Company sold and issued 1,333,361 Units
(2,666,722 shares of common stock and related $5.63 warrants to
purchase 1,333,361 shares of common stock) for gross proceeds of
$12.0 million (net cash proceeds of $10,403,000 after the
underwriting discount and offering costs). The warrants were valued
at $4,445,000 as of the issuance date of March&amp;#xA0;28, 2012, using
the closing price of $4.20, a life of 5 years, a volatility of 119%
and a risk free interest rate of 1.05%. Based upon the
Company&amp;#x2019;s analysis of the criteria contained in ASC Topic
815-40, &amp;#x201C;Derivatives and Hedging &amp;#x2014; Contracts in
Entity&amp;#x2019;s Own Equity&amp;#x201D; the Company has determined that
warrants issued in connection with this financing transaction were
not derivative liabilities and therefore, were recorded as
additional paid-in capital.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
March&amp;#xA0;28, 2012, in connection with this underwritten financing
as per the underwriting agreement, the Company issued a total of
46,378 common stock purchase warrants to the underwriters. These
warrants expire May&amp;#xA0;2, 2016, have an exercise price of $5.63
per share, and are exercisable beginning one year from
March&amp;#xA0;22, 2012 (the date of the underwriting agreement). These
warrants were valued at $143,000 as of the date of issuance (March
28, 2012), using the closing price of $4.20, life of 4.1 years,
volatility of 117% and risk free interest rate of 0.78%. Based upon
the Company&amp;#x2019;s analysis of the criteria contained in ASC Topic
815-40, &amp;#x201C;Derivatives and Hedging &amp;#x2014; Contracts in
Entity&amp;#x2019;s Own Equity&amp;#x201D;, the Company has determined that
these warrants issued in connection with this financing transaction
were not derivative liabilities and therefore, were recorded as
additional paid-in capital.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Effective as of
March&amp;#xA0;23, 2012, and in connection with the pricing of the
offering of Units, the Company effected a one-for-six reverse split
of its Common Stock. Per the terms of the reverse split, all
fractional shares were rounded up. Based on the effective split
date of March&amp;#xA0;23, 2012, the Company issued 3,324&amp;#xA0;shares
of common stock to cover fractional shares.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Series A
12% Convertible Preferred Stock &amp;#x2014; February&amp;#xA0;4, 2008
Private Placement&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
February&amp;#xA0;4, 2008, the Company&amp;#xA0;closed&amp;#xA0;a private
placement begun in October 2007&amp;#xA0;of its Series A 12%
Convertible Preferred Stock (&amp;#x201C;Series A&amp;#x201D;) and related
warrants. In this transaction, the Company sold units of securities
at $6.00 per unit, each unit comprised of (i)&amp;#xA0;one share of
Series A Preferred, (ii)&amp;#xA0;a warrant to purchase one share of
common stock for $9.00, and (iii)&amp;#xA0;a warrant to purchase one
share of common stock for $12.00. Each share of the Series A is
entitled to dividends at the rate of 12%&amp;#xA0;per annum payable at
the Company&amp;#x2019;s option in cash or shares of common stock valued
at the higher of $6.00 per share or 100% of the value weighted
average price of the Company&amp;#x2019;s share price for the 20
consecutive trading days prior to the applicable dividend payment
date. Dividends are payable semi-annually on March&amp;#xA0;30 and
September&amp;#xA0;30. The dividend paid on the initial dividend
payment date is calculated from the date the Company deposited each
subscription advance.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The shares of
Series A are entitled to vote as a class with the Company&amp;#x2019;s
common stock and each share of Series A is convertible at any time
to one-sixth of a share of common stock, subject to adjustment in
the event of a stock dividend, stock split or combination,
reclassification or similar event. The Company has the right to
require conversion if the closing price of the common stock exceeds
$18.00 for 15 consecutive trading days and a registration statement
covering the resale of the shares of common stock issuable upon
conversion of the Series A is then in effect. Each warrant is
exercisable solely for cash beginning August&amp;#xA0;3, 2008 and
expired on February&amp;#xA0;4, 2012. The exercise price of each
warrant is adjustable in the event of a stock split or stock
combination, capital reorganization, merger or similar
event.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As of
December&amp;#xA0;31, 2007, the Company had received subscription
advances of $1,667,500 for Series A.&amp;#xA0;In 2008, the Company
received additional subscription advances of $75,000 resulting in
total gross proceeds of $1,742,500. On February&amp;#xA0;4, 2008 the
Company closed the private placement. The Company incurred $52,000
of cash transaction costs resulting in net cash proceeds of
$1,691,000. In addition, the Company incurred $3,000 of costs for
1,400 warrants exercisable at $9.00 issued to placement agents.
Proceeds of $984,000 were allocated to investor warrants using the
Black-Scholes method with the following assumptions as of
February&amp;#xA0;4, 2008: risk free interest rate 2.51%, volatility
95%, fair market value of the company&amp;#x2019;s common stock on
February&amp;#xA0;4, 2008, and the share price on the closing date of
the transaction of $3.54. The warrants were originally accounted
for as freestanding derivative instruments in the consolidated
balance sheet formerly under the caption &amp;#x201C;Warrant
Liabilities&amp;#x201D;. These warrants were originally classified as a
liability because the February 2006 warrants contain an
anti-dilution provision in the event of a subsequent dilutive
issuance and the potential number of shares issuable exceeded the
Company&amp;#x2019;s authorized shares. Changes in fair value were
recognized as either a gain or loss in the consolidated statement
of operations under the caption &amp;#x201C;Change in fair value of
warrant liabilities&amp;#x201D;. In the second quarter of 2008, the
warrants were reclassified to equity as a result of an amendment to
the Company&amp;#x2019;s articles of incorporation approved at the
May&amp;#xA0;21, 2008 annual meeting of shareholders increasing the
Company&amp;#x2019;s authorized common. Through May&amp;#xA0;21, 2008, these
warrants were marked to market resulting in a reduction in warrant
liabilities in the balance sheet and an offsetting credit to change
in fair value of warrant liabilities in the statement of operations
in the amount of $100,000. The remaining fair value of $502,000 was
credited to additional paid-in capital in the balance
sheet.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Series B
Redeemable Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
February&amp;#xA0;12, 2009, the Company entered into a securities
purchase agreement (the &amp;#x201C;10X Agreement&amp;#x201D;) pursuant to
which it agreed to issue and sell to 10X Fund LP, at two or more
closings, up to: (i)&amp;#xA0;3,000,000 shares its Series B convertible
preferred stock (&amp;#x201C;Series B redeemable convertible preferred
stock&amp;#x201D; or &amp;#x201C;Series&amp;#xA0;B&amp;#x201D;) with an aggregate
stated value of $6.0 million and convertible into 2,000,000 shares
of common stock at December&amp;#xA0;31, 2011 and (ii)&amp;#xA0;warrants to
purchase 6,000,000 shares of common stock.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Through a
series of closings from February 2009 through May 2010, the Company
issued and sold, pursuant to the 10X Agreement, a total of
(i)&amp;#xA0;900,000 shares of Series B-1 convertible preferred stock
(&amp;#x201C;Series B-1 redeemable convertible preferred stock&amp;#x201D; or
&amp;#x201C;Series B-1&amp;#x201D;) and related common stock warrants for
1,800,000 shares of common stock and (ii)&amp;#xA0;2,100,000 shares of
Series B-2 convertible preferred stock (&amp;#x201C;Series B-2
redeemable convertible preferred stock&amp;#x201D; or &amp;#x201C;Series
B-2&amp;#x201D;) and related warrants for 4,200,000 shares of common
stock. During 2010, the Company received total net cash proceeds of
$1,463,000 from the issuance of 770,000 shares of Series B-2 and
related warrants. During 2009, the Company received total net cash
proceeds of $1,548,000 from the issuance of 900,000 shares of
Series B-1 and related warrants and $2,472,000 from the issuance of
1,330,000 shares of Series B-2 and related warrants.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Series B
closings were as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
February&amp;#xA0;12, 2009, the Company issued and sold, pursuant to
the 10X Agreement: (i)&amp;#xA0;900,000 shares of Series B-1
convertible preferred stock (&amp;#x201C;Series B-1 redeemable
convertible preferred stock&amp;#x201D; or &amp;#x201C;Series B-1&amp;#x201D;)
convertible into 600,000 shares of common stock;
(ii)&amp;#xA0;Class&amp;#xA0;A-1 warrants exercisable to purchase 300,000
shares of common stock; (iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants
exercisable to purchase 300,000 shares of common stock; and
(iv)&amp;#xA0;Class B warrants exercisable to purchase 1,200,000 shares
of common stock. Net proceeds from the closing were
$1,548,000.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On May&amp;#xA0;13,
2009, the Company issued and sold, pursuant to the 10X Agreement:
(i)&amp;#xA0;450,000 shares of Series B-2 convertible preferred stock
(&amp;#x201C;Series B-2 redeemable convertible preferred stock&amp;#x201D; or
&amp;#x201C;Series B-2&amp;#x201D;) convertible into 300,000 shares of common
stock; (ii)&amp;#xA0;Class&amp;#xA0;A-1 warrants exercisable to purchase
150,000 shares of common stock; (iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants
exercisable to purchase 150,000 shares of common stock; and
(iv)&amp;#xA0;Class B warrants exercisable to purchase 600,000 shares
of common stock. Net proceeds from the closing were
$801,000.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
June&amp;#xA0;30, 2009, the Company issued and sold, pursuant to the
10X Agreement: (i)&amp;#xA0;250,000 shares of Series B-2 convertible
into 166,666 shares of common stock; (ii)&amp;#xA0;Class&amp;#xA0;A-1
warrants exercisable to purchase 83,333 shares of common stock;
(iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants exercisable to purchase 83,333
shares of common stock; and (iv)&amp;#xA0;Class B warrants exercisable
to purchase 333,333 shares of common stock. Net proceeds from the
closing were $473,000.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
August&amp;#xA0;12, 2009, the Company issued and sold, pursuant to the
10X Agreement: (i)&amp;#xA0;150,000 shares of Series B-2 convertible
into 100,000 shares of common stock; (ii)&amp;#xA0;Class&amp;#xA0;A-1
warrants exercisable to purchase 50,000 shares of common stock;
(iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants exercisable to purchase 50,000
shares of common stock; and (iv)&amp;#xA0;Class B warrants exercisable
to purchase 200,000 shares of common stock. Net proceeds from the
closing were $287,000.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
September&amp;#xA0;30, 2009, the Company issued and sold, pursuant to
the 10X Agreement: (i)&amp;#xA0;162,500 shares of Series B-2
convertible into 108,333 shares of common stock;
(ii)&amp;#xA0;Class&amp;#xA0;A-1 warrants exercisable to purchase 54,166
shares of common stock; (iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants
exercisable to purchase 54,166 shares of common stock; and
(iv)&amp;#xA0;Class B warrants exercisable to purchase 216,666 shares
of common stock. Net proceeds from the closing were
$305,000.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
November&amp;#xA0;4, 2009, the Company issued and sold, pursuant to the
10X Agreement: (i)&amp;#xA0;155,000 shares of Series B-2 convertible
into 103,333 shares of common stock; (ii)&amp;#xA0;Class&amp;#xA0;A-1
warrants exercisable to purchase 51,666 shares of common stock;
(iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants exercisable to purchase 51,666
shares of common stock; and (iv)&amp;#xA0;Class B warrants exercisable
to purchase 206,666 shares of common stock. Net proceeds from the
closing were $296,000.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
December&amp;#xA0;8, 2009, the Company issued and sold, pursuant to the
10X Agreement: (i)&amp;#xA0;162,500 shares of Series B-2 convertible
into 108,333 shares of common stock; (ii)&amp;#xA0;Class&amp;#xA0;A-1
warrants exercisable to purchase 54,167 shares of common stock;
(iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants exercisable to purchase 54,167
shares of common stock; and (iv)&amp;#xA0;Class B warrants exercisable
to purchase 216,667 shares of common stock. Net proceeds from the
closing were $310,000.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
January&amp;#xA0;29, 2010, the Company issued and sold, pursuant to the
10X Agreement: (i)&amp;#xA0;162,500 shares of Series B-2 convertible
into 108,334 shares of common stock; (ii)&amp;#xA0;Class&amp;#xA0;A-1
warrants exercisable to purchase 54,167 shares of common stock;
(iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants exercisable to purchase 54,167
shares of common stock; and (iv)&amp;#xA0;Class B warrants exercisable
to purchase 216,667 shares of common stock. Net proceeds from the
closing were $308,000.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
March&amp;#xA0;8, 2010, the Company issued and sold, pursuant to the
10X Agreement: (i)&amp;#xA0;167,500 shares of Series B-2 convertible
into 111,667 shares of common stock; (ii)&amp;#xA0;Class&amp;#xA0;A-1
warrants exercisable to purchase 55,834 shares of common stock;
(iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants exercisable to purchase 55,834
shares of common stock; and (iv)&amp;#xA0;Class B warrants exercisable
to purchase 223,334 shares of common stock. Net proceeds from the
closing were $322,000.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
April&amp;#xA0;30, 2010, the Company issued and sold, pursuant to the
10X Agreement: (i)&amp;#xA0;155,000 shares of Series B-2 convertible
into 103,334 shares of common stock; (ii)&amp;#xA0;Class&amp;#xA0;A-1
warrants exercisable to purchase 51,667 shares of common stock;
(iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants exercisable to purchase 51,667
shares of common stock; and (iv)&amp;#xA0;Class B warrants exercisable
to purchase 206,667 shares of common stock. Net proceeds from the
closing were $297,000.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On May&amp;#xA0;10,
2010, the Company issued and sold, pursuant to the 10X Agreement:
(i)&amp;#xA0;285,000 shares of Series B-2 convertible into 190,000
shares of common stock; (ii)&amp;#xA0;Class&amp;#xA0;A-1 warrants
exercisable to purchase 95,000 shares of common stock;
(iii)&amp;#xA0;Class&amp;#xA0;A-2 warrants exercisable to purchase 95,000
shares of common stock; and (iv)&amp;#xA0;Class B warrants exercisable
to purchase 380,000 shares of common stock. Net proceeds from the
closing were $536,000.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The terms of
the Series B are as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Dividends&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Holders of the Series
B will be entitled to receive cumulative dividends at the rate of
12%&amp;#xA0;per share per annum (compounding monthly) payable
quarterly which may, at the Company&amp;#x2019;s option, be paid in cash
or common stock. Pursuant to an agreement with the holder of all
shares of Series B, on January&amp;#xA0;26, 2011, the Company amended
and restated the Certificate of Designation of Preferences, Rights
and Limitations for the Series B-1 and Series B-2, to provide that
dividends are payable in cash or shares of Common Stock valued at
100% of the volume weighted average price of the Common Stock for
the 20 consecutive trading days prior to the dividend payment date
on and after September&amp;#xA0;30, 2011. If the Company does not pay
any dividend on the Series B, dividends will accrue at the rate of
15%&amp;#xA0;per annum (compounding monthly).&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Conversion
Rights&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Each share of Series B is
convertible into four-sixths (approximately 0.667) shares of common
stock at the conversion price of $3.00 per share at the option of
(i)&amp;#xA0;the holder, at any time and (ii)&amp;#xA0;the Company, at any
time after February&amp;#xA0;12, 2010 (and upon 10 days notice) if the
common stock is quoted at or above $9.00 for 15 consecutive trading
days and an effective registration statement regarding the
underlying shares of common stock is in effect (subject to certain
monthly volume limits). Pursuant to an agreement with the holder of
all shares of Series B, on January&amp;#xA0;26, 2011, the Company
amended and restated the Certificate of Designation of Preferences,
Rights and Limitations for the Series B-1 and Series B-2, to remove
the Company&amp;#x2019;s right to compel conversion of the Series B
Preferred Stock to shares of its Common Stock&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Redemption
Rights&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Pursuant to an agreement with
the holder of all shares of Series B, on January&amp;#xA0;26, 2011, the
Company amended and restated the Certificate of Designation of
Preferences, Rights and Limitations for the Series B-1 and Series
B-2, to provide that, upon notice of not less than 30 trading days,
a holder of Series B may require the Company to redeem, in whole or
in part at any time on or after the earlier of
(a)&amp;#xA0;February&amp;#xA0;12, 2019 or (b)&amp;#xA0;the date of issuance of
a promissory note to David Platt (see Note 11) in connection with
the achievement of certain milestones under his separation
agreement.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The redemption
price will be equal to the sum of the stated value of the Series B,
plus all accrued but unpaid dividends thereon, as of the redemption
date. If the Company fails to pay the redemption price in cash on
the redemption date, then the holders of the Series B requesting
redemption may, at their sole option, automatically convert their
shares of Series B into a promissory note bearing interest at the
rate of 15%&amp;#xA0;per year and secured by a lien on all of the
Company&amp;#x2019;s assets. So long as any shares of the Series B
remain outstanding, the Company is also subject to restrictions
limiting, among other things, amendments to the Company&amp;#x2019;s
organizational documents; the purchase or redemption of the
Company&amp;#x2019;s capital stock; mergers, consolidations,
liquidations and dissolutions; sales of assets; dividends and other
restricted payments; investments and acquisitions; joint ventures,
licensing agreements, exclusive marketing and other distribution
agreements; issuances of securities; incurrence of indebtedness;
incurrence of liens and other encumbrances and issuances of any
common stock equivalents.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Voting
Rights&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Except as noted below, the
holder of each share of Series B shall be entitled to the number of
votes equal to the number of shares of Common Stock into which such
share of Series B would be convertible, and shall otherwise have
voting rights and powers equal to the voting rights and powers of
the Common Stock. With respect to the election of directors, the
holders of the Series B shall vote together as a separate class to
elect two (2)&amp;#xA0;members of the Board of Directors (the
&amp;#x201C;Series B Directors&amp;#x201D;), and the Company shall take all
reasonably necessary or desirable actions within its control
(including, without limitation, calling special meetings of the
Board of Directors, nominating such persons designated by the
holders of the Series B as directors on the applicable proxy
statements and recommending their election) to permit the holders
of the Series B to appoint two additional (2)&amp;#xA0;members of the
Board of Directors (the &amp;#x201C;Series B Nominees&amp;#x201D;), who shall
be subject to election by all shares of voting stock of the Company
voting together as a single group, until such time as all
authorized shares of Series B have has been issued and sold, after
which the number of Series B Nominees shall be three (3), and shall
remain three (3)&amp;#xA0;until there are no longer any shares of
Series B outstanding. The holders of Series B shall vote together
with the holders of Common Stock and other voting capital stock of
the Company to elect all other members of the Board of
Directors.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Other
Restrictions&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;So long as any shares of
the Series B remain outstanding, the Company may not, without the
approval of the holders of a majority of the shares of Series B
outstanding, among other things, (i)&amp;#xA0;change the size of the
Company&amp;#x2019;s Board of Directors; (ii)&amp;#xA0;amend or repeal the
Company&amp;#x2019;s Articles of Incorporation or Bylaws or file any
articles of amendment designating the preferences, limitations and
relative rights of any series of preferred stock; (iii)&amp;#xA0;create
or increase the authorized amount of any additional class or series
of shares of stock that is equal to or senior to Series B;
(iv)&amp;#xA0;increase or decrease the authorized number of shares of
the Series B; (v)&amp;#xA0;purchase, redeem or otherwise acquire for
value any shares of any class of capital stock; (vi)&amp;#xA0;merge or
consolidate the Company into or with any other corporation or sell,
assign, lease, pledge, encumber or otherwise dispose of all or
substantially all of the Company&amp;#x2019;s assets or those of any
subsidiary; (vii)&amp;#xA0;voluntarily or involuntarily liquidate,
dissolve or wind up the Company or the Company&amp;#x2019;s business;
(viii)&amp;#xA0;pay or declare dividends on any capital stock other
than the Preferred Stock, unless the Series B share ratably in such
dividend and all accrued dividends payable with respect to the
Series B have been paid prior to the payment or declaration of such
dividend; (ix)&amp;#xA0;acquire an equitable interest in, or the assets
or business of any other entity in any form of transaction;
(x)&amp;#xA0;create or commit us to enter into a joint venture,
licensing agreement or exclusive marketing or other distribution
agreement with respect to the Company&amp;#x2019;s products, other than
in the ordinary course of business; (xi)&amp;#xA0;permit the Company or
any subsidiary to sell or issue any security of such subsidiary to
any person or entity other than the Company; (xii)&amp;#xA0;enter into,
create, incur, assume or guarantee any indebtedness for borrowed
money of any kind (other than indebtedness existing on the initial
closing date and approved by Series B shareholders);
(xiii)&amp;#xA0;enter into, create, incur or assume any liens of any
kind (other than certain permitted liens); (xiv)&amp;#xA0;issue any
common stock equivalents; (xv)&amp;#xA0;increase the number of shares
of the Company&amp;#x2019;s common stock that may be issued pursuant to
options, warrants or rights to employees, directors, officers,
consultants or advisors above 250,000.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Warrants&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Each Class&amp;#xA0;A-1
warrant, Class&amp;#xA0;A-2 warrant and Class B warrant is exercisable
at $3.00 per share of common stock at any time on or after the date
of issuance until the fifth anniversary of the respective issue
date. The Company may, upon 30 days notice and so long as an
effective registration statement regarding the underlying shares of
common stock is in effect, issue a termination notice with respect
to (i)&amp;#xA0;each Class&amp;#xA0;A-1 warrant on any trading day on which
the market value of the common stock for each of the 15 previous
trading days exceeded $7.50 per share and (ii)&amp;#xA0;each
Class&amp;#xA0;A-2 warrant on any trading day on which the market value
of the common stock for each of the 15 previous trading days
exceeded $10.50 per share.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The fair value
of the warrants issued in connection with the Series B-1 was
$1,296,000 at the date of issuance based on the following
assumptions: an expected life of 5 years, volatility of 118%, risk
free interest rate of 1.79% and zero dividends. The Company
allocated the gross proceeds based on the relative fair value of
the Series B-1 and the related warrants, resulting in $1,105,000 of
the proceeds being allocated to additional paid-in capital. The
Company analyzed the Series B-1, post-allocation of the gross
proceeds, and determined that there was no beneficial conversion
feature at the date of issuance. The issuance costs of the Series
B-1 and the amounts allocated to warrants were recorded as a
reduction to the carrying value of the Series B-1 when issued, and
are accreted to the redemption value of the Series B-1 through the
earliest redemption date. Due to the redemption feature, the
Company has presented the Series B-1 outside of permanent equity,
in the mezzanine of the consolidated balance sheet at
December&amp;#xA0;31, 2012 and 2011.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The fair value
of the warrants issued during the year ended December&amp;#xA0;31, 2010
in connection with the Series B-2 was $4,148,000 at the dates of
issuance based on the following assumptions: an expected life of 5
years, volatility of 126% to 129%, risk free interest rates of
2.27% to 2.43% and zero dividends. The fair value of the warrants
issued during the year ended December&amp;#xA0;31, 2009 in connection
with the Series B-2 was $5,333,000 at the dates of issuance based
on the following assumptions: an expected life of 5 years,
volatility of 124% to 127%, risk free interest rates of 1.98% to
2.70% and zero dividends. The Company allocated the gross proceeds
based on the relative fair value of the Series B-2 and the related
warrants, resulting in $1,028,000 and $1,732,000 of the proceeds
being allocated to additional paid-in capital for the years ended
December&amp;#xA0;31, 2010 and 2009, respectively. The issuance costs
of the Series B-2 and the amounts allocated to warrants were
recorded as a reduction to the carrying value of the Series B-2
when issued, and are accreted to the redemption value of the Series
B-2 through the earliest redemption dates. Due to the redemption
feature, the Company has presented the Series B-2 outside of
permanent equity, in the mezzanine of the consolidated balance
sheet at December&amp;#xA0;31, 2012 and 2011.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
analyzed the Series B-2, post-allocation of the gross proceeds, and
determined that there was a beneficial conversion feature at the
dates of issuance. Because the closing price of the common stock on
the closing date was greater than the effective conversion price,
$388,000 and $628,000 of the proceeds (limited to the allocation of
the proceeds) during the years ended December&amp;#xA0;31, 2010 and
2009, respectively, were allocated to an embedded beneficial
conversion feature of the Series&amp;#xA0;B-2. The amount allocated to
the beneficial conversion feature was recorded as a discount to the
Series B-2 is being accreted, with such accretion being charged
through the earliest redemption dates.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Series C
6% Super Dividend Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
December&amp;#xA0;29, 2010, the Company designated and authorized the
sale and issuance of up to 1,000 shares of Series C Super Dividend
Convertible Preferred Stock (&amp;#x201C;Series C&amp;#x201D;) with a par
value of $0.01 and a stated value equal to $10,000 (the
&amp;#x201C;Stated Value&amp;#x201D;).&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
December&amp;#xA0;30, 2010, the Company sold and issued 212 shares of
Series C at a price of $10,000 per share for gross proceeds of
$2,120,000. The Company incurred $47,000 of cash transaction costs
resulting in net cash proceeds of $2,073,000. In addition, the
Company issued 500 warrants exercisable at $7.20 to a placement
agent which had a de minimis value.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The terms of
the Series C are as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Conversion
Rights&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Each holder of Series C may
convert all, but not less than all, of his Series C shares plus
accrued and unpaid dividends into Common Stock at the price of
$6.00 per share of Common Stock (&amp;#x201C;Conversion Price&amp;#x201D;),
such that approximately 1,667 shares of Common Stock will be issued
per each converted share of Series C (accrued and unpaid dividends
will be issued as additional shares). At December&amp;#xA0;31, 2011,
the 220 shares of Series C were convertible into a total of 366,676
shares of Common Stock.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Subject to the
continuing obligation to pay post conversion dividends, the Company
may convert all, but not less than all, of the Series C (plus all
accrued and unpaid dividends) into Common Stock, at the Conversion
Price, upon such time that the closing price of the Common Stock is
no less than $18.00 per share for 15 consecutive trading
days.&lt;/font&gt;&lt;/p&gt;
&lt;p style="PADDING-BOTTOM: 0px; MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Dividends&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Holders of Series C
shall be entitled to receive cumulative non-compounding dividends
at the rate per share of Series C equal to the greater of
(i)&amp;#xA0;6%&amp;#xA0;per annum of the Stated Value (also defined as the
&amp;#x201C;Floor&amp;#x201D;) or (ii)&amp;#xA0;2.5% of net sales until the total
dividends paid is equal to the initial investment and 1.25% of net
sales thereafter. The maximum amount each Series C shareholder will
receive in dividend payments is equal to $100,000 (the
&amp;#x201C;Maximum Payout&amp;#x201D;).&amp;#xA0;For purposes of this dividend
calculation, net sales shall mean gross revenues actually received
by the Company, from the sale or licensing of the product
DAVANAT&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline"&gt;&amp;#xAE;&lt;/sup&gt;&lt;/font&gt;
(GM-CT-01), less chargebacks, returns, expenses attributable to
product recalls, duties, customs, sales tax, freight, insurance,
shipping expenses, allowances and other customary
deductions.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The dividend
shall be payable in arrears semi annually on March&amp;#xA0;31 and
September&amp;#xA0;30, beginning with the first such date after the
original issue date; provided, however, that all dividends and all
other distributions shall cease, and no further dividends or other
distributions shall be paid, in respect of each share of Series C
from and after such time that the Maximum Payout has been paid in
respect of such share of Series C. Such dividends shall be payable
at the Company&amp;#x2019;s option either in cash or in duly authorized,
fully paid and non-assessable shares of Common Stock valued at the
higher of (i)&amp;#xA0;$3.00 per share or (ii)&amp;#xA0;the average of the
Common Stock trading price for the ten (10)&amp;#xA0;consecutive
trading days ending on the trading day that is immediately prior to
the dividend payment date.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Series C
Post Conversion Dividend Right&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;In the
event that any share of Series C is converted into Common Stock
before the Maximum Payout is paid in respect of such converted
share of Series C, then the holder shall have the right to continue
to receive dividends in respect of such converted share of Series C
equal to the remaining payout (the &amp;#x201C;Series C Preferred Stock
Post Conversion Dividend Right&amp;#x201D;) which shall be equal to the
Maximum Payout less the cumulative dividends received through the
conversion date. One share of Series C Preferred Stock Post
Conversion Dividend Right shall be issued for each such converted
share of Series C. The holder of each Series C Preferred Stock Post
Conversion Dividend Right shall receive the remaining payout on an
equal basis and in conjunction with the then outstanding shares of
Series C and all the other then outstanding Series C Post
Conversion Dividend Rights, in the same manner and subject to the
same terms and conditions as applicable to the payment of dividends
on each share of Series C, except that for purposes of calculating
the dividend the Floor shall not apply. The Series C Preferred
Stock Post Conversion Dividend Right shall have no stated value,
liquidation preference or right to any dividends or distributions
other than the remaining payout. The Series C Preferred Stock Post
Conversion Right is subject to redemption in the same manner as
outstanding Series C shares.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;At the date of
issuance, the Series C have an embedded dividend right to continue
to receive dividend payments after conversion to common stock (the
Series C Post Conversion Dividend Right) which requires
bifurcation. The value of this post conversion dividend right on
the date of issuance was determined to be de minimis due to the
fact that the payment of a dividend stream other than the 6%
dividend and conversion of Series C prior to the Company achieving
sales of GM-CT-01 was deemed improbable at that time. Upon a
conversion of the Series C, the Company will be required to record
a liability and the related expense during the period of
conversion.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In July 2011, 5
shares of Series C were converted into 8,334 shares of common stock
and 5 Series C Post Conversion Dividend Rights (Dividend Rights)
were issued. In January 2013, 5 shares of Series C were converted
into 8,334 shares of common stock and 5 Dividend Rights were
issued. Per the terms of the Series C, these Dividend Rights shall
continue to participate in dividends, however the Floor shall not
apply. At December&amp;#xA0;31, 2012, these Dividend Rights were
determined to have a de minimis value, as the payment of a dividend
is considered improbable at this time. The Company will continue to
evaluate and assess the Series C Post Conversion Dividend Right for
each reporting period.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Liquidation
Rights&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;In the event of any liquidation,
dissolution or winding up of the Company, either voluntarily or
involuntarily, the holders of Series C will receive $10,000 per
share plus accrued and unpaid dividends, payable prior and in
preference to any distributions to the holders of Common Stock but
after and subordinate to the Series A 12% Convertible Preferred
Stock (&amp;#x201C;Series A&amp;#x201D;), Series B-1 and Series B-2, subject
to the Maximum Payout.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Redemption&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Upon a sale of the
Company, the Company shall redeem all of the then outstanding
shares of Series C and Series C Preferred Stock Post Conversion
Rights within thirty (30)&amp;#xA0;days after the transaction
constituting the sale of the Company is closed and such closing is
fully funded. The price to redeem a share of Series C and each
redeemed Series C Preferred Stock Post Conversion Redemption Right
shall be equal to (i)&amp;#xA0;(A)&amp;#xA0;the applicable return on
investment (&amp;#x201C;ROI&amp;#x201D;) percentage, multiplied by
(B)&amp;#xA0;$10,000, minus (ii)&amp;#xA0;the cumulative dividends received
through the redemption date. The redemption price shall be payable
at the Company&amp;#x2019;s option either in cash or in shares of common
stock valued at the higher of (i)&amp;#xA0;$3.00 per share or
(ii)&amp;#xA0;the average market price for the ten consecutive trading
days ending immediately prior to the date of redemption. The ROI
Percentage shall mean the percentage that applies as of the
redemption date, as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="15%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td width="82%"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" nowrap="nowrap" align="center"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em" align="center"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;u&gt;ROI&amp;#xA0;Percentage&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="8"&gt;&lt;/td&gt;
&lt;td height="8" colspan="2"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" nowrap="nowrap" align="center"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em" align="center"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;200%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;before the second anniversary of the date of
issuance;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" nowrap="nowrap" align="center"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em" align="center"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;250%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;on or after the second anniversary of the date of issuance, but
before the third anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" nowrap="nowrap" align="center"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em" align="center"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;300%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;on or after the third anniversary of the date of issuance, but
before the fourth anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" nowrap="nowrap" align="center"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em" align="center"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;350%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;on or after the fourth anniversary of the date of issuance, but
before the fifth anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" nowrap="nowrap" align="center"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em" align="center"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;400%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;on or after the fifth anniversary of the date of issuance, but
before the sixth anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" nowrap="nowrap" align="center"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em" align="center"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;450%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;on or after the sixth anniversary of the date of issuance, but
before the seventh anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" nowrap="nowrap" align="center"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em" align="center"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;500%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;on or after the seventh anniversary of the date of issuance,
but before the eighth anniversary of the date of issuance;
and&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" nowrap="nowrap" align="center"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em" align="center"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;550%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;on or after the eighth anniversary of the date of issuance, but
before the ninth anniversary of the date of issuance.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Due to the
redemption feature, the Company has presented the Series C outside
of permanent equity, in the mezzanine of the consolidated balance
sheets at December&amp;#xA0;31, 2012 and 2011. At December&amp;#xA0;31,
2012, the Series C redemption value was $5,204,000 and the Series C
Post Conversion Dividend Right redemption value was $123,000. At
March&amp;#xA0;29, 2013, the Series C redemption value was $5,151,000
and the Series C Post Conversion Dividend Right redemption value
was $241,000.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Voting
Rights&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Series C shares have no
voting rights.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_1BB73C8E-496F-4888-A849-1C50DCD0B7CA_1_5">162000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_1_4">-9899000</us-gaap:OperatingIncomeLoss>
  <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_1C67116B-BAC2-41CA-8645-5581919A9182_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Revenue
Recognition&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company records revenue
provided that there is persuasive evidence that an arrangement
exists, the price is fixed and determinable, services were rendered
and collectability is reasonably assured.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
  <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_C9ACA02F-4B32-494E-8562-8B40DA2614C3_1_0">&lt;div&gt;
&lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
&lt;tr&gt;
&lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;3.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;Agreement with PROCAPS
S.A. and Research Grants&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Agreement
with PROCAPS S.A.&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%;padding-bottom:0px;"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;On
March&amp;#xA0;25, 2010, the Company granted PROCAPS S.A.
(&amp;#x201C;PROCAPS&amp;#x201D;) (in the form of a definitive term sheet)
exclusive rights to market and sell GM-CT-01 (formerly
DAVANAT&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;sup style="vertical-align:baseline; position:relative; bottom:.8ex"&gt;&amp;#xAE;&lt;/sup&gt;&lt;/font&gt;)
to treat cancer in Colombia, South America. PROCAPS is an
international, privately held pharmaceutical company based in
Barranquilla, Colombia. In October 2010, the Company received a
payment of $200,000 and shipped GM-CT-01 to PROCAPS to be used by
PROCAPS to qualify its vial filling process and to replicate the
Company&amp;#x2019;s stability study. The $200,000 payment from PROCAPS
was included as deferred income on the condensed consolidated
balance sheets as of December&amp;#xA0;31, 2011.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;On
October&amp;#xA0;18, 2011, the Company entered into a Collaboration,
Supply, Marketing and Distribution Agreement (the
&amp;#x201C;Agreement&amp;#x201D;) with PROCAPS. The Agreement granted
PROCAPS first negotiation rights to enter into similar agreements
in other Central and South American countries. The Company was to
be the sole manufacturer and supplier of GM-CT-01 to PROCAPS. The
Agreement obligated PROCAPS to procure regulatory approvals
necessary for the marketing and sale of GM-CT-01 naming the Company
as the owner of such approvals to the extent permitted by law, or
alternatively hold the approvals for the Company&amp;#x2019;s benefit.
PROCAPS was to pay the Company a stated fee for each dose it
purchased and royalties at an incremental rate determined by annual
net sales of GM-CT-01. The Company retains all intellectual
property rights to GM-CT-01 and related products and PROCAPS may
not produce, modify, reverse engineer, or otherwise interfere with
the GM-CT-01 compound. PROCAPS was not able to manufacture or sell
products that compete with GM-CT-01 during the term of the
Agreement and for five years thereafter.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;PROCAPS had not
obtained approval to sell GM-CT-01 in Columbia as required by the
Agreement and, as they were in material breach of the Agreement,
the Company terminated the Agreement, effective September&amp;#xA0;29,
2012. With no further obligations, the Company recognized the
$200,000 payment as Other Income in the Statements of Operations
during the year ended December&amp;#xA0;31, 2012.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:18px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Qualifying
Therapeutic Discovery Project&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;In October 2010,
the Company was notified that it was awarded $489,000 total in two
federal grants under the Qualifying Therapeutic Discovery Project
(&amp;#x201C;QTDP&amp;#x201D;) Program for its GM-CT-01 anti-cancer compound
and for its GR/GM-Series of anti-fibrotic, cirrhosis compounds for
work performed during 2010 and 2009. The Company recognized this
grant in other income in the statement of operations for the year
ended December&amp;#xA0;31, 2010. The Company received $255,000 of the
grant in 2010 and the remaining $234,000 was received in
2011.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_1_21">10403000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_31D7BB77-EB99-47E7-9A78-47F8A8C7E149_2001_3">P5Y4M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_E0251F3D-14EF-4B36-9001-30C1E99F3898_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Stock-Based
Compensation.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;Stock-based compensation
cost is measured at the grant date based on the fair value of the
award and is recognized as expense over the service period, which
generally represents the vesting period. For awards that have
performance based vesting conditions the Company recognizes the
expense over the estimated period that the awards are expected to
be earned. The Company generally uses the Black-Scholes
option-pricing model to calculate the grant date fair value of
stock options. For options that only vest upon the achievement of
market conditions, the Company values the options using a Monte
Carlo model to calculate the grant date fair value of the stock
options. The expense related to options that vest based on market
conditions is not reversed should those options not ultimately
vest. The expense recognized over the service period is required to
include an estimate of the awards that will be
forfeited.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_12013_1600022">56000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_12013_1600037">2766000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_D38119FE-C309-44C9-B627-B9E50FDE3850_7001_400007">1379739</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_D546B06A-BF8A-4705-B46E-20FE1079F7F8_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Property and
Equipment.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;Property and equipment,
including leasehold improvements, are stated at cost, net of
accumulated depreciation, and are depreciated using the
straight-line method over the estimated useful lives of the related
assets of generally three years for computers and office equipment,
five years for furniture and fixtures and the shorter of the useful
life or life of the lease for leasehold improvements.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="pure" decimals="2" id="id_1168147_307FDB3A-2104-4989-929B-253F32FC3091_1_2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_DE5EEE53-1E24-4615-A064-FF2D735D3CC0_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Cash and
Cash Equivalents.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;The Company considers
all highly-liquid investments with original maturities of 90 days
or less at the time of acquisition to be cash
equivalents.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:EarningsPerShareTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_4A8C75B0-8194-4C5E-B3E0-FF7B9F6976A9_1_0">&lt;div&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr&gt;
&lt;td valign="top" width="4%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;10.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Loss Per
Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Basic net loss
per common share is computed by dividing the net loss available to
common stockholders by the weighted average number of common shares
outstanding during the period. Diluted net loss per common share is
computed by dividing the net loss available to common stockholders
by the weighted average number of common shares and other potential
common shares then outstanding. Potential common shares consist of
common shares issuable upon the assumed exercise of in-the-money
stock options and warrants and potential common shares related to
the conversion of the preferred stock. The computation of diluted
net loss per share does not assume the issuance of common shares
that have an anti-dilutive effect on net loss per share.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"&gt;
&lt;tr&gt;
&lt;td width="77%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year&amp;#xA0;Ended&amp;#xA0;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(in&amp;#xA0;thousands,&amp;#xA0;except&amp;#xA0;share&lt;br /&gt;
and per share amounts)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;2012&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;2011&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Basic and diluted net loss
per common share:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(9,675&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(10,915&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Preferred stock
dividends&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(976&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,568&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Preferred stock
accretion&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(230&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(230&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss applicable to
common stockholders&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(10,881&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(12,713&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Weighted average common
shares outstanding&amp;#x2014;basic and diluted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;15,131&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;11,986&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss per common
share&amp;#x2014;basic and diluted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.72&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1.06&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Dilutive shares
which could exist pursuant to the exercise of outstanding stock
instruments and which were not included in the calculation because
their affect would have been anti-dilutive during are as
follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"&gt;
&lt;tr&gt;
&lt;td width="74%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(Shares)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(Shares)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Warrants to purchase shares
of common stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,424,241&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6,673,405&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Options to purchase shares
of common stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,539,961&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,091,474&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Shares of common stock
issuable upon conversion preferred stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,627,110&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,627,110&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;13,591,312&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;12,391,989&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_1_4">2792000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_DD7E11D3-E508-4A68-939D-30C68D6D67C1_7001_7">2.13</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_1168147_978BDCCB-1131-4951-BEF4-C79D4419A824_1_4">0.033</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_DD7E11D3-E508-4A68-939D-30C68D6D67C1_7001_8">8.93</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_1_12">-577000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInRestrictedCash contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_1_17">-69000</us-gaap:IncreaseDecreaseInRestrictedCash>
  <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_C19F9181-1F26-4028-B374-8EE6B0F4C153_1_0">&lt;div&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;The components
of the net deferred tax assets are as follows at
December&amp;#xA0;31:&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
&lt;tr&gt;
&lt;td width="77%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="6" align="center"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;(in
thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Operating loss
carryforwards&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;21,753&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;19,119&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Tax credit
carryforwards&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;317&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;330&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Other temporary
differences&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2,921&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2,070&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;24,991&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;21,519&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Less valuation
allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(24,991&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(21,519&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Net deferred tax
asset&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_1_13">6000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_1_16">-0.72</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_1BB73C8E-496F-4888-A849-1C50DCD0B7CA_1_0">51830</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:FairValueDisclosuresTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_45701AEC-F5DC-48B7-8D33-B3A5F1D132B1_1_0">&lt;div&gt;
&lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
&lt;tr&gt;
&lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;9.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;Fair Value of Financial
Instruments&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;A summary of
changes in the Warrant Liabilities is as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="84%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
&lt;tr&gt;
&lt;td width="84%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="13%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Fair&amp;#xA0;Value&amp;#xA0;of&lt;br /&gt;
Warrant&lt;br /&gt;
Liabilities&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;(in&amp;#xA0;thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Balance December&amp;#xA0;31,
2010&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;861&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:3.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Change in fair value of
warrant liabilities&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;524&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:3.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Intrinsic value of liability
warrants exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(1,385&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Balance December&amp;#xA0;31,
2011&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;The warrant
liabilities in the table above were classified as a Level 2
liability and were valued using the Black-Scholes pricing
model.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:BasisOfAccounting contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_825B7F39-70BF-4B65-875E-517C6AA77DA8_1_0">&lt;div&gt;
&lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
&lt;tr&gt;
&lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;1.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;Nature of Business and
Basis of Presentation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;Galectin
Therapeutics Inc. (the &amp;#x201C;Company&amp;#x201D;) is a
development-stage company that is applying its leadership in
galectin science and drug development to create new therapies for
fibrotic disease and cancer. These candidates are based on the
Company&amp;#x2019;s targeting of galectin proteins which are key
mediators of biologic and pathologic function. These compounds also
may have application for drugs to treat other diseases and chronic
health conditions.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;On
March&amp;#xA0;23, 2012, the Company effected a one-for-six reverse
stock split. All common share and per share amounts in these
financial statements have been adjusted to reflect the effect of
the reverse split. On March&amp;#xA0;28, 2012, the Company sold
2,666,722 shares of common stock and related $5.63 warrants to
purchase 1,333,361 shares of common stock for gross proceeds of
$12,000,000 (net proceeds of $10,403,000). See Note 6, for further
discussion of the transaction.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;The Company has
operated at a loss since its inception and has had no significant
revenues. The Company anticipates that losses will continue for the
foreseeable future. At December 31, 2012, the Company had
$9,364,000 of unrestricted cash and cash equivalents available to
fund future operations. The Company believes that with the cash on
hand at December 31, 2012, there is sufficient cash to fund
operations through the first quarter of 2014. The Company&amp;#x2019;s
ability to fund operations after its current cash resources are
exhausted depends on its ability to obtain additional financing or
achieve profitable operations, as to which no assurances can be
given. The Company has developed several plans, including cost
containment efforts and potential strategic alternatives in the
event that such financing cannot be realized by the Company.
Accordingly, based on the forecasts and estimates underlying the
Company&amp;#x2019;s current operating plan, the financial statements do
not currently include any adjustments that might be necessary if
the Company is unable to continue as a going concern.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;As shown in the
consolidated financial statements, the Company incurred cumulative
net losses applicable to common stockholders of $80.3 million for
the cumulative period from inception (July 10, 2000) through
December&amp;#xA0;31, 2012. The Company&amp;#x2019;s net losses have
resulted principally from costs associated with (i)&amp;#xA0;research
and development expenses, including clinical trial costs,
(ii)&amp;#xA0;general and administrative activities and (iii)&amp;#xA0;the
Company&amp;#x2019;s financing transactions including interest, dividend
payments, and the costs related to fair value accounting for the
Company&amp;#x2019;s convertible debt instruments. As a result of
planned expenditures for future research, discovery, development
and commercialization activities and potential legal cost to
protect its intellectual property, the Company expects to incur
additional losses and use additional cash in its operations for the
foreseeable future. Through December&amp;#xA0;31, 2012, the Company had
raised a net total of $68.8 million in capital through sale and
issuance of common stock, common stock purchase warrants,
convertible preferred stock and debt securities in public and
private offerings. From inception (July 10, 2000) through
December&amp;#xA0;31, 2012, the Company used cash of $58.6 million in
its operations.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;The Company was
founded in July 2000, was incorporated in the State of Nevada in
January 2001 under the name &amp;#x201C;Pro-Pharmaceuticals,
Inc.,&amp;#x201D; and changed its name to &amp;#x201C;Galectin Therapeutics
Inc.&amp;#x201D; on May&amp;#xA0;26, 2011.&amp;#xA0;On&amp;#xA0;March&amp;#xA0;23, 2012,
the Company began trading on The NASDAQ Capital Market under the
symbol GALT. Prior to March&amp;#xA0;23, 2012, the Company was traded
on the Over-the Counter Bulletin Board (&amp;#x201C;OTCBB&amp;#x201D;) under
the symbol GALT.OB (previously PRWP.OB) from January&amp;#xA0;21, 2009
to March&amp;#xA0;22, 2012 after the Company was delisted from the NYSE
Alternext US (&amp;#x201C;Exchange&amp;#x201D;), formerly the American Stock
Exchange, due to non-compliance with the Exchange minimum
shareholders&amp;#x2019; equity requirements on January&amp;#xA0;9,
2009.&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:1px;margin-top:12px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="margin-top:0px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;The Company is
subject to a number of risks similar to those of other
development-stage companies, including dependence on key
individuals, uncertainty of product development and generation of
revenues, dependence on outside sources of capital, risks
associated with clinical trials of products, dependence on
third-party collaborators for research operations, need for
regulatory approval of products, risks associated with protection
of intellectual property, and competition with larger,
better-capitalized companies. Successful completion of the
Company&amp;#x2019;s development program and, ultimately, the attainment
of profitable operations is dependent upon future events, including
obtaining adequate financing to fulfill its development activities
and achieving a level of revenues adequate to support the
Company&amp;#x2019;s cost structure. There are no assurances that the
Company will be able to obtain additional financing on favorable
terms, or at all, or successfully market its products.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:BasisOfAccounting>
  <us-gaap:ConcentrationRiskCreditRisk contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_0DC8716D-F2F7-4684-B4CA-B90954CC30D9_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Concentration of Credit
Risk.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;Financial instruments that subject
the Company to credit risk consist of cash and cash equivalents and
certificates of deposit. The Company maintains cash and cash
equivalents and certificates of deposit with well-capitalized
financial institutions. At times, those amounts may exceed
federally insured limits. The Company has no significant
concentrations of credit risk.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_1_3">9000</us-gaap:DepreciationAndAmortization>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="pure" decimals="2" id="id_1168147_978BDCCB-1131-4951-BEF4-C79D4419A824_1_6">0.00</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_E83B26F4-E3A6-4973-A21B-1379180C02C0_1_1">P5Y9M22D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ProceedsFromStockOptionsExercised contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_1BB73C8E-496F-4888-A849-1C50DCD0B7CA_1_2">0</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_1_14">-7500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_1_19">64000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_1_6">24000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_6C061010-CFE1-44A6-BF58-17E645015C79_1_0">&lt;div&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;Property and
equipment consists of the following at December&amp;#xA0;31:&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
&lt;tr&gt;
&lt;td width="85%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="6" align="center"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;(in
thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Leasehold
improvements&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;15&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Computer and office
equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;13&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;199&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Furniture and
fixtures&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;59&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;107&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;74&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;321&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Less accumulated
depreciation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(66&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(315&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:3.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Property and
equipment&amp;#x2014;net&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;8&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;6&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_08BAA335-03E2-4AFF-82E1-64E4D8648A95_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Intangible
Assets.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;Intangible assets include patent
costs, consisting primarily of related capitalized legal fees,
which are amortized over an estimated useful life of five years
from issuance. Amortization expense in 2012 and 2011 was $6,000 and
$3,000, respectively. Gross intangible assets at December&amp;#xA0;31,
2012 and 2011 totaled $78,000 each year, and accumulated
amortization at December&amp;#xA0;31, 2012 and 2011 totaled $48,000 and
$42,000, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_DD7E11D3-E508-4A68-939D-30C68D6D67C1_7001_9">2.31</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_1168147_978BDCCB-1131-4951-BEF4-C79D4419A824_1_1">-0.053</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_1168147_17A1D7D0-FFF8-4C9B-9B71-F0B6F71BA213_1_1">68800000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_1_16">5000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_1_31">2967000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_1_2">5372000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:DerivativesPolicyTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_E194271E-F78D-41F8-8B53-BBB9C1EAC0AC_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Warrants.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;The Company has issued
common stock warrants in connection with the execution of certain
equity and debt financings. Certain warrants were accounted for as
derivative liabilities at fair value. Such warrants did not meet
the accounting criteria that a contract should not be considered a
derivative instrument if it is (1)&amp;#xA0;indexed to its own stock
and (2)&amp;#xA0;classified in stockholders&amp;#x2019; equity. Changes in
fair value of derivative liabilities are recorded in the
consolidated statement of operations under the caption
&amp;#x201C;Change in fair value of warrant liabilities.&amp;#x201D; Warrants
that are not considered derivative liabilities are accounted for at
fair value at the date of issuance in additional paid-in capital.
The fair value of warrants was determined using the Black-Scholes
option-pricing model. There were no warrant liabilities as of
December&amp;#xA0;31, 2012 or 2011.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_1_11">55000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_EF3241BF-3468-4E6A-8B5F-2F8915F3B83C_7001_7">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:SubsequentEventsTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_E53C418E-6118-4E06-BBC1-88B41717A828_1_0">&lt;div&gt;
&lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
&lt;tr&gt;
&lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;13.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;Subsequent
Events&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;The Company has
evaluated all events or transactions that occurred through the date
on which the financial statements were issued, noting the
following:&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:18px;margin-bottom:0px; margin-left:2%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Agreement
with CTI for Phase I Clinical Trial&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;On&amp;#xA0;February
1, 2013, the Company entered into an Amended and Restated Master
Services Agreement (the &amp;#x201C;Agreement&amp;#x201D;) with CTI Clinical
Trial Services, Inc. and CTI Clinical Consulting Services,
Inc.&amp;#xA0;(individually and collectively, &amp;#x201C;CTI&amp;#x201D;),
whereby CTI will assist the Company in the design, development and
conduct of one or more clinical research studies from time to
time.&amp;#xA0;All work performed by CTI for the Company will be
conducted pursuant to the terms of work orders that describe the
specific obligations undertaken by CTI with respect to any
particular clinical research study sponsored or conducted by the
Company.&amp;#xA0;Unless otherwise terminated sooner in accordance with
the terms of the Agreement, the Agreement will be effective until
January&amp;#xA0;31, 2018.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;On
February&amp;#xA0;1, 2013, the Company entered into a work order (the
&amp;#x201C;Work Order&amp;#x201D;) with CTI in accordance with the terms of
the Agreement.&amp;#xA0;The Work Order provides that CTI will provide
services with respect to the Company&amp;#x2019;s Phase I Clinical Trial
to evaluate the safety of the Company&amp;#x2019;s drug GR-MD-02 in
subjects with Non-Alcoholic Steatohepatitis (&amp;#x201C;NASH&amp;#x201D;)
with advanced hepatic fibrosis.&amp;#xA0;CTI will provide the following
services, amongst others,&amp;#xA0;with respect to the Work Order:
reviewing and providing notices regarding IND safety reports,
selecting investigators and monitors for the study, informing
investigators of new observations, monitoring the progress of the
study and reviewing ongoing investigations, keeping certain
records, inspecting the Company&amp;#x2019;s records and reports, and
disposing of any unused supply of the investigational
drug.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;The Work Order
provides for CTI&amp;#x2019;s anticipated involvement in the study from
February&amp;#xA0;1, 2013 until March&amp;#xA0;31, 2014.&amp;#xA0;The estimated
budget for the Work Order is $2,155,000, which is subject to change
as necessary, with payments made throughout the term of the project
as the work is performed.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;The Agreement or
any work order may be terminated for any reason by any party upon
ninety (90)&amp;#xA0;days prior written notice to the other party. In
addition, the Agreement may be terminated by either party
immediately if the other party becomes insolvent, is dissolved or
liquidated, makes a general assignment for the benefit of its
creditors, files or has filed against it (and does not obtain a
dismissal within ninety (90)&amp;#xA0;days) a petition of bankruptcy,
or has a receiver appointed for it or a substantial part of its
assets, among other reasons. Further, the Agreement or any relevant
work order may be terminated immediately by written notice from the
Company, in the following circumstances: (1)&amp;#xA0;the FDA withdraws
authorization and approval to conduct a study; or (2)&amp;#xA0;the
Company reasonably determines that for medical, clinical or patient
safety reasons, a study should terminate immediately. In addition,
either party may terminate the Agreement or any work order for
material breach upon thirty (30)&amp;#xA0;days&amp;#x2019; written notice
specifying the nature of the breach, if such breach has not been
substantially cured within the thirty (30)&amp;#xA0;day
period.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:18px;margin-bottom:0px; margin-left:2%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Drug
Discovery Program with the University of Georgia&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;In February
2013, the Company established a collaborative drug discovery
program at the&amp;#xA0;Complex Carbohydrate Research Center&amp;#xA0;at
the&amp;#xA0;University of Georgia. This program is focused on the
discovery of new carbohydrate molecules that can be used in the
therapy of diseases where galectin proteins play a major role,
including cancer and inflammatory and fibrotic disorders. The term
of the agreement is effective through December&amp;#xA0;31, 2013, for
which the Company will provide funding of $154,000.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_9B5DC16D-9A0A-45B4-843D-87D967EF0B53_1_3">P3Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_0AFF21F1-4760-4F29-8286-95362EFBABF0_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
table summarizes the stock option activity in the stock based
compensation plans:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"&gt;
&lt;tr&gt;
&lt;td width="49%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number of&lt;br /&gt;
Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Average&lt;br /&gt;
Exercise&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
Average&lt;br /&gt;
Remaining&lt;br /&gt;
Contractual&lt;br /&gt;
Life&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(in
years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Aggregate&lt;br /&gt;
Intrinsic&amp;#xA0;Value&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(in
thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding,
December&amp;#xA0;31, 2010&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,965,748&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.42&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 5em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,676,712&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7.02&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 5em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Forfeited/Cancelled&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(334,543&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8.93&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 5em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(216,443&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.21&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding,
December&amp;#xA0;31, 2011&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,091,474&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.83&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 5em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;800,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.13&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 5em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Forfeited/Cancelled&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(299,683&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8.93&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 5em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(51,830&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.31&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding,
December&amp;#xA0;31, 2012&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,539,961&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.66&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.79&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;279&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercisable,
December&amp;#xA0;31, 2012&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,067,910&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.96&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.41&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;268&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ConversionOfStockSharesIssued1 contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_1BB73C8E-496F-4888-A849-1C50DCD0B7CA_1_4">51830</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:OtherNonoperatingIncome contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_1_10">200000</us-gaap:OtherNonoperatingIncome>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_31D7BB77-EB99-47E7-9A78-47F8A8C7E149_2001_2">P6Y9M15D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_1_1">4527000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_1168147_978BDCCB-1131-4951-BEF4-C79D4419A824_1_2">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_1_30">10403000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_1A86DEE4-E7F8-42E5-8438-61C21ADF36A7_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Income
Taxes.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company accounts for income
taxes in accordance with the accounting rules that requires an
asset and liability approach to accounting for income taxes based
upon the future expected values of the related assets and
liabilities. Deferred income tax assets and liabilities are
determined based on the differences between the financial reporting
and tax bases of assets and liabilities and for tax loss and credit
carry forwards, and are measured using the expected tax rates
estimated to be in effect when such basis differences reverse.
Valuation allowances are established, if necessary, to reduce the
deferred tax asset to the amount that will, more likely than not,
be realized.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_A8F49F29-3CD0-43C6-94A2-3451CC20A3EF_1_0">&lt;div&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;Dilutive shares
which could exist pursuant to the exercise of outstanding stock
instruments and which were not included in the calculation because
their affect would have been anti-dilutive during are as
follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
&lt;tr&gt;
&lt;td width="74%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;(Shares)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;(Shares)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Warrants to purchase shares
of common stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;7,424,241&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;6,673,405&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Options to purchase shares
of common stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3,539,961&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3,091,474&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Shares of common stock
issuable upon conversion preferred stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2,627,110&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2,627,110&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;13,591,312&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;12,391,989&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_1DAEC18C-88ED-42D1-82AD-9277A93E3A5C_1_0">&lt;div&gt;
&lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
&lt;tr&gt;
&lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;4.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;Property and
Equipment&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;Property and
equipment consists of the following at December&amp;#xA0;31:&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
&lt;tr&gt;
&lt;td width="85%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="6" align="center"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;(in
thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Leasehold
improvements&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;15&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Computer and office
equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;13&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;199&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Furniture and
fixtures&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;59&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;107&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;74&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;321&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Less accumulated
depreciation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(66&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(315&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:3.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Property and
equipment&amp;#x2014;net&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;8&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;6&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; text-indent:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;Depreciation
expense for the years ended December&amp;#xA0;31, 2012 and 2011 was
$3,000 and $6,000, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_EF3241BF-3468-4E6A-8B5F-2F8915F3B83C_7001_8">299683</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_1E68D82E-2AE2-4F01-91AE-ADF1868D9BCD_1_0">&lt;div&gt;
&lt;p style="margin-top:0px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;The following
table summarizes information with regard to outstanding warrants
issued in connection with equity and debt financings and
consultants as of December&amp;#xA0;31, 2012.&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
&lt;tr&gt;
&lt;td width="50%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;
&lt;p style="border-bottom:1px solid #000000;width:90pt"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Issued in Connection
With&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
Issued&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Exercise&lt;br /&gt;
Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Exercisable&amp;#xA0;Date&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Expiration&amp;#xA0;Date&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;February&amp;#xA0;25, 2008
Common Stock Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.70 Investor
Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;710,834&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;4.20&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;August&amp;#xA0;25,&amp;#xA0;2008&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;August&amp;#xA0;25,&amp;#xA0;2013&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;February&amp;#xA0;12, 2009
Series B-1 Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;300,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;February&amp;#xA0;12,&amp;#xA0;2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;February&amp;#xA0;12,&amp;#xA0;2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,200,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;February 12,
2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;February 12,
2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May&amp;#xA0;13, 2009 Series B-2
Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;150,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 13, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 13, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;600,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 13, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 13, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June&amp;#xA0;30, 2009 Series
B-2 Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;83,333&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June 30, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June 30, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;333,333&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June 30, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June 30, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;April&amp;#xA0;15, 2009
Consultant Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;33,333&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;April 15, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;April 15, 2013&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May&amp;#xA0;1, 2009 Consultant
Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;74,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 1, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 1, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June&amp;#xA0;30, 2009
Consultant Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;40,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June 30, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June 30, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;July&amp;#xA0;26, 2009
Consultant Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;16,667&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;July 26, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;July 26, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;August&amp;#xA0;12, 2009 Series
B-2 Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;50,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;August 12, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;August 12, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;200,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;August 12, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;August 12, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;September&amp;#xA0;30, 2009
Series B-2 Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;54,166&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;September&amp;#xA0;30,&amp;#xA0;2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;September&amp;#xA0;30,&amp;#xA0;2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;216,666&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;September 30,
2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;September 30,
2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;November&amp;#xA0;4, 2009 Series
B-2 Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;51,666&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;November 4, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;November 4, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;206,666&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;November 4, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;November 4, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December&amp;#xA0;8, 2009 Series
B-2 Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;54,167&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December 8, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December 8, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;216,667&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December 8, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December 8, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;January&amp;#xA0;29, 2010 Series
B-2 Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;54,167&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;January 29, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;January 29, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;216,667&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;January 29, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;January 29, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;March&amp;#xA0;8, 2010 Series
B-2 Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;55,834&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;March 8, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;March 8, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;223,334&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;March 8, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;March 8, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;April&amp;#xA0;30, 2010 Series
B-2 Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;51,667&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;April 30, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;April 30, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;206,667&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;April 30, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;April 30, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May&amp;#xA0;10, 2010 Series B-2
Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;95,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 10, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 10, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;380,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 10, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 10, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May&amp;#xA0;25, 2010 Consultant
Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;28,334&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;4.50&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 25, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 25, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May&amp;#xA0;25, 2010 Consultant
Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;7,500&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;15.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 25, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 25, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June&amp;#xA0;15, 2010
Consultant Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;100,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;4.26&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June 15, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June 15, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December&amp;#xA0;9, 2010
Consultant Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;33,334&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.90&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December 9, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December 9, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December&amp;#xA0;30, 2010
Placement Agent Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;500&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;7.20&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December 30,
2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December 30,
2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;March&amp;#xA0;28, 2012 Offering
Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,333,361&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5.63&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;March 28, 2012&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;March 28, 2017&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2012 Offering Placement
Agent Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;46,378&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5.63&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;March 28, 2012&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 2, 2016&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:7.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Total outstanding
warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;7,424,241&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
  <us-gaap:OperatingExpenses contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_1_3">9899000</us-gaap:OperatingExpenses>
  <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_4141865C-0410-4126-830B-14337AC29F81_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Comprehensive Income
(Loss).&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;Comprehensive income (loss) is
defined as the change in equity of a business enterprise during a
period from transactions and other events and circumstances from
non-owner sources. The Company does not have any items of
comprehensive income (loss) other than net losses as
reported.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="pure" decimals="2" id="id_1168147_E83B26F4-E3A6-4973-A21B-1379180C02C0_1_2">1.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_F11ABBE1-1880-4DD8-80ED-6B4A2241675E_1_0">&lt;div&gt;
&lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
&lt;tr&gt;
&lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;12.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;Income
Taxes&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;The components
of the net deferred tax assets are as follows at
December&amp;#xA0;31:&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
&lt;tr&gt;
&lt;td width="77%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="6" align="center"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;(in
thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Operating loss
carryforwards&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;21,753&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;19,119&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Tax credit
carryforwards&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;317&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;330&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Other temporary
differences&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2,921&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2,070&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;24,991&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;21,519&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Less valuation
allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(24,991&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(21,519&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Net deferred tax
asset&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;The primary
factors affecting the Company&amp;#x2019;s income tax rates were as
follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="84%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
&lt;tr&gt;
&lt;td width="85%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Tax benefit at U.S.
statutory rates&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(34&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(34&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;State tax benefit&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(5.3&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(5.3&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Credit&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(0.2&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(1.0&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Permanent
differences&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1.4&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.5&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Expiring state
NOL&amp;#x2019;s&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.3&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.4&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Changes in valuation
allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;34.8&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;33.4&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;As of
December&amp;#xA0;31, 2012, the Company has federal and state net
operating loss carryforwards totaling $60,886,000 and $25,160,000
respectively, which expire through 2032. The net operating losses
include Federal and State excess benefits related to stock options
of $707,000 that will be charged to additional paid-in capital when
utilized. In addition, the Company has federal and state research
and development credits of $223,000 and $143,000, respectively,
which expire through 2032. Ownership changes, as defined by
Section&amp;#xA0;382 of the Internal Revenue Code, may have limited the
amount of net operating loss carryforwards that can be utilized
annually to offset future taxable income. Subsequent ownership
changes could further affect the limitation in future years.
Because of the Company&amp;#x2019;s limited operating history and its
recorded losses, management has provided, in each of the last two
years, a 100% valuation allowance against the Company&amp;#x2019;s net
deferred tax assets.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;On
January&amp;#xA0;3, 2013, the American Taxpayer Relief Act of 2012 was
signed into law reinstating the federal research and development
credit for the 2012 and 2013 years.&amp;#xA0;Under ASC 740-10-25 the
effects are recognized as a component of income tax expense or
benefit from continuing operations in the financial statements for
the interim or annual period that includes the enactment
date.&amp;#xA0;The benefit related to the 2012 federal research and
development credit $61,000 will be recorded during 2013.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;At
December&amp;#xA0;31, 2012 the Company has $1,082,000 of unrecognized
tax benefits, $923,000 of which would affect the effective tax
rate. The Company has not recognized an adjustment to the deficit
accumulated during the development stage for unrecognized tax
benefits because a full valuation allowance has been recorded
against net operating loss carry forwards. Since the
Company&amp;#x2019;s net deferred tax assets and the unrecognized tax
benefits would not result in a cash payment, the Company has not
accrued for any interest and penalties relating to these
unrecognized tax benefits. Should the Company incur interest and
penalties related to income taxes, those amounts would be included
in income tax expense. Total amounts of unrecognized tax benefits
are not expected to significantly increase or decrease within 12
months of the reporting date.&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:1px;margin-top:12px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="margin-top:0px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;The Company is
subject to taxation in the U.S. and various states. Based on the
history of net operating losses all jurisdictions and tax years are
open for examination until the operating losses are utilized or the
statute of limitations expires.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_0B3CE1A1-8B44-43D5-8DB8-85364BE1CC38_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Restricted
Cash and Security Deposit.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;Restricted
cash consists of security deposits principally for a real estate
lease at December&amp;#xA0;31, 2011. At December&amp;#xA0;31, 2012, the
Company had a security deposit of $6,000 for leased office
space.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="pure" decimals="2" id="id_1168147_978BDCCB-1131-4951-BEF4-C79D4419A824_1_0">-0.34</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:ConsolidationPolicyTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_194E4279-EC35-46E7-91AF-CE754227E795_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Basis of
Consolidation.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;The consolidated
financial statements include the accounts of the Company and
Galectin Therapeutics Security Corp., its wholly-owned subsidiary,
which was incorporated in Delaware on December&amp;#xA0;23, 2003.
Galectin Therapeutics Security Corp. holds the cash and cash
equivalents that are not required to fund current operating needs.
All intercompany transactions have been eliminated.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
  <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_9D0FF1EB-321A-4E87-9896-DB74CFC23551_1_0">&lt;div&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;Accrued expenses
consist of the following at December&amp;#xA0;31:&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
&lt;tr&gt;
&lt;td width="82%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="6" align="center"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;(in
thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Legal and accounting
fees&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;109&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;69&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Accrued
compensation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;42&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;385&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Severance agreement (Note
11)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;10&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;97&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:3.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,161&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,551&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
  <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_C41A5CD7-A99E-44BD-A8F6-5C39A1D28556_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Research and
Development Expenses.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;Costs associated
with research and development are expensed as incurred. Research
and development expenses include, among other costs, salaries and
other personnel-related costs, and costs incurred by outside
laboratories and other accredited facilities in connection with
clinical trials and preclinical studies.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_1168147_978BDCCB-1131-4951-BEF4-C79D4419A824_1_5">0.348</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:Depreciation contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_A273B911-C806-4E8D-A439-0FAB037F8A4F_1_0">3000</us-gaap:Depreciation>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_F522E258-7681-48E9-B4BD-BD98F093EE2A_1_0">&lt;div&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr&gt;
&lt;td valign="top" width="4%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;11.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Commitments and
Contingencies&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Lease
Commitments&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In September
2012, the Company entered into an operating lease for office space
in Norcross, GA for a term of twenty-six months, beginning on
October&amp;#xA0;1, 2012 and ending November&amp;#xA0;30, 2014 at a rate of
$3,000 per month. The lease provides for free rent for the first
two months of the lease and required a security deposit of $6,000.
In addition to base rental payments included in the contractual
obligations table above, we are responsible for our pro-rata share
of the operating expenses for the building.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In October
2012, the Company entered into an operating lease for office space
collocated with lab space for research and development activities.
The lease is for a period of one year, beginning on October&amp;#xA0;1,
2012, for a rate of $15,000 for the term, payable in equal monthly
increments.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In July 2011,
the Company entered into an agreement to amend its lease for
offices in Newton, MA to extend the term for a period of one year,
which expired on September&amp;#xA0;30, 2012, at a base rent of
$235,000 for the period. In addition to base rental payments, the
Company was responsible for its pro-rata share of increases in the
operating expenses for the building. In connection with this lease,
a commercial bank issued a letter of credit collateralized by cash,
which the Company had on deposit with the bank of $59,000 at
December&amp;#xA0;31, 2011 and which was released during 2012 after the
lease term ended. In July 2011, the Company entered into an
operating lease for an apartment for Company executive use for a
one-year term, which ended in August 2012, at a rate of $44,000 for
the term.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Rent expense
under the above operating leases was $216,000 and $293,000 for the
years ended December&amp;#xA0;31, 2012 and 2011,
respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Future minimum
payments under this lease as of December&amp;#xA0;31, 2012 are as
follows (in thousands):&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="84%" align="center"&gt;
&lt;tr&gt;
&lt;td width="93%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;
&lt;p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 88pt"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year ended
December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2013&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;49&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2014&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;36&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total lease
payments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;85&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Separation Agreement&amp;#x2014;Former Chief Executive Officer
and Chairman of the Board of Directors&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In February
2009, the Company entered into a Separation Agreement in connection
with the resignation of David Platt, Ph.D., the Company&amp;#x2019;s
former Chief Executive Officer and Chairman of the Board of
Directors. The Separation Agreement provides for the deferral of a
$1.0 million separation payment due to Dr.&amp;#xA0;Platt upon the
earlier occurrence of any of the following milestone events:
(i)&amp;#xA0;the approval by the Food and Drug Administration for a new
drug application (&amp;#x201C;NDA&amp;#x201D;) for any drug candidate or drug
delivery candidate based on the Company&amp;#x2019;s GM-CT-01 technology
(whether or not such technology is patented), in which case
Dr.&amp;#xA0;Platt is also entitled to a fully vested 10-year
cashless-exercise stock option to purchase at least 83,334 shares
of common stock at an exercise price not less than the fair market
value of the common stock determined as of the date of grant;
(ii)&amp;#xA0;consummation of a transaction with a pharmaceutical
company expected to result in at least $10.0 million of equity
investment or $50 million of royalty revenue to the Company, in
which case Dr.&amp;#xA0;Platt is also entitled to stock options on the
same terms to purchase at least 50,000 shares of common stock; or
(iii)&amp;#xA0;the renewed listing of the Company&amp;#x2019;s securities on
a national securities exchange and the achievement of a market
capitalization of $100 million. Payment upon the events
(i)&amp;#xA0;and (iii)&amp;#xA0;may be deferred up to six months, and if
the Company has insufficient cash at the time of any of such
events, it may issue Dr.&amp;#xA0;Platt a secured promissory note for
such amount. If the Company files a voluntary or involuntary
petition for bankruptcy, whether or not a milestone event has
occurred, such event shall trigger the obligation to pay the $1.0
million with the result that Dr.&amp;#xA0;Platt may assert a claim for
such obligation against the bankruptcy estate. During 2011, when it
became probable that the Company could be relisted on a national
securities exchange and eventually reach a market capitalization of
$100 million, the Company recognized the $1.0 million severance
payment due to Dr.&amp;#xA0;Platt and it is included in accrued
expenses at December&amp;#xA0;31, 2012 and December&amp;#xA0;31,
2011.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On May&amp;#xA0;2,
2012, Dr.&amp;#xA0;Platt instituted arbitration before the American
Arbitration Association, seeking a $1.0 million separation payment
based on a claim that a milestone event in the Separation Agreement
has occurred (see clause (iii)&amp;#xA0;above). On March&amp;#xA0;22, 2012,
the Company&amp;#x2019;s common stock was listed on the NASDAQ Capital
Markets, but since that date, the stock has not achieved the
required market capitalization. Therefore, it is the
Company&amp;#x2019;s position that a milestone event has not yet
occurred. The arbitration hearing was held on October&amp;#xA0;16 - 17,
2012 and on November&amp;#xA0;1, 2012, the arbitrator denied
Dr.&amp;#xA0;Platt&amp;#x2019;s demand in all respects. Insofar as the
Company does not dispute its obligations under the Separation
Agreement to pay Dr.&amp;#xA0;Platt upon the occurrence of a milestone
event, it has recorded the payment as an accrued expense payable if
and when the milestone event occurs.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
October&amp;#xA0;12, 2012, Dr.&amp;#xA0;Platt commenced a lawsuit under the
Massachusetts Wage Act against Dr.&amp;#xA0;Traber and
Mr.&amp;#xA0;McGauley who in their capacities as the Company&amp;#x2019;s
Chief Executive Officer and Chief Financial Officer respectively
can be held individually liable under the Wage Act for non-payment
of wages. The lawsuit is based on the facts and issues raised in
the arbitration regarding the payment of the $1.0 million
separation payment under the Separation Agreement, and other
unspecified &amp;#x201C;wages&amp;#x201D;. The statute provides that a
successful claimant may be entitled to multiple damages, interest
and attorneys fees. Although the Company is not a party to the
lawsuit, it plans to indemnify Dr.&amp;#xA0;Traber and
Mr.&amp;#xA0;McGauley consistent with its obligations under the by-laws
and applicable law, believes the lawsuit is without merit, and
intends a vigorous defense on their behalf.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
March&amp;#xA0;29, 2013, the Company instituted arbitration before the
American Arbitration Association, seeking to rescind or reform the
Separation Agreement discussed above. The Company claims that
Dr.&amp;#xA0;Platt fraudulently induced the Company to enter into the
Separation Agreement, breached his fiduciary duty to the Company,
and was unduly enriched from his conduct. Along with removal of the
$1.0 million milestone payment provided for under the Separation
Agreement, the Company is seeking repayment of all separation
benefits paid to Dr.&amp;#xA0;Platt to date. Depending on the outcome
of the arbitration, the previously accrued $1.0 million could be
reversed. The timing and ultimate outcome of this arbitration,
though, is uncertain and there is no guarantee that the Company
will be successful in this demand.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Series C
Post Conversion Dividend Rights&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In July 2011, 5
shares of the Company&amp;#x2019;s Series C Super Dividend Convertible
Preferred Stock (&amp;#x201C;Series C&amp;#x201D;) were converted into 8,334
shares of common stock which also resulted in the issuance of 5
Series C post-conversion dividend rights (&amp;#x201C;Dividend
Rights&amp;#x201D;). Under the terms of the Series C, the Dividend
Rights entitle the holder only to dividend payments based on a
percentage of actual sales of GM-CT-01 but not, following a
conversion to common stock, the 6% dividend payable on outstanding
shares of Series C. At December&amp;#xA0;31, 2012, the outstanding
Dividend Rights were determined to have a de minimis value, because
payment of a dividend for the Dividend Rights is considered
improbable at this time and the Company has not recorded a
liability related to the Dividend Rights. The Company will continue
to evaluate and assess the Dividend Rights for each reporting
period.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Other
Legal Proceedings&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
records accruals for such contingencies to the extent that the
Company concludes that their occurrence is probable and the related
damages are estimable. There are no other pending legal proceedings
except as noted above.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="shares" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_1_17">15131000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_6F15DE00-64F2-478A-BCC9-41BC1FDFA9E0_1_0">&lt;div&gt;
&lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
&lt;tr&gt;
&lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;5.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;Accrued
Expenses&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;Accrued expenses
consist of the following at December&amp;#xA0;31:&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
&lt;tr&gt;
&lt;td width="82%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="6" align="center"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;(in
thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Legal and accounting
fees&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;109&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;69&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Accrued
compensation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;42&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;385&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Severance agreement (Note
11)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;10&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;97&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:3.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,161&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,551&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
  <us-gaap:PreferredStockDividendsIncomeStatementImpact contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_1_13">976000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
  <us-gaap:TaxBenefitFromStockOptionsExercised1 contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_3652F6D0-94AB-477B-9DBD-D5D3EA68D1D3_1_9">707000</us-gaap:TaxBenefitFromStockOptionsExercised1>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_FCF2A95D-045B-4B70-BD2B-18AF7103A1F1_1_3">13591312</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_36FDB76E-C89C-47E5-95CB-CA832E1EDCC9_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Fair Value
Measurements&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company has certain
financial assets and liabilities recorded at fair value. Fair
values determined by Level 1 inputs utilize observable data such as
quoted prices in active markets. Fair values determined by Level 2
inputs utilize data points other than quoted prices in active
markets that are observable either directly or indirectly. Fair
values determined by Level 3 inputs utilize unobservable data
points in which there is little or no market data, which require
the reporting entity to develop its own assumptions. The estimated
value of accounts payable and accrued expenses approximates their
carrying value due to their short-term nature using level 3 inputs
as defined above. Included in cash and cash equivalents, as of
December&amp;#xA0;31, 2012 and 2011, the Company had $583,000 and
$6,123,000, respectively, invested in money market funds which had
calculated net asset values and were therefore classified as
Level&amp;#xA0;2.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
  <us-gaap:NetIncomeLoss contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_1_12">-9675000</us-gaap:NetIncomeLoss>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_1_11">224000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_1_14">230000</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_5DF9B4B9-8DED-4016-8955-BF0CF2506A9A_1_0">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_38F37FEB-97E4-48AA-9EA6-F89F8B939B60_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Long-Lived
Assets.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company reviews all
long-lived assets for impairment whenever events or circumstances
indicate the carrying amount of such assets may not be recoverable.
Recoverability of assets to be held or used is measured by
comparison of the carrying value of the asset to the future
undiscounted net cash flows expected to be generated by the asset.
If such asset is considered to be impaired, the impairment
recognized is measured by the amount by which the carrying value of
the asset exceeds the discounted future cash flows expected to be
generated by the asset.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
  <us-gaap:LeaseAndRentalExpense contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_5B3A8141-EB22-46AB-B25C-ECCCD233AE81_1_0">216000</us-gaap:LeaseAndRentalExpense>
  <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_D06B793F-338D-4BF4-8188-22F5733E6B17_1_0">&lt;div&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;Following is the
stock-based compensation expense related to common stock options,
restricted common stock and common stock warrants:&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
&lt;tr&gt;
&lt;td width="82%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Year Ended&lt;br /&gt;
December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Research and
development&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;922&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,558&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;General and
administrative&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,870&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,687&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:3.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Total stock-based
compensation expense&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2,792&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3,245&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_7CCAEE5F-0EAB-470B-B5E2-3C1934078BCF_1_0">&lt;div&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr&gt;
&lt;td valign="top" width="4%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Summary of Significant
Accounting Policies&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The
accompanying consolidated financial statements reflect the
application of certain accounting policies, as described in this
note and elsewhere in the accompanying notes to the consolidated
financial statements.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Basis of
Consolidation.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;The consolidated
financial statements include the accounts of the Company and
Galectin Therapeutics Security Corp., its wholly-owned subsidiary,
which was incorporated in Delaware on December&amp;#xA0;23, 2003.
Galectin Therapeutics Security Corp. holds the cash and cash
equivalents that are not required to fund current operating needs.
All intercompany transactions have been eliminated.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Use of
Estimates.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;The preparation of financial
statements in conformity with accounting principles generally
accepted in the United States of America requires management to
make estimates and judgments that may affect the reported amounts
of assets, liabilities, equity, revenue, expenses and related
disclosure of contingent assets and liabilities. Management&amp;#x2019;s
estimates and judgments include assumptions used in stock option
and warrant liability valuations, useful lives of property and
equipment and intangible assets, accrued liabilities, deferred
income taxes and various other assumptions that are believed to be
reasonable under the circumstances. Actual results may differ from
those estimates under different assumptions or
conditions.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Fair Value
Measurements&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company has certain
financial assets and liabilities recorded at fair value. Fair
values determined by Level 1 inputs utilize observable data such as
quoted prices in active markets. Fair values determined by Level 2
inputs utilize data points other than quoted prices in active
markets that are observable either directly or indirectly. Fair
values determined by Level 3 inputs utilize unobservable data
points in which there is little or no market data, which require
the reporting entity to develop its own assumptions. The estimated
value of accounts payable and accrued expenses approximates their
carrying value due to their short-term nature using level 3 inputs
as defined above. Included in cash and cash equivalents, as of
December&amp;#xA0;31, 2012 and 2011, the Company had $583,000 and
$6,123,000, respectively, invested in money market funds which had
calculated net asset values and were therefore classified as
Level&amp;#xA0;2.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Cash and
Cash Equivalents.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;The Company considers
all highly-liquid investments with original maturities of 90 days
or less at the time of acquisition to be cash
equivalents.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Prepaid
Expenses and Other Current
Assets.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Prepaid expenses and other
assets consist principally of prepaid insurance and prepaid rent on
the Company&amp;#x2019;s leased executive office space.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Property and
Equipment.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;Property and equipment,
including leasehold improvements, are stated at cost, net of
accumulated depreciation, and are depreciated using the
straight-line method over the estimated useful lives of the related
assets of generally three years for computers and office equipment,
five years for furniture and fixtures and the shorter of the useful
life or life of the lease for leasehold improvements.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Restricted
Cash and Security Deposit.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;Restricted
cash consists of security deposits principally for a real estate
lease at December&amp;#xA0;31, 2011. At December&amp;#xA0;31, 2012, the
Company had a security deposit of $6,000 for leased office
space.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Intangible
Assets.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;Intangible assets include patent
costs, consisting primarily of related capitalized legal fees,
which are amortized over an estimated useful life of five years
from issuance. Amortization expense in 2012 and 2011 was $6,000 and
$3,000, respectively. Gross intangible assets at December&amp;#xA0;31,
2012 and 2011 totaled $78,000 each year, and accumulated
amortization at December&amp;#xA0;31, 2012 and 2011 totaled $48,000 and
$42,000, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Long-Lived
Assets.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company reviews all
long-lived assets for impairment whenever events or circumstances
indicate the carrying amount of such assets may not be recoverable.
Recoverability of assets to be held or used is measured by
comparison of the carrying value of the asset to the future
undiscounted net cash flows expected to be generated by the asset.
If such asset is considered to be impaired, the impairment
recognized is measured by the amount by which the carrying value of
the asset exceeds the discounted future cash flows expected to be
generated by the asset.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Warrants.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;The Company has issued
common stock warrants in connection with the execution of certain
equity and debt financings. Certain warrants were accounted for as
derivative liabilities at fair value. Such warrants did not meet
the accounting criteria that a contract should not be considered a
derivative instrument if it is (1)&amp;#xA0;indexed to its own stock
and (2)&amp;#xA0;classified in stockholders&amp;#x2019; equity. Changes in
fair value of derivative liabilities are recorded in the
consolidated statement of operations under the caption
&amp;#x201C;Change in fair value of warrant liabilities.&amp;#x201D; Warrants
that are not considered derivative liabilities are accounted for at
fair value at the date of issuance in additional paid-in capital.
The fair value of warrants was determined using the Black-Scholes
option-pricing model. There were no warrant liabilities as of
December&amp;#xA0;31, 2012 or 2011.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Revenue
Recognition&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company records revenue
provided that there is persuasive evidence that an arrangement
exists, the price is fixed and determinable, services were rendered
and collectability is reasonably assured.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Research and
Development Expenses.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;Costs associated
with research and development are expensed as incurred. Research
and development expenses include, among other costs, salaries and
other personnel-related costs, and costs incurred by outside
laboratories and other accredited facilities in connection with
clinical trials and preclinical studies.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Income
Taxes.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;The Company accounts for income
taxes in accordance with the accounting rules that requires an
asset and liability approach to accounting for income taxes based
upon the future expected values of the related assets and
liabilities. Deferred income tax assets and liabilities are
determined based on the differences between the financial reporting
and tax bases of assets and liabilities and for tax loss and credit
carry forwards, and are measured using the expected tax rates
estimated to be in effect when such basis differences reverse.
Valuation allowances are established, if necessary, to reduce the
deferred tax asset to the amount that will, more likely than not,
be realized.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Comprehensive Income
(Loss).&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;Comprehensive income (loss) is
defined as the change in equity of a business enterprise during a
period from transactions and other events and circumstances from
non-owner sources. The Company does not have any items of
comprehensive income (loss) other than net losses as
reported.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Concentration of Credit
Risk.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;Financial instruments that subject
the Company to credit risk consist of cash and cash equivalents and
certificates of deposit. The Company maintains cash and cash
equivalents and certificates of deposit with well-capitalized
financial institutions. At times, those amounts may exceed
federally insured limits. The Company has no significant
concentrations of credit risk.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Stock-Based
Compensation.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;Stock-based compensation
cost is measured at the grant date based on the fair value of the
award and is recognized as expense over the service period, which
generally represents the vesting period. For awards that have
performance based vesting conditions the Company recognizes the
expense over the estimated period that the awards are expected to
be earned. The Company generally uses the Black-Scholes
option-pricing model to calculate the grant date fair value of
stock options. For options that only vest upon the achievement of
market conditions, the Company values the options using a Monte
Carlo model to calculate the grant date fair value of the stock
options. The expense related to options that vest based on market
conditions is not reversed should those options not ultimately
vest. The expense recognized over the service period is required to
include an estimate of the awards that will be
forfeited.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_8E660CB7-3554-4F03-916E-70B93451CC88_1_1">2447000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_1_15">-10881000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:UseOfEstimates contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_269DF3F2-EF86-4FF4-8D54-B793D34065B1_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Use of
Estimates.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/i&gt;The preparation of financial
statements in conformity with accounting principles generally
accepted in the United States of America requires management to
make estimates and judgments that may affect the reported amounts
of assets, liabilities, equity, revenue, expenses and related
disclosure of contingent assets and liabilities. Management&amp;#x2019;s
estimates and judgments include assumptions used in stock option
and warrant liability valuations, useful lives of property and
equipment and intangible assets, accrued liabilities, deferred
income taxes and various other assumptions that are believed to be
reasonable under the circumstances. Actual results may differ from
those estimates under different assumptions or
conditions.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_2348E8F3-A545-4431-AA9C-535AC874BF7E_1_0">&lt;div&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;The fair value
of the options granted is determined using the Black-Scholes
option-pricing model. The following weighted average assumptions
were used:&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
&lt;tr&gt;
&lt;td width="60%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Cumulative&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Period&amp;#xA0;
from&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Inception&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;(July&amp;#xA0;10,&amp;#xA0;2000)&amp;#xA0; to&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Risk-free interest
rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;0.90&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1.90&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1.84&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Expected life of the
options&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5.81&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5.13&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5.19&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Expected volatility of the
underlying stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;116&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;131&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;119&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Expected dividend
rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_092AF047-4BDB-424B-A773-B7CB84A64FDE_1_0">&lt;div&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr&gt;
&lt;td valign="top" width="4%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;8.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Stock-Based
Compensation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Summary
of Stock-Based Compensation Plans&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;At
December&amp;#xA0;31, 2012, the Company had three stock-based
compensation plans where the Company&amp;#x2019;s common stock has been
made available for equity-based incentive grants as part of the
Company&amp;#x2019;s compensation programs (the &amp;#x201C;Incentive
Plans&amp;#x201D;) as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;2001 Stock
Incentive Plan&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;In October 2001, the
Company&amp;#x2019;s Board of Directors adopted the Pro-Pharmaceuticals,
Inc. 2001 Stock Incentive Plan (the &amp;#x201C;Incentive Plan&amp;#x201D;),
which permits awards of incentive and nonqualified stock options
and other forms of incentive compensation to employees and
non-employees such as directors and consultants. The Board has
833,334 shares of common stock for issuance upon exercise of grants
made under the Incentive Plan. Options granted under the Incentive
Plan vest either immediately or over a period of up to three years,
and expire 3 years to 10 years from the grant date. At
December&amp;#xA0;31, 2012, 291,992 shares were available for future
grant under the Incentive Plan.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;2003
Non-Employee Director Stock Option
Plan&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;In 2003, the stockholders approved
the Pro-Pharmaceuticals, Inc. 2003 Non-Employee Director Stock
Option Plan (the &amp;#x201C;Director Plan&amp;#x201D;), which permits awards
of stock options to non-employee directors. The stockholders
reserved 166,667 shares of common stock for issuance upon exercise
of grants made under the Director Plan. At December&amp;#xA0;31, 2012,
146,557 shares were available for future grant under the Director
Plan.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;2009
Incentive Compensation Plan&lt;/i&gt;.&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;In February
2009, the Company adopted the 2009 Incentive Compensation Plan (the
&amp;#x201C;2009 Plan&amp;#x201D;) which provides for the issuance of up to
3,333,334 shares of the Company&amp;#x2019;s common stock in the form of
options, stock appreciation rights, restricted stock and other
stock-based awards to employees, officers, directors, consultants
and other eligible persons. At December&amp;#xA0;31, 2012, 979,259
shares were available for future grant under the 2009
Plan.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In addition,
the Company has awarded 1,477,379 non-plan stock option grants to
employees and non-employees. These non-plan grants have vesting
periods and expiration dates similar to those options granted under
the Incentive Plans. At December&amp;#xA0;31, 2012, 1,440,045 non-plan
grants were outstanding.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Stock-Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Following is
the stock-based compensation expense related to common stock
options, restricted common stock and common stock
warrants:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"&gt;
&lt;tr&gt;
&lt;td width="82%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year Ended&lt;br /&gt;
December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Research and
development&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;922&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,558&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;General and
administrative&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,870&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,687&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total stock-based
compensation expense&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,792&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,245&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The fair value
of the options granted is determined using the Black-Scholes
option-pricing model. The following weighted average assumptions
were used:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"&gt;
&lt;tr&gt;
&lt;td width="60%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Cumulative&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Period&amp;#xA0;
from&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Inception&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(July&amp;#xA0;10,&amp;#xA0;2000)&amp;#xA0; to&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Risk-free interest
rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.90&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.90&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.84&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected life of the
options&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.81&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.13&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.19&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected volatility of the
underlying stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;116&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;131&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;119&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected dividend
rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As noted above,
the fair value of stock options is determined by using the
Black-Scholes option pricing model. For all options granted since
January&amp;#xA0;1, 2006 the Company has generally used option terms of
between 5 to 10 years, with 5 years representing the estimated life
of options granted to employees. The volatility of the common stock
is estimated using historical volatility over a period equal to the
expected life at the date of grant. The risk-free interest rate
used in the Black-Scholes option pricing model is determined by
reference to historical U.S. Treasury constant maturity rates with
terms equal to the expected terms of the awards. An expected
dividend yield of zero is used in the option valuation model,
because the Company does not expect to pay any cash dividends in
the foreseeable future. At December&amp;#xA0;31, 2012, the Company does
not anticipate any option awards will be forfeited in the
calculation of compensation expense due to the limited number of
employees that receive stock option grants and the Company&amp;#x2019;s
historical employee turnover.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Of the options
granted during 2011, 166,668 vest only upon the achievement of
certain market conditions (83,334 and 83,334 upon the Company
achieving a market capitalization of $5 billion and $10 billion,
respectively). These market condition stock option awards were
valued at $1,006,000 using a Monte Carlo model and will be
recognized over a weighted average period of 5.5 years. Assumptions
used to value these options included the following: annualized
volatility of 110%, annualized drift/risk-free interest rate of
3.5% and a forecast horizon/life of 10 years.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
table summarizes the stock option activity in the stock based
compensation plans:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"&gt;
&lt;tr&gt;
&lt;td width="49%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number of&lt;br /&gt;
Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Average&lt;br /&gt;
Exercise&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
Average&lt;br /&gt;
Remaining&lt;br /&gt;
Contractual&lt;br /&gt;
Life&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(in
years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Aggregate&lt;br /&gt;
Intrinsic&amp;#xA0;Value&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(in
thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding,
December&amp;#xA0;31, 2010&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,965,748&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.42&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 5em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,676,712&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7.02&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 5em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Forfeited/Cancelled&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(334,543&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8.93&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 5em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(216,443&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.21&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding,
December&amp;#xA0;31, 2011&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,091,474&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.83&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 5em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;800,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.13&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 5em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Forfeited/Cancelled&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(299,683&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8.93&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 5em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(51,830&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.31&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding,
December&amp;#xA0;31, 2012&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,539,961&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.66&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.79&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;279&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercisable,
December&amp;#xA0;31, 2012&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,067,910&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.96&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.41&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;268&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The aggregate
intrinsic value in the table above represents the total pre-tax
amount, net of exercise price, which would have been received by
option holders if all option holders had exercised all options with
an exercise price lower than the market price on December&amp;#xA0;31,
2012, based on the closing price of the Company&amp;#x2019;s common
stock of $2.05 on that date.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The
weighted-average grant-date fair values of options granted during
2012 and 2011 were $1.77 and $6.07, respectively. As of
December&amp;#xA0;31, 2012 and December&amp;#xA0;31, 2011, there were
unvested options to purchase 1,472,051 and 1,317,480 shares of
common stock, respectively. Total expected unrecognized
compensation cost related to such unvested options is $5,628,000 at
December&amp;#xA0;31, 2012, which is expected to be recognized over a
weighted-average period of 3.7 years.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;During the
years ended December&amp;#xA0;31 2012 and 2011, 51,830 and 216,400,
respectively, shares were issued upon the exercise of options
valued at $96,000 and $253,000, respectively. During the years
ended December&amp;#xA0;31, 2012 and 2011, the Company received $0 and
$234,000, respectively, for the exercise of stock options. During
2012 and 2011, 90,253 and 83,334 options were exercised cashlessly
resulting in the issuance of 51,830 and 64,273 shares,
respectively. The intrinsic value of options exercised during the
years ended December&amp;#xA0;31, 2012 and 2011 and from the period
from inception to December&amp;#xA0;31, 2012 was $162,000, $1,174,000
and $1,724,000, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;During the
years ended December&amp;#xA0;31, 2012 and 2011, 595,420 and 380,391
options vested, respectively. The total fair value of options
vested during the years ended December&amp;#xA0;31, 2012, 2011 and the
cumulative period from inception to December&amp;#xA0;31, 2012 was
$2,447,000, $2,153,000 and $13,056,000, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Other
Stock Based Compensation Transactions&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;During 2001,
the Company entered into a consulting agreement with a
non-employee, who was also a Board member and former member of the
Audit Committee, pursuant to which the Company granted 33,334
options to purchase common stock at an exercise price of $21.00 in
consideration for services to be performed. At the time of
issuance, these options were valued at $239,000 based on a deemed
fair market value of the Company&amp;#x2019;s common stock of $13.68 per
share. Total expense for the years ended December&amp;#xA0;31, 2003,
2002 and 2001 related to these options was $71,000, $64,000 and
$147,000, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In March 2002,
the Company entered into a second agreement with the same
non-employee, by which the Company granted 334 options a month to
purchase common stock at an exercise price of $21.00 in
consideration for monthly consulting services. On November&amp;#xA0;11,
2002 such agreement was superseded by an amendment, which was
effective retroactively to the date of the original agreement,
March&amp;#xA0;1, 2002. Under the amended agreement, the Company
granted 4,000 options on March&amp;#xA0;1, 2002, which vest at a rate
of 334 options per month, as services are performed. These options
were valued at $11,000 using the Black-Scholes option-pricing
model, based on a grant date fair value of the Company&amp;#x2019;s
common stock of $12.96 per share. During 2002, the Company recorded
a $41,000 charge to stock compensation expense related to the 3,334
options that vested during the year. As of December&amp;#xA0;31, 2002,
the Company had deferred compensation of $11,000 that related to
the remaining unvested options, which was recognized in
2003.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In June 2003,
the Company entered into a third agreement with the same
non-employee, by which the Company granted 4,000 options effective
retroactively to March&amp;#xA0;1, 2003, which vest at a rate of 334
options per month as services are performed. These options were
valued at $33,000 using the Black-Scholes option-pricing model,
based on a fair market value of the Company&amp;#x2019;s common stock of
$21.00 per share. The consulting arrangement was concluded on
March&amp;#xA0;1, 2004. The Company recorded fair value adjustments of
($2,000) and $21,000 related to the unvested consultant options
during 2004 and 2003, respectively. Total expense for the years
ended December&amp;#xA0;31, 2004 and 2003 related to these options was
$17,000 and $40,000, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In January
2003, the Company granted 16,667 options at an exercise price of
$21.00 to a Board member for consulting services unrelated to
services performed as a director. One-third of the options vested
immediately and the balance vests in equal amounts on the first and
second anniversaries of the award. The options were valued at
$156,000 using the Black-Scholes option-pricing model, based on a
fair market value of the Company&amp;#x2019;s common stock of $16.80 per
share. The consulting services were completed and the consulting
arrangement was concluded as of March&amp;#xA0;31, 2004. The Company
recorded fair value adjustments of $4,000 and $82,000 related to
the unvested consultant options during 2004 and 2003, respectively.
Total expense for the years ended December&amp;#xA0;31, 2004 and 2003
related to these options was $51,000 and $193,000,
respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In May 2003,
the Company granted 1,667 options at an exercise price of $21.00 to
a new member of the Scientific Advisory Board. One-half of the
options vested immediately and the balance vests on the second
anniversary. These options were valued at $16,000 using the
Black-Scholes option-pricing model based on a fair market value of
the Company&amp;#x2019;s common stock of $16.80 per share. The Company
recorded fair value adjustments of $2,000 and $6,000 related to the
unvested consultant options during 2004 and 2003, respectively.
Total expense for the years ended December&amp;#xA0;31, 2004 and 2003
related to these options was $5,000 and $13,000,
respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In September
2003, the Company granted 4,167 options each to a Board member and
to a member of the Scientific Advisory Board for consulting
services. The options were exercisable immediately at $24.30 per
share. These options were valued using the Black-Scholes
option-pricing model based on a grant date fair value of the
Company&amp;#x2019;s common stock of $14.64 per share. The Company
recorded a $122,000 charge to stock compensation expense in 2003
related to these awards.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In October
2003, in connection with the resignation of its former Chief
Financial Officer, the Company accelerated the vesting on 16,667
options granted to such officer in September 2003 at an exercise
price of $24.30, which was equal to the fair market value of the
common stock on the date of grant. As the fair market value of the
common stock was $26.70 per share at the time the vesting was
accelerated, the Company recorded a $40,000 charge to stock
compensation expense. Also, in October 2003, such officer exercised
on a cashless basis 8,334 options at an exercise price of $17.82
per share resulting in the issuance of 2,772 shares. As the fair
market value of the Company&amp;#x2019;s common stock on the date of
exercise was $26.70 per share, the Company recorded a charge of
$74,000 to stock compensation expense in 2003 related to the
exercise of these options.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In March 2004,
the Company issued 4,167 options in fulfillment of a September 2003
agreement with an investor relations firm. The agreement obligated
the Company to pay a monthly retainer and issue options at a rate
of 834 options per month, up to a maximum of 16,667 options,
exercisable at $34.80 per share as services are performed. The
Company concluded the engagement in February 2004. The options were
exercisable immediately and expired on March&amp;#xA0;26, 2007.
Accordingly, the Company recorded $29,000 as stock compensation
expense in 2003 on the 2,500 options that vested as of
December&amp;#xA0;31, 2003 and an additional stock compensation expense
of $23,000 in 2004 on the 10,000 options that vested in January and
February 2004. The stock compensation expense was determined based
on a fair market value of the options when the options were earned.
These options expired unexercised in 2007.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In April 2004,
the Company entered into an agreement with an investor relations
firm. The agreement obligated the Company to pay a monthly retainer
and issue options at a rate of 834&amp;#xA0;per month up to a maximum
of 10,000 options exercisable at $30.96 per share as services are
performed. During 2004, 7,500 options were earned but not issued.
During 2005, 2,500 options were earned and the full 10,000 options
were issued. The Company recorded $67,000 in 2004 and $14,000 in
2005 as stock compensation expense related to this agreement. The
stock compensation expense was determined based on the fair market
value of the options when the options were earned. The options were
exercisable immediately and expired three years from the agreement
date. These options expired unexercised in 2007.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In November
2005, the Company issued 834 options to a member of the Scientific
Advisory Board for consulting services. The options were
exercisable immediately at $15.66 per share. These options were
valued using the Black-Scholes option-pricing model based on a
grant date fair value of the Company&amp;#x2019;s common stock of $8.10
per share which was the fair market value at the date of the grant.
The Company recorded a $7,000 charge to stock compensation expense
in 2005 related to this award. These options expired unexercised in
2010.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In March 2006
the Company issued 2,500 options to a consultant for consulting
services, of which 834 of the options were exercisable immediately,
833 options vested in March 2008 and 833 options vested in March
2009. The options are exercisable at $22.50 per share. These
options were valued using the Black-Scholes option-pricing model
based on a grant date fair value of the Company&amp;#x2019;s common
stock of $13.20 per share which was the fair market value at the
date of the grant. The Company recorded a $33,000 charge to stock
compensation expense over the vesting period of the
options.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In December
2007, the Company issued 834 options to a consultant for consulting
services. The options were exercisable immediately at $3.78 per
share. These options were valued using the Black-Scholes
option-pricing model based on a grant date fair value of the
Company&amp;#x2019;s common stock of $2.76 per share which was the fair
market value at the date of the grant. The Company recorded a
$2,000 charge to stock compensation expense in 2007 related to this
award.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In April 2008,
the Company issued 8,000 options to a consultant for consulting
services. The options were exercisable immediately at $2.64 per
share. These options were valued using the Black-Scholes
option-pricing model based on a grant date fair value of the
Company&amp;#x2019;s common stock of $2.34 per share which was the fair
market value at the date of the grant. The Company recorded a
$15,000 charge to stock compensation expense in 2008 related to
this award.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In February
2009, the Company issued 33,334 options to a consultant for
consulting services. The options were exercisable immediately at $0
per share. These options were valued using the Black-Scholes
option-pricing model based on a grant date fair value of the
Company&amp;#x2019;s common stock of $0.72 per share which was the fair
market value at the date of the grant. The Company recorded a
$24,000 charge to stock compensation expense in 2009 related to
this award.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;During the year
ended December&amp;#xA0;31, 2012, the Company modified the terms of
certain option grants for four employees to extend the exercisable
period from ninety days post-employment to the remaining legal life
of the option grant. During the year ended December&amp;#xA0;31, 2012,
the Company modified certain cashless exercise terms for one
employee. The modification of these option terms resulted in
additional stock-based compensation expense of $271,000 during the
year ended December&amp;#xA0;31, 2012. During the year ended
December&amp;#xA0;31, 2011, the Company modified the options of one
employee to extend the exercisable period post-employment from
ninety days to the remaining legal life of the option, resulting in
additional stock-based compensation expense of $63,000.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In May 2012,
the Company granted 7,000 shares of common stock to a consultant
for payment of past services. These shares of common stock were
valued at $16,000, based on the market value of the shares at the
date of grant and are included in stock based compensation expense
for the year ended December&amp;#xA0;31, 2012.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In August 2012,
the Company granted 4,348 shares of common stock to a consultant
for payment of services. These shares of common stock were valued
at $10,000, based on the market value of the shares at the date of
grant and are included in stock based compensation expense for the
year ended December&amp;#xA0;31, 2012.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Restricted Stock&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;During the year
ended December&amp;#xA0;31, 2009, the Company granted 416,670 shares of
restricted common stock to members of its Board of Directors. These
shares were restricted and any unvested shares were subject to
forfeiture upon termination and would revert back to the Company.
Of the 416,670 shares, 390,628 were vested as of December&amp;#xA0;31,
2010, and the final 26,042 vested in 2011. The restricted shares
were valued at $450,000 ($1.08 per share) at the date of grant and
were recognized over the vesting period. During 2011, the Company
recognized stock-based compensation of $18,000 related to these
restricted stock grants.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In 2011, the
Company issued 20,834 shares of restricted common stock to a
consultant. These shares were restricted until November&amp;#xA0;15,
2011 and any unvested shares were subject to forfeiture upon
termination and would revert back to the Company. At
December&amp;#xA0;31, 2011 there no restricted shares remaining. The
restricted shares were valued at $113,000 ($5.40 per share) at
November&amp;#xA0;15, 2011, and the Company recognized expense of
$110,000 during 2011 related to these shares.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="84%" align="center"&gt;
&lt;tr&gt;
&lt;td width="70%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number&amp;#xA0;of&lt;br /&gt;
Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Average&lt;br /&gt;
Price&amp;#xA0;on&amp;#xA0; Grant&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Unvested restricted shares
outstanding, December&amp;#xA0;31, 2010&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;26,042&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.08&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Restricted shares
issued&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;20,834&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8.04&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Restricted shares
vested&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(46,876&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.17&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Unvested restricted shares
outstanding, December&amp;#xA0;31, 2011&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:AmortizationOfIntangibleAssets contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_5DF9B4B9-8DED-4016-8955-BF0CF2506A9A_1_1">6000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_D38119FE-C309-44C9-B627-B9E50FDE3850_7001_400008">616726</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_CEB6A671-F2EA-46E5-952D-D74D7F1025E8_1_0">&lt;div&gt;
&lt;table cellspacing="0" cellpadding="0" width="84%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
&lt;tr&gt;
&lt;td width="70%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Number&amp;#xA0;of&lt;br /&gt;
Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;
&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Average&lt;br /&gt;
Price&amp;#xA0;on&amp;#xA0; Grant&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Unvested restricted shares
outstanding, December&amp;#xA0;31, 2010&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;26,042&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1.08&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:3.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Restricted shares
issued&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;20,834&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;8.04&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:3.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Restricted shares
vested&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(46,876&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;4.17&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Unvested restricted shares
outstanding, December&amp;#xA0;31, 2011&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_9B5DC16D-9A0A-45B4-843D-87D967EF0B53_1_0">1.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <galt:SupplementalDividendsOnConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_1_41">976000</galt:SupplementalDividendsOnConvertiblePreferredStock>
  <galt:IssuanceOfCommonStockAndWarrantsValue contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_12013_1600023">10403000</galt:IssuanceOfCommonStockAndWarrantsValue>
  <galt:ConversionOfAccruedLiabilitiesToCommonStock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_1_37">26000</galt:ConversionOfAccruedLiabilitiesToCommonStock>
  <galt:IssuanceOfEquityWarrantsInConnectionWithEquityOfferings contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_1_36">4445000</galt:IssuanceOfEquityWarrantsInConnectionWithEquityOfferings>
  <galt:ReversalOfSharebasedCompensation contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_39B43C17-E15C-4241-95FE-C81063BBF22A_1_0">100000</galt:ReversalOfSharebasedCompensation>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_12013_1600024">1597000</galt:StockIssuanceCosts>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriod contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_D38119FE-C309-44C9-B627-B9E50FDE3850_7001_400009">12177</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriod>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_1168147_8E660CB7-3554-4F03-916E-70B93451CC88_1_0">595420</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod>
  <galt:OperatingLeaseExpirationPeriod contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_6A41BFF6-0AB8-411E-A7BC-6052F587C84E_1_0">P1Y</galt:OperatingLeaseExpirationPeriod>
  <galt:PrepaidExpensesAndOtherPolicyTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_40870191-F052-4587-8D1A-30518A3E0ACC_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Prepaid
Expenses and Other Current
Assets.&lt;/i&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Prepaid expenses and other
assets consist principally of prepaid insurance and prepaid rent on
the Company&amp;#x2019;s leased executive office space.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</galt:PrepaidExpensesAndOtherPolicyTextBlock>
  <galt:StockWarrantsTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_53A23997-BD96-4B6F-93E3-0168BAA1276B_1_0">&lt;div&gt;
&lt;table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
&lt;tr&gt;
&lt;td width="4%" valign="top" align="left"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;7.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;Warrants and Warrant
Liabilities&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:2%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; text-indent:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;Warrant activity
is summarized as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
&lt;tr&gt;
&lt;td width="86%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Outstanding at
December&amp;#xA0;31, 2010&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;8,585,872&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Issued&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Cancelled&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(141,084&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(1,771,383&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Outstanding at December 31,
2011&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;6,673,405&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Issued&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,379,739&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Cancelled&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(616,726&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(12,177&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Outstanding at December 31,
2012&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;7,424,241&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font-size:1px;margin-top:12px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="margin-top:0px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;The following
table summarizes information with regard to outstanding warrants
issued in connection with equity and debt financings and
consultants as of December&amp;#xA0;31, 2012.&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
&lt;tr&gt;
&lt;td width="50%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;
&lt;p style="border-bottom:1px solid #000000;width:90pt"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Issued in Connection
With&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
Issued&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Exercise&lt;br /&gt;
Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Exercisable&amp;#xA0;Date&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Expiration&amp;#xA0;Date&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;February&amp;#xA0;25, 2008
Common Stock Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.70 Investor
Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;710,834&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;4.20&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;August&amp;#xA0;25,&amp;#xA0;2008&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;August&amp;#xA0;25,&amp;#xA0;2013&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;February&amp;#xA0;12, 2009
Series B-1 Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;300,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;February&amp;#xA0;12,&amp;#xA0;2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;February&amp;#xA0;12,&amp;#xA0;2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,200,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;February 12,
2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;February 12,
2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May&amp;#xA0;13, 2009 Series B-2
Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;150,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 13, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 13, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;600,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 13, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 13, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June&amp;#xA0;30, 2009 Series
B-2 Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;83,333&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June 30, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June 30, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;333,333&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June 30, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June 30, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;April&amp;#xA0;15, 2009
Consultant Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;33,333&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;April 15, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;April 15, 2013&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May&amp;#xA0;1, 2009 Consultant
Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;74,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 1, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 1, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June&amp;#xA0;30, 2009
Consultant Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;40,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June 30, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June 30, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;July&amp;#xA0;26, 2009
Consultant Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;16,667&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;July 26, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;July 26, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;August&amp;#xA0;12, 2009 Series
B-2 Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;50,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;August 12, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;August 12, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;200,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;August 12, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;August 12, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;September&amp;#xA0;30, 2009
Series B-2 Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;54,166&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;September&amp;#xA0;30,&amp;#xA0;2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;September&amp;#xA0;30,&amp;#xA0;2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;216,666&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;September 30,
2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;September 30,
2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;November&amp;#xA0;4, 2009 Series
B-2 Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;51,666&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;November 4, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;November 4, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;206,666&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;November 4, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;November 4, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December&amp;#xA0;8, 2009 Series
B-2 Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;54,167&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December 8, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December 8, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;216,667&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December 8, 2009&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December 8, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;January&amp;#xA0;29, 2010 Series
B-2 Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;54,167&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;January 29, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;January 29, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;216,667&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;January 29, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;January 29, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;March&amp;#xA0;8, 2010 Series
B-2 Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;55,834&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;March 8, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;March 8, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;223,334&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;March 8, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;March 8, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;April&amp;#xA0;30, 2010 Series
B-2 Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;51,667&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;April 30, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;April 30, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;206,667&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;April 30, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;April 30, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May&amp;#xA0;10, 2010 Series B-2
Transaction&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class&amp;#xA0;A-2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;95,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 10, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 10, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:5.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$0.50 Investor
Warrants&amp;#x2014;Class B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;380,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 10, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 10, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May&amp;#xA0;25, 2010 Consultant
Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;28,334&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;4.50&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 25, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 25, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May&amp;#xA0;25, 2010 Consultant
Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;7,500&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;15.00&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 25, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 25, 2014&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June&amp;#xA0;15, 2010
Consultant Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;100,000&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;4.26&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June 15, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;June 15, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December&amp;#xA0;9, 2010
Consultant Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;33,334&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3.90&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December 9, 2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December 9, 2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December&amp;#xA0;30, 2010
Placement Agent Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;500&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;7.20&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December 30,
2010&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;December 30,
2015&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;March&amp;#xA0;28, 2012 Offering
Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,333,361&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5.63&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;March 28, 2012&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;March 28, 2017&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2012 Offering Placement
Agent Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;46,378&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5.63&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;March 28, 2012&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;May 2, 2016&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:7.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Total outstanding
warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;7,424,241&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font-size:1px;margin-top:18px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="margin-top:0px;margin-bottom:0px; margin-left:2%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Consultant
Warrants&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;In May 2008 the
Company entered into an agreement with Investor Relations Group
(&amp;#x201C;IRG&amp;#x201D;) for IRG to provide investor relations services
to the Company in exchange for cash and warrants on a monthly
basis. On September&amp;#xA0;30, 2008 the Company terminated the
agreement under the provisions of the agreement. During the
effective contract period IRG earned 6,500 warrants valued at
$3,000. The expense associated with these warrants was calculated
using the Black-Scholes option-pricing model and charged to stock
compensation expense. The warrants are exercisable at $3.00 per
share for a period of three years.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;In April 2009,
the Company entered into agreements with consultants that provided
for the grant of warrants for the purchase of 55,000 shares of
common stock at an exercise price of $3.00 per share. Of the 55,000
warrants, 13,334 vested immediately and 41,666 will vest upon the
achievement of certain milestones. The initial 13,334 warrants were
valued at $32,000 on issuance based on the following assumptions:
an expected life of 4 years, volatility of 134%, risk free interest
rate of 1.76% and zero dividends and the expense recognized upon
issuance. During the year ended December&amp;#xA0;31, 2010, 8,334
warrants vested (valued at $16,000 on the vesting date using the
following assumptions: expected life of 3.06 years, volatility of
140%, risk free interest rates of 1.69% and zero dividends). In
2010, when it appeared probable that the remaining 33,332 warrants
would vest, the Company valued the warrants at $124,000 as of
December&amp;#xA0;31, 2010 using the following assumptions: expected
life of 2.29 years, volatility of 141%, risk free interest rates of
0.61% and zero dividends. The Company valued the warrants at
$104,000 as of December&amp;#xA0;31, 2011 using the following
assumptions: expected life of 1.29 years, volatility of 70%, risk
free interest rates of 0.12% and zero dividends. The Company
recognized expense related to the 33,332 warrants of $111,000 for
the year ended December&amp;#xA0;31, 2010 and a reversal of expense of
$13,000 for the year ended December&amp;#xA0;31, 2011. During the year
ended December&amp;#xA0;31, 2012, these warrants were no longer
expected to vest and the Company recognized a reversal of
previously recognized expense related to these warrants of $100,000
for the year ended December&amp;#xA0;31, 2012.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;In May 2009, the
Company entered into agreements with consultants that provided for
the grant of warrants to purchase 95,834 shares of common stock at
an exercise price of $3.00 per share of which 74,000 vested and
21,834 were forfeited. The warrants were valued at $232,000 on
issuance based on the following assumptions: an expected life of 5
years, volatility of 124%, risk free interest rate of 2.16% and
zero dividends. The Company recognized expense related to these
warrants of $53,000 during the year ended December&amp;#xA0;31, 2010.
As of December&amp;#xA0;31, 2010, 74,000 of these warrants were vested
and 21,834 shares were forfeited.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;In May 2010, the
Company granted warrants to consultants for the purchase of 35,001
shares of common stock at an exercise price of $4.50 per share. The
warrants were valued at $134,000 on issuance based on the following
assumptions: an expected life of 4 years, volatility of 143%, risk
free interest rate of 1.610% and zero dividends. The warrants
vested immediately and the company recognized an expense of
$134,000 related to these warrants during the year ended
December&amp;#xA0;31, 2010.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;In May 2010, the
Company entered into an agreement with a consultant that provided
for the grant of warrants for the purchase of 12,000 shares of
common stock at an exercise price of $15.00 per share. The warrants
were initially valued at $40,000 on issuance based on the following
assumptions: an expected life of 4 years, volatility of 143%, risk
free interest rate of 1.610% and zero dividends. The warrants vest
at a rate of 500&amp;#xA0;per month and the unvested warrants will be
revalued as they vest. At December&amp;#xA0;31, 2011, 7,500 warrants
were vested and 4,500 were forfeited upon cancellation of the
agreement. The following assumptions were used to value the
warrants for the year ended December&amp;#xA0;31, 2011: an expected
life of 2.99 to 3.32 years, volatility of 128% to 130%, risk free
interest rate of 0.79% to 1.29% and zero dividends. The following
assumptions were used to value the warrants for the year ended
December&amp;#xA0;31, 2010: an expected life of 3.40 to 3.99 years,
volatility of 130% to 144%, risk free interest rate of 0.51% to
1.68% and zero dividends. The company recognized an expense of
$12,000 and $15,000 related to these warrants during the years
ended December&amp;#xA0;31, 2011 and 2010, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:1px;margin-top:12px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="margin-top:0px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;In August 2010,
the Company entered into an agreement with a consultant, who was
also a board member, which provided for the grant of warrants for
100,000 shares of common stock at an exercise price of $4.26 per
share. Of the 100,000 warrants, 25,000 vested immediately on
signing of the agreement, 25,000 were to vest at the end of one
year and the remaining 50,000 warrants were to vest based on the
achievement of certain milestones. The following assumptions were
used to value the remaining unvested warrants on March&amp;#xA0;7, 2011
at the date the consultant effectively became an employee of the
Company: an expected life of 4.28 years, volatility of 135%, risk
free interest rate of 1.705% and zero dividends. Pursuant to an
employment agreement entered into in May 2011, all remaining
unvested warrants were immediately vested. The Company recognized
expense of $340,000 and $219,000 related to these warrants during
the years ended December&amp;#xA0;31, 2011 and 2010,
respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;In December
2010, the Company granted warrants to a consultant for the purchase
of 33,334 shares of common stock at an exercise price of $3.90 per
share. The warrants were valued at $112,000 on issuance based on
the following assumptions: an expected life of 5 years, volatility
of 130%, risk free interest rate of 1.9% and zero dividends. The
warrants vested immediately and the company recognized an expense
of $112,000 related to these warrants during the year ended
December&amp;#xA0;31, 2010.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;In December
2010, the Company issued warrants to a placement agent for the
purchase of 500 shares of common stock at an exercise price of
$7.20 per share. These warrants were valued at $2,000 using the
following assumptions: an expected life of 5 years, volatility of
130%, risk free interest rate of 2.06% and zero
dividends.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:18px;margin-bottom:0px; margin-left:2%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Impact of
Adopting Provisions Regarding Warrant
Liabilities&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;In June 2008,
the Financial Accounting Standards Board (&amp;#x201C;FASB&amp;#x201D;)
ratified standards related to determining whether an instrument (or
an embedded feature) is indexed to an entity&amp;#x2019;s own stock. The
standards provide that an entity should use a two step approach to
evaluate whether an equity-linked financial instrument (or embedded
feature) is indexed to its own stock, including evaluating the
instrument&amp;#x2019;s contingent exercise and settlement provisions.
The standard is effective for fiscal years beginning after
December&amp;#xA0;15, 2008. The Company adopted the standard on
January&amp;#xA0;1, 2009 and determined that the 1,164,929 warrants
issued in connection with the February 2006 Transaction that had
been classified as equity and included in additional paid-in
capital at December&amp;#xA0;31, 2008, should be classified as
liabilities due to repricing and anti-dilution provisions contained
in the warrant agreements. The impact of adopting new accounting
provisions on January&amp;#xA0;1, 2009, which required the treatment of
warrants with certain features as liabilities rather than equity,
was a decrease in additional paid-in-capital by $458,000, which was
the fair value recorded at the time the warrants were transferred
from a liability to equity during the year ended December&amp;#xA0;31,
2008, an increase of warrant liabilities by $204,000, the fair
value of the warrants as of January&amp;#xA0;1, 2009 and a credit to
accumulated deficit for the difference.&lt;/font&gt;&lt;/p&gt;
&lt;p style="margin-top:12px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;During the year
ended December&amp;#xA0;31, 2011, the Company recognized a loss of
$524,000 in its consolidated statements of operations related to
the change in fair value of warrant liabilities.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</galt:StockWarrantsTextBlock>
  <galt:ScheduleOfStockholdersEquityNoteWarrantsAndCommonStockActivityTableTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_0C77F787-725B-4F9F-938A-0503BD111E91_1_0">&lt;div&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; text-indent:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;Warrant activity
is summarized as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
&lt;tr&gt;
&lt;td width="86%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Outstanding at
December&amp;#xA0;31, 2010&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;8,585,872&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Issued&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Cancelled&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(141,084&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(1,771,383&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Outstanding at December 31,
2011&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;6,673,405&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Issued&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,379,739&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Cancelled&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(616,726&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(12,177&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Outstanding at December 31,
2012&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;7,424,241&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</galt:ScheduleOfStockholdersEquityNoteWarrantsAndCommonStockActivityTableTextBlock>
  <galt:EffectiveIncomeTaxRateReconciliationPermanentDifferences contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_1168147_978BDCCB-1131-4951-BEF4-C79D4419A824_1_3">0.014</galt:EffectiveIncomeTaxRateReconciliationPermanentDifferences>
  <galt:ScheduleOfChangesInFairValueOfWarrantLiabilityTableTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_27DFD013-1A8A-43C0-B379-1DC7764C4281_1_0">&lt;div&gt;
&lt;p style="margin-top:6px;margin-bottom:0px; margin-left:4%"&gt;
&lt;font style="font-family:Times New Roman" size="2"&gt;A summary of
changes in the Warrant Liabilities is as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="font-size:12px;margin-top:0px;margin-bottom:0px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="84%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
&lt;tr&gt;
&lt;td width="84%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="13%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Fair&amp;#xA0;Value&amp;#xA0;of&lt;br /&gt;
Warrant&lt;br /&gt;
Liabilities&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;(in&amp;#xA0;thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Balance December&amp;#xA0;31,
2010&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;861&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:3.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Change in fair value of
warrant liabilities&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;524&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:3.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Intrinsic value of liability
warrants exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(1,385&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Balance December&amp;#xA0;31,
2011&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</galt:ScheduleOfChangesInFairValueOfWarrantLiabilityTableTextBlock>
  <galt:DeferredIncomeTaxExpenseBenefitCapitalizedResearchAndDevelopmentCosts contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_57908764-0B6C-42C9-B604-69CA694B05A6_1_0">61000</galt:DeferredIncomeTaxExpenseBenefitCapitalizedResearchAndDevelopmentCosts>
  <galt:ScheduleOfEquityAndOtherInvestmentsTableTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_59F4A68A-9BF0-4A54-A60A-060C64F54B4C_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The ROI
Percentage shall mean the percentage that applies as of the
redemption date, as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="15%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td width="82%"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" nowrap="nowrap" align="center"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em" align="center"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;u&gt;ROI&amp;#xA0;Percentage&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="8"&gt;&lt;/td&gt;
&lt;td height="8" colspan="2"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" nowrap="nowrap" align="center"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em" align="center"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;200%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;before the second anniversary of the date of
issuance;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" nowrap="nowrap" align="center"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em" align="center"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;250%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;on or after the second anniversary of the date of issuance, but
before the third anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" nowrap="nowrap" align="center"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em" align="center"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;300%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;on or after the third anniversary of the date of issuance, but
before the fourth anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" nowrap="nowrap" align="center"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em" align="center"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;350%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;on or after the fourth anniversary of the date of issuance, but
before the fifth anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" nowrap="nowrap" align="center"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em" align="center"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;400%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;on or after the fifth anniversary of the date of issuance, but
before the sixth anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" nowrap="nowrap" align="center"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em" align="center"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;450%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;on or after the sixth anniversary of the date of issuance, but
before the seventh anniversary of the date of issuance;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" nowrap="nowrap" align="center"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em" align="center"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;500%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;on or after the seventh anniversary of the date of issuance,
but before the eighth anniversary of the date of issuance;
and&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" nowrap="nowrap" align="center"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em" align="center"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;550%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;on or after the eighth anniversary of the date of issuance, but
before the ninth anniversary of the date of issuance.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</galt:ScheduleOfEquityAndOtherInvestmentsTableTextBlock>
  <galt:CashlessExerciseOfStockOptionsAndWarrants contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_1_38">235000</galt:CashlessExerciseOfStockOptionsAndWarrants>
  <galt:AdditionalShareBasedCompensationExpenseRelatedToModifiedStockOptions contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_0614232D-083F-47F6-92A9-1016025BDF3A_1_1">271000</galt:AdditionalShareBasedCompensationExpenseRelatedToModifiedStockOptions>
  <galt:StockIssuedDuringPeriodSharesStockOptionsExercisedAmount contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_1BB73C8E-496F-4888-A849-1C50DCD0B7CA_1_1">96000</galt:StockIssuedDuringPeriodSharesStockOptionsExercisedAmount>
  <galt:ScheduleOfComputationOfBasicAndDilutedEarningsPerShareTableTextBlock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0" id="id_1168147_5DA1E6F1-60E7-4647-AA2D-FC5490A0B630_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The computation
of diluted net loss per share does not assume the issuance of
common shares that have an anti-dilutive effect on net loss per
share.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"&gt;
&lt;tr&gt;
&lt;td width="77%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year&amp;#xA0;Ended&amp;#xA0;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(in&amp;#xA0;thousands,&amp;#xA0;except&amp;#xA0;share&lt;br /&gt;
and per share amounts)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;2012&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;2011&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Basic and diluted net loss
per common share:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(9,675&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(10,915&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Preferred stock
dividends&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(976&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,568&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Preferred stock
accretion&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(230&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(230&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss applicable to
common stockholders&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(10,881&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(12,713&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Weighted average common
shares outstanding&amp;#x2014;basic and diluted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;15,131&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;11,986&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss per common
share&amp;#x2014;basic and diluted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.72&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1.06&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</galt:ScheduleOfComputationOfBasicAndDilutedEarningsPerShareTableTextBlock>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantsInPeriod contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_498429x585047" unitRef="shares" decimals="0" id="id_1168147_DE44A988-F774-4F5B-8EF9-818FF5E73989_1001_0">1477379</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_498752x506779" unitRef="iso4217_USD" decimals="-3" id="id_1168147_02BAABA8-2F08-4E1C-A1AF-8DCF2C1BC2C7_1001_0">922000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_498752x510320" unitRef="iso4217_USD" decimals="-3" id="id_1168147_02BAABA8-2F08-4E1C-A1AF-8DCF2C1BC2C7_2001_1">1870000</us-gaap:ShareBasedCompensation>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_504957x513639" id="id_1168147_307FDB3A-2104-4989-929B-253F32FC3091_1001_0">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_504957x514053" id="id_1168147_307FDB3A-2104-4989-929B-253F32FC3091_2001_1">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x500343" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_12012_1500022">56000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:NetIncomeLoss contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x500343" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_12012_1500038">-9675000</us-gaap:NetIncomeLoss>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x500343_513696x498640" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_13012_1500027">103000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x500343_513696x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_14012_1500033">127000</us-gaap:DividendsPreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x500343_513696x511225" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_15012_1500021">174000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x500343_513696x516922" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_16012_1500029">224000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x500343_513696x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_17012_1500031">522000</us-gaap:DividendsPreferredStock>
  <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_12009_1200025">3324</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_12009_1200036">51830</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <galt:IssuanceOfCommonStockAndWarrantsValue contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x501348" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_12009_1300023">3000</galt:IssuanceOfCommonStockAndWarrantsValue>
  <galt:StockIssuedDuringPeriodSharesStockWarrantsExercised contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_12009_1200035">12177</galt:StockIssuedDuringPeriodSharesStockWarrantsExercised>
  <galt:IssuanceOfCommonStockAndWarrantsShares contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_12009_1200023">2666722</galt:IssuanceOfCommonStockAndWarrantsShares>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x501348_513696x498640" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_13009_1200026">31250</us-gaap:PreferredStockDividendsShares>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x501348_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_14009_1200032">46053</us-gaap:PreferredStockDividendsShares>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x501348_513696x516922" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_16009_1200028">95584</us-gaap:PreferredStockDividendsShares>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x501348_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_17009_1200030">223027</us-gaap:PreferredStockDividendsShares>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x501348_513696x551546" unitRef="shares" decimals="INF" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_18009_1200034">11348</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_12011_1400037">2766000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <galt:IssuanceOfCommonStockAndWarrantsValue contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_12011_1400023">10400000</galt:IssuanceOfCommonStockAndWarrantsValue>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x508619_513696x498640" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_13011_1400027">-103000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x508619_513696x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_14011_1400033">-127000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x508619_513696x516922" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_16011_1400029">-224000</us-gaap:DividendsPreferredStock>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x508619_513696x516922" unitRef="iso4217_USD" decimals="0" id="id_1168147_CA67B86B-A42F-409D-B0B5-78B4BAB62832_1001_5">1105000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x508619_513696x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_17011_1400031">-522000</us-gaap:DividendsPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x508619_513696x551546" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_18011_1400034">26000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x516922_513696x511225" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_15001_500021">-17000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_12003_700022">-56000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x516923_513696x511225" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_15003_700021">-157000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_507189x534240" unitRef="shares" decimals="INF" id="id_1168147_1BB73C8E-496F-4888-A849-1C50DCD0B7CA_1001_3">90253</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <galt:ExtensionOfExercisePeriod contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_508454x506554" id="id_1168147_0614232D-083F-47F6-92A9-1016025BDF3A_1001_0">P90D</galt:ExtensionOfExercisePeriod>
  <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_508681x502974" unitRef="iso4217_USD" decimals="0" id="id_1168147_3652F6D0-94AB-477B-9DBD-D5D3EA68D1D3_1001_4">223000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
  <galt:OperatingLossCarryforwardsExpirationYear contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_508681x502974" id="id_1168147_3652F6D0-94AB-477B-9DBD-D5D3EA68D1D3_1001_2">2032</galt:OperatingLossCarryforwardsExpirationYear>
  <galt:ResearchAndDevelopmentCreditsExpirationYear contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_508681x502974" id="id_1168147_3652F6D0-94AB-477B-9DBD-D5D3EA68D1D3_1001_6">2032</galt:ResearchAndDevelopmentCreditsExpirationYear>
  <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_508681x509983" unitRef="iso4217_USD" decimals="0" id="id_1168147_3652F6D0-94AB-477B-9DBD-D5D3EA68D1D3_2001_5">143000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
  <galt:OperatingLossCarryforwardsExpirationYear contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_508681x509983" id="id_1168147_3652F6D0-94AB-477B-9DBD-D5D3EA68D1D3_2001_3">2032</galt:OperatingLossCarryforwardsExpirationYear>
  <galt:ResearchAndDevelopmentCreditsExpirationYear contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_508681x509983" id="id_1168147_3652F6D0-94AB-477B-9DBD-D5D3EA68D1D3_2001_7">2032</galt:ResearchAndDevelopmentCreditsExpirationYear>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517823_510623x624796" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2001_3">2008-08-25</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517823_510623x624796" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_1001_2">0.70</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624797" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2002_3">2009-02-12</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624797" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_2001_4">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624798" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2004_3">2009-05-13</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624798" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_3001_7">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624799" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2006_3">2009-06-30</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624799" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_4001_10">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624804" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2012_3">2009-08-12</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624804" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_5001_17">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624805" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2014_3">2009-09-30</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624805" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_6001_20">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624806" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2016_3">2009-11-04</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624806" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_7001_23">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624807" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2018_3">2009-12-08</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624807" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_8001_26">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624808" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2020_3">2010-01-29</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624808" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_9001_29">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624809" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2022_3">2010-03-08</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624809" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_10001_32">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624810" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2024_3">2010-04-30</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624810" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_11001_35">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624811" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2026_3">2010-05-10</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624811" unitRef="iso4217_USD_per_shares" decimals="1" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_12001_38">0.5</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624797" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2003_3">2009-02-12</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624797" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_13001_5">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624798" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2005_3">2009-05-13</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624798" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_14001_8">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624799" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2007_3">2009-06-30</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624799" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_15001_11">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624804" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2013_3">2009-08-12</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624804" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_16001_18">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624805" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2015_3">2009-09-30</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624805" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_17001_21">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624806" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2017_3">2009-11-04</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624806" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_18001_24">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624807" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2019_3">2009-12-08</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624807" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_19001_27">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624808" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2021_3">2010-01-29</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624808" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_20001_30">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624809" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2023_3">2010-03-08</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624809" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_21001_33">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624810" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2025_3">2010-04-30</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624810" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_22001_36">0.50</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624811" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2027_3">2010-05-10</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <galt:IssuanceOfWarrantsPricePerShare contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624811" unitRef="iso4217_USD_per_shares" decimals="1" id="id_1168147_6F4ECDEE-83FF-43A9-B525-08882465E45F_23001_39">0.5</galt:IssuanceOfWarrantsPricePerShare>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x624800" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2008_3">2009-04-15</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x624801" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2009_3">2009-05-01</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x624802" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2010_3">2009-06-30</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x624803" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2011_3">2009-07-26</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x624812_542884x531496" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2028_3">2010-05-25</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x624812_542884x531497" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2029_3">2010-05-25</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x624813" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2030_3">2010-06-15</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x625047" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2031_3">2010-12-09</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x625048" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2032_3">2010-12-30</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x678629" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2033_3">2012-03-28</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x678630" id="id_1168147_0966D521-6699-4403-953E-19878DBD1E00_2034_3">2012-03-28</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_510903x500372" id="id_1168147_BE57A811-5B9B-4ACE-91F0-3AA50379AEE5_1001_1">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_510903x537720" id="id_1168147_BE57A811-5B9B-4ACE-91F0-3AA50379AEE5_2001_0">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_513696x501142" unitRef="iso4217_USD" decimals="0" id="id_1168147_ECA4B083-20A9-46C0-8130-AD8E950277AB_1001_1">123000</us-gaap:DividendsPreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_513696x511225" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_15013_1600021">174000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_513696x516922" unitRef="pure" decimals="4" id="id_1168147_CA67B86B-A42F-409D-B0B5-78B4BAB62832_2001_3">0.0179</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_513696x516922" unitRef="pure" decimals="2" id="id_1168147_CA67B86B-A42F-409D-B0B5-78B4BAB62832_2001_4">0.00</us-gaap:FairValueAssumptionsExpectedDividendRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_513696x516922" unitRef="pure" decimals="2" id="id_1168147_CA67B86B-A42F-409D-B0B5-78B4BAB62832_2001_2">1.18</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsExpectedTerm contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_513696x516922" id="id_1168147_CA67B86B-A42F-409D-B0B5-78B4BAB62832_2001_1">P5Y</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_513696x551546" unitRef="iso4217_USD" decimals="-3" id="id_1168147_DD931382-0858-49F6-BD44-60DF219E6EE3_18013_1600034">26000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_514791x507534" unitRef="shares" decimals="INF" id="id_1168147_FCF2A95D-045B-4B70-BD2B-18AF7103A1F1_1001_2">2627110</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_514791x507958" unitRef="shares" decimals="INF" id="id_1168147_FCF2A95D-045B-4B70-BD2B-18AF7103A1F1_2001_0">7424241</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_514791x514283" unitRef="shares" decimals="INF" id="id_1168147_FCF2A95D-045B-4B70-BD2B-18AF7103A1F1_3001_1">3539961</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <galt:OperatingLeaseExpirationPeriod contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_530649x607894" id="id_1168147_96C5EC65-7100-4DFA-87ED-214F2EB3B320_1001_0">P26M</galt:OperatingLeaseExpirationPeriod>
  <galt:LongTermOperatingLeaseExpirationDate contextRef="eol_PE87402---1210-K0013_STD_366_20121231_0_530649x607894" id="id_1168147_96C5EC65-7100-4DFA-87ED-214F2EB3B320_1001_1">2014-11-30</galt:LongTermOperatingLeaseExpirationDate>
  <us-gaap:PreferredStockRedemptionDate contextRef="eol_PE87402---1210-K0013_STD_367_20110131_0_513696x511225" id="id_1168147_75D42140-96F7-401C-8A46-95B8F5F4F9EF_1001_1">2019-02-12</us-gaap:PreferredStockRedemptionDate>
  <galt:NoticePeriodToCureBreachOfAgreement contextRef="eol_PE87402---1210-K0013_STD_367_20130201_0_506663x511390" id="id_1168147_B1CB87D8-D1F4-4E03-B68D-EC43203242AD_1001_1">P30D</galt:NoticePeriodToCureBreachOfAgreement>
  <galt:NoticePeriodForTerminationOfAgreement contextRef="eol_PE87402---1210-K0013_STD_367_20130201_0_506663x511390" id="id_1168147_B1CB87D8-D1F4-4E03-B68D-EC43203242AD_1001_0">P90D</galt:NoticePeriodForTerminationOfAgreement>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE87402---1210-K0013_STD_38_20040407_0_510623x531324" unitRef="iso4217_USD" decimals="0" id="id_1168147_F4673881-5A95-4A92-96E0-2482B64179F4_1001_2">3983000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_38_20040407_0_510623x531324" unitRef="iso4217_USD" decimals="0" id="id_1168147_F4673881-5A95-4A92-96E0-2482B64179F4_1001_3">466000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_38_20040407_0_510623x531324" unitRef="shares" decimals="INF" id="id_1168147_F4673881-5A95-4A92-96E0-2482B64179F4_1001_0">206019</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_38_20040407_0_510623x531324" unitRef="shares" decimals="INF" id="id_1168147_F4673881-5A95-4A92-96E0-2482B64179F4_1001_4">103010</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_38_20040407_0_510623x547978" unitRef="shares" decimals="INF" id="id_1168147_F4673881-5A95-4A92-96E0-2482B64179F4_2001_5">10301</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="pure" decimals="4" id="id_1168147_E83B26F4-E3A6-4973-A21B-1379180C02C0_3_0">0.0184</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_1BB73C8E-496F-4888-A849-1C50DCD0B7CA_3_5">1724000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_3_4">-74646000</us-gaap:OperatingIncomeLoss>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_21">39093000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_5D6D86AB-9A82-441B-B138-4EB82BF62FA7_2013_1600002">11635000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_29">9000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="pure" decimals="2" id="id_1168147_E83B26F4-E3A6-4973-A21B-1379180C02C0_3_3">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_4">12374000</us-gaap:ShareBasedCompensation>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_12">1626000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:PaymentsToAcquireProductiveAssets contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_18">404000</us-gaap:PaymentsToAcquireProductiveAssets>
  <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_13">6000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
  <us-gaap:SubscriptionRevenue contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_29177D8F-89DD-4C3A-8C4D-A52BF998B661_2013_1600004">150000</us-gaap:SubscriptionRevenue>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_40">171000</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <us-gaap:StockIssued1 contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_43">107000</us-gaap:StockIssued1>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_3">555000</us-gaap:DepreciationAndAmortization>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" id="id_1168147_E83B26F4-E3A6-4973-A21B-1379180C02C0_3_1">P5Y2M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_14">-58553000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_39">12243000</us-gaap:DebtConversionOriginalDebtAmount1>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_19">-835000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_3_6">818000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_16">431000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_31">9364000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_3_2">47036000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_11">156000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:OtherNonoperatingIncome contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_3_10">691000</us-gaap:OtherNonoperatingIncome>
  <us-gaap:RepaymentsOfConvertibleDebt contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_27">1641000</us-gaap:RepaymentsOfConvertibleDebt>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_3_1">27610000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_30">68752000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:OperatingExpenses contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_3_3">74646000</us-gaap:OperatingExpenses>
  <us-gaap:PaidInKindInterest contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_5">4279000</us-gaap:PaidInKindInterest>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="pure" decimals="2" id="id_1168147_E83B26F4-E3A6-4973-A21B-1379180C02C0_3_2">1.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_8">351000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
  <us-gaap:InterestPaid contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_34">114000</us-gaap:InterestPaid>
  <us-gaap:PreferredStockDividendsIncomeStatementImpact contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_3_13">4235000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
  <us-gaap:NetIncomeLoss contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_3_12">-71992000</us-gaap:NetIncomeLoss>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_3_11">2654000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_3_14">4045000</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
  <us-gaap:ProceedsFromConvertibleDebt contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_26">10621000</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_8E660CB7-3554-4F03-916E-70B93451CC88_3_1">13056000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_3_15">-80272000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_5D6D86AB-9A82-441B-B138-4EB82BF62FA7_2013_1600003">53000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:InterestExpense contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_3_7">4451000</us-gaap:InterestExpense>
  <galt:ProceedsFromStockOptionAndWarrantExercises contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_28">11293000</galt:ProceedsFromStockOptionAndWarrantExercises>
  <galt:ReclassificationOfWarrantsToLiability contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_2013_1600010">3193000</galt:ReclassificationOfWarrantsToLiability>
  <galt:CumulativeEffectOfInitialAdoptionOfNewAccountingPrincipleGross contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_5D6D86AB-9A82-441B-B138-4EB82BF62FA7_2013_1600004">-204000</galt:CumulativeEffectOfInitialAdoptionOfNewAccountingPrincipleGross>
  <galt:StockBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_5D6D86AB-9A82-441B-B138-4EB82BF62FA7_2013_1600001">157000</galt:StockBasedCompensation>
  <galt:StockIssuedDuringPeriodValueMerger contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A03BFB5A-1EFA-47D9-936A-954C88058A1F_2013_1600005">107000</galt:StockIssuedDuringPeriodValueMerger>
  <galt:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_2013_1600010">14307000</galt:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <galt:SupplementalDividendsOnConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_41">4155000</galt:SupplementalDividendsOnConvertiblePreferredStock>
  <galt:ChangeInFairValueOfWarrant contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_3_9">9022000</galt:ChangeInFairValueOfWarrant>
  <galt:IssuanceOfCommonStockAndWarrantsValue contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_2013_1600002">2221000</galt:IssuanceOfCommonStockAndWarrantsValue>
  <galt:UnrealizedGainLossInDebtInstrumentFairValue contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_CEA9DA2E-329B-4BA0-8D3A-315EC5EAF42A_3_8">-3426000</galt:UnrealizedGainLossInDebtInstrumentFairValue>
  <galt:ValueOfBeneficialConversionFeatureOfPreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A03BFB5A-1EFA-47D9-936A-954C88058A1F_2013_1600002">222000</galt:ValueOfBeneficialConversionFeatureOfPreferredStock>
  <galt:StockIssuedDuringPeriodValueConversionOrExchangeOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A03BFB5A-1EFA-47D9-936A-954C88058A1F_2013_1600003">1036000</galt:StockIssuedDuringPeriodValueConversionOrExchangeOfConvertibleSecurities>
  <galt:ConversionOfAccruedLiabilitiesToCommonStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_37">329000</galt:ConversionOfAccruedLiabilitiesToCommonStock>
  <galt:IssuanceOfEquityWarrantsInConnectionWithEquityOfferings contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_36">9482000</galt:IssuanceOfEquityWarrantsInConnectionWithEquityOfferings>
  <galt:IssuanceOfWarrantsToInduceConversionOfNotesPayable contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_42">503000</galt:IssuanceOfWarrantsToInduceConversionOfNotesPayable>
  <galt:StockIssuedDuringPeriodValueFounders contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A03BFB5A-1EFA-47D9-936A-954C88058A1F_2013_1600001">9000</galt:StockIssuedDuringPeriodValueFounders>
  <galt:AdjustmentsToAdditionalPaidInCapitalDeferredCompensation contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_2013_1600011">455000</galt:AdjustmentsToAdditionalPaidInCapitalDeferredCompensation>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_2013_1600003">17000</galt:StockIssuanceCosts>
  <galt:CashlessExerciseOfStockOptionsAndWarrants contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3_38">674000</galt:CashlessExerciseOfStockOptionsAndWarrants>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x498640_507189x505866_513696x498640_542884x516857" unitRef="iso4217_USD" decimals="-3" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_4007_1100001">704000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:IssuanceOfRedeemablePreferredStockShares contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x498640_507189x505866_513696x498640_542884x516857" unitRef="shares" decimals="0" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_4007_1000001">1742500</galt:IssuanceOfRedeemablePreferredStockShares>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x498640_513696x498640" unitRef="shares" decimals="INF" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_4007_1000002">-180000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x498640_513696x498640" unitRef="iso4217_USD" decimals="-3" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_4007_1100002">-72000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:NetIncomeLoss contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x500343" unitRef="iso4217_USD" decimals="-3" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_3012_1500006">-71992000</us-gaap:NetIncomeLoss>
  <galt:CumulativeEffectOfInitialAdoptionOfNewAccountingPrincipleGross contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x500343" unitRef="iso4217_USD" decimals="-3" id="id_1168147_5D6D86AB-9A82-441B-B138-4EB82BF62FA7_2012_1500004">254000</galt:CumulativeEffectOfInitialAdoptionOfNewAccountingPrincipleGross>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x500343_507189x517123_513696x516922" unitRef="iso4217_USD" decimals="-3" id="id_1168147_5D6D86AB-9A82-441B-B138-4EB82BF62FA7_3012_1500007">1303000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x500343_507189x517124_513696x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_3012_1500001">2057000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x500343_507189x517125_513696x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_4012_1500008">685000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x500343_513696x498640" unitRef="iso4217_USD" decimals="-3" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_5012_1500008">922000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x500343_513696x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_5012_1500007">257000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x500343_513696x516922" unitRef="iso4217_USD" decimals="-3" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_6012_1500003">1034000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x500343_513696x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_7012_1500005">2022000</us-gaap:DividendsPreferredStock>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501142_513696x501142_542884x516860" unitRef="shares" decimals="INF" id="id_1168147_39B090E1-3B0A-4251-9388-CBE5B9A5DE3A_2005_800006">-5</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501142_513696x501142_542884x516860" unitRef="iso4217_USD" decimals="-3" id="id_1168147_39B090E1-3B0A-4251-9388-CBE5B9A5DE3A_2005_900006">-49000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501142_513696x501142_542884x516860" unitRef="iso4217_USD" decimals="-3" id="id_1168147_39B090E1-3B0A-4251-9388-CBE5B9A5DE3A_2005_900004">2203000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:IssuanceOfRedeemablePreferredStockShares contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501142_513696x501142_542884x516860" unitRef="shares" decimals="0" id="id_1168147_39B090E1-3B0A-4251-9388-CBE5B9A5DE3A_2005_800004">225</galt:IssuanceOfRedeemablePreferredStockShares>
  <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_3009_1200005">3324</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348" unitRef="iso4217_USD" decimals="-3" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_2009_1300009">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1168147_5D6D86AB-9A82-441B-B138-4EB82BF62FA7_2009_1200003">12515</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_2009_1200009">454167</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <galt:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348" unitRef="iso4217_USD" decimals="-3" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_2009_1300010">3000</galt:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <galt:StockIssuedDuringPeriodValueFounders contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A03BFB5A-1EFA-47D9-936A-954C88058A1F_2009_1300001">2000</galt:StockIssuedDuringPeriodValueFounders>
  <galt:StockIssuedDuringPeriodSharesMerger contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1168147_A03BFB5A-1EFA-47D9-936A-954C88058A1F_2009_1200004">203649</galt:StockIssuedDuringPeriodSharesMerger>
  <galt:StockIssuedDuringPeriodSharesStockWarrantsExercised contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_2009_1200010">3419570</galt:StockIssuedDuringPeriodSharesStockWarrantsExercised>
  <galt:StockIssuedDuringPeriodSharesConversionOrExchangeOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1168147_A03BFB5A-1EFA-47D9-936A-954C88058A1F_2009_1200003">110054</galt:StockIssuedDuringPeriodSharesConversionOrExchangeOfConvertibleSecurities>
  <galt:IssuanceOfCommonStockAndWarrantsShares contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_2009_1200002">114884</galt:IssuanceOfCommonStockAndWarrantsShares>
  <galt:StockIssuedDuringPeriodSharesFounders contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348" unitRef="shares" decimals="0" id="id_1168147_A03BFB5A-1EFA-47D9-936A-954C88058A1F_2009_1200001">2059112</galt:StockIssuedDuringPeriodSharesFounders>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x501039_542884x516858" unitRef="shares" decimals="INF" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_3009_1200004">31000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x501039_542884x517233" unitRef="iso4217_USD" decimals="-3" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_3009_1300004">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x501039_542884x517233" unitRef="shares" decimals="INF" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_3009_1200004">1250000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x504935_542884x517223" unitRef="shares" decimals="INF" id="id_1168147_29177D8F-89DD-4C3A-8C4D-A52BF998B661_3009_1200005">33618</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x505866_542884x516859" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_4009_1300006">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x505866_542884x516859" unitRef="shares" decimals="INF" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_4009_1200006">537227</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x505866_542884x517221" unitRef="shares" decimals="INF" id="id_1168147_29177D8F-89DD-4C3A-8C4D-A52BF998B661_4009_1200001">181334</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x505866_542884x517224" unitRef="iso4217_USD" decimals="-3" id="id_1168147_29177D8F-89DD-4C3A-8C4D-A52BF998B661_5009_1300006">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x505866_542884x517224" unitRef="shares" decimals="INF" id="id_1168147_29177D8F-89DD-4C3A-8C4D-A52BF998B661_5009_1200006">399917</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x505866_542884x517225" unitRef="shares" decimals="INF" id="id_1168147_01EC07E9-026F-4CA9-A87B-7A14E62F2087_3009_1200002">219096</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x505866_542884x517226" unitRef="shares" decimals="INF" id="id_1168147_01EC07E9-026F-4CA9-A87B-7A14E62F2087_4009_1200005">206019</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x505866_542884x517232" unitRef="iso4217_USD" decimals="-3" id="id_1168147_016244F5-B102-4FA9-A85F-06D65AF62D3E_2009_1300001">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x505866_542884x517232" unitRef="shares" decimals="INF" id="id_1168147_016244F5-B102-4FA9-A85F-06D65AF62D3E_2009_1200001">333334</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x508125_542884x516857" unitRef="shares" decimals="INF" id="id_1168147_01EC07E9-026F-4CA9-A87B-7A14E62F2087_5009_1200004">2772</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x532491_542884x516857" unitRef="shares" decimals="INF" id="id_1168147_A03BFB5A-1EFA-47D9-936A-954C88058A1F_3009_1200006">99705</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x532491_542884x516860" unitRef="shares" decimals="INF" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_7009_1200008">17647</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x534083_542884x517222" unitRef="shares" decimals="INF" id="id_1168147_29177D8F-89DD-4C3A-8C4D-A52BF998B661_6009_1200003">2042</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_513696x498640" unitRef="shares" decimals="INF" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_5009_1200007">160330</us-gaap:PreferredStockDividendsShares>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_513696x498640" unitRef="shares" decimals="INF" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_4009_1200002">30000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_513696x501142" unitRef="shares" decimals="INF" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_5009_1200006">63119</us-gaap:PreferredStockDividendsShares>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_513696x501142_542884x516860" unitRef="shares" decimals="INF" id="id_1168147_39B090E1-3B0A-4251-9388-CBE5B9A5DE3A_2009_1200006">8334</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_513696x516922" unitRef="shares" decimals="INF" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_6009_1200002">298807</us-gaap:PreferredStockDividendsShares>
  <us-gaap:PreferredStockDividendsShares contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_7009_1200004">568721</us-gaap:PreferredStockDividendsShares>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_542884x516857" unitRef="shares" decimals="INF" id="id_1168147_016244F5-B102-4FA9-A85F-06D65AF62D3E_3009_1200003">79367</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_542884x516858" unitRef="shares" decimals="INF" id="id_1168147_016244F5-B102-4FA9-A85F-06D65AF62D3E_4009_1200004">1227972</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_542884x516858" unitRef="shares" decimals="INF" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_5009_1200001">398937</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_542884x516858" unitRef="iso4217_USD" decimals="-3" id="id_1168147_016244F5-B102-4FA9-A85F-06D65AF62D3E_4009_1300004">1000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_542884x516858" unitRef="iso4217_USD" decimals="-3" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_5009_1300001">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_542884x516859" unitRef="shares" decimals="INF" id="id_1168147_016244F5-B102-4FA9-A85F-06D65AF62D3E_5009_1200005">867558</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_542884x516859" unitRef="iso4217_USD" decimals="-3" id="id_1168147_016244F5-B102-4FA9-A85F-06D65AF62D3E_5009_1300005">1000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_542884x517235" unitRef="iso4217_USD" decimals="-3" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_6009_1300003">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_542884x517235" unitRef="shares" decimals="INF" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_6009_1200003">2666722</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_5D6D86AB-9A82-441B-B138-4EB82BF62FA7_2011_1400002">11635000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:SubscriptionRevenue contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_29177D8F-89DD-4C3A-8C4D-A52BF998B661_2011_1400004">150000</us-gaap:SubscriptionRevenue>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_2011_1400009">-1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_5D6D86AB-9A82-441B-B138-4EB82BF62FA7_2011_1400003">53000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <galt:ReclassificationOfWarrantsToLiability contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_2011_1400010">3193000</galt:ReclassificationOfWarrantsToLiability>
  <galt:CumulativeEffectOfInitialAdoptionOfNewAccountingPrincipleGross contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_5D6D86AB-9A82-441B-B138-4EB82BF62FA7_2011_1400004">-458000</galt:CumulativeEffectOfInitialAdoptionOfNewAccountingPrincipleGross>
  <galt:StockBasedCompensation contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_5D6D86AB-9A82-441B-B138-4EB82BF62FA7_2011_1400001">157000</galt:StockBasedCompensation>
  <galt:StockIssuedDuringPeriodValueMerger contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A03BFB5A-1EFA-47D9-936A-954C88058A1F_2011_1400005">107000</galt:StockIssuedDuringPeriodValueMerger>
  <galt:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_2011_1400010">14304000</galt:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <galt:IssuanceOfCommonStockAndWarrantsValue contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_2011_1400002">2221000</galt:IssuanceOfCommonStockAndWarrantsValue>
  <galt:ValueOfBeneficialConversionFeatureOfPreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A03BFB5A-1EFA-47D9-936A-954C88058A1F_2011_1400002">222000</galt:ValueOfBeneficialConversionFeatureOfPreferredStock>
  <galt:StockIssuedDuringPeriodValueConversionOrExchangeOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A03BFB5A-1EFA-47D9-936A-954C88058A1F_2011_1400003">1036000</galt:StockIssuedDuringPeriodValueConversionOrExchangeOfConvertibleSecurities>
  <galt:StockIssuedDuringPeriodValueFounders contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A03BFB5A-1EFA-47D9-936A-954C88058A1F_2011_1400001">7000</galt:StockIssuedDuringPeriodValueFounders>
  <galt:AdjustmentsToAdditionalPaidInCapitalDeferredCompensation contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="-3" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_2011_1400011">455000</galt:AdjustmentsToAdditionalPaidInCapitalDeferredCompensation>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x501039_542884x516858" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_3011_1400004">602000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x501039_542884x517233" unitRef="iso4217_USD" decimals="-3" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_3011_1400004">1043000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x504935_542884x517223" unitRef="iso4217_USD" decimals="-3" id="id_1168147_29177D8F-89DD-4C3A-8C4D-A52BF998B661_3011_1400005">302000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x505866_542884x516858" unitRef="iso4217_USD" decimals="-3" id="id_1168147_01EC07E9-026F-4CA9-A87B-7A14E62F2087_2011_1400001">261000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x505866_542884x516859" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_4011_1400006">2860000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x505866_542884x517221" unitRef="iso4217_USD" decimals="-3" id="id_1168147_29177D8F-89DD-4C3A-8C4D-A52BF998B661_4011_1400001">1070000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x505866_542884x517224" unitRef="iso4217_USD" decimals="-3" id="id_1168147_29177D8F-89DD-4C3A-8C4D-A52BF998B661_5011_1400006">4409000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x505866_542884x517225" unitRef="iso4217_USD" decimals="-3" id="id_1168147_01EC07E9-026F-4CA9-A87B-7A14E62F2087_3011_1400002">1319000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x505866_542884x517226" unitRef="iso4217_USD" decimals="-3" id="id_1168147_01EC07E9-026F-4CA9-A87B-7A14E62F2087_4011_1400005">1898000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x505866_542884x517232" unitRef="iso4217_USD" decimals="-3" id="id_1168147_016244F5-B102-4FA9-A85F-06D65AF62D3E_2011_1400001">489000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x506023_542884x516857" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_5011_1400001">503000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x506023_542884x516858" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_6011_1400009">236000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x508125_542884x516857" unitRef="iso4217_USD" decimals="-3" id="id_1168147_01EC07E9-026F-4CA9-A87B-7A14E62F2087_5011_1400004">74000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x532491_542884x516857" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A03BFB5A-1EFA-47D9-936A-954C88058A1F_3011_1400006">1126000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x532491_542884x516860" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_7011_1400008">290000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x534083_542884x517222" unitRef="iso4217_USD" decimals="-3" id="id_1168147_29177D8F-89DD-4C3A-8C4D-A52BF998B661_6011_1400003">12000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_513696x498640" unitRef="iso4217_USD" decimals="-3" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_4011_1400002">72000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_513696x498640" unitRef="iso4217_USD" decimals="-3" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_5011_1400008">-875000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_513696x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_5011_1400007">-224000</us-gaap:DividendsPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_513696x501142_542884x516860" unitRef="iso4217_USD" decimals="-3" id="id_1168147_39B090E1-3B0A-4251-9388-CBE5B9A5DE3A_2011_1400006">49000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_513696x516922" unitRef="iso4217_USD" decimals="-3" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_6011_1400003">-1034000</us-gaap:DividendsPreferredStock>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_513696x516922_542884x516858" unitRef="iso4217_USD" decimals="-3" id="id_1168147_5D6D86AB-9A82-441B-B138-4EB82BF62FA7_4011_1400005">1105000</galt:IssuanceOfRedeemablePreferredStockValue>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_513696x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_7011_1400005">-2022000</us-gaap:DividendsPreferredStock>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_513696x516923_542884x516859" unitRef="iso4217_USD" decimals="-3" id="id_1168147_39B090E1-3B0A-4251-9388-CBE5B9A5DE3A_3011_1400001">2761000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:ValueOfBeneficialConversionFeatureOfPreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_513696x516923_542884x517065" unitRef="iso4217_USD" decimals="-3" id="id_1168147_39B090E1-3B0A-4251-9388-CBE5B9A5DE3A_4011_1400003">1016000</galt:ValueOfBeneficialConversionFeatureOfPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_542884x516857" unitRef="iso4217_USD" decimals="-3" id="id_1168147_016244F5-B102-4FA9-A85F-06D65AF62D3E_3011_1400003">1745000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_542884x516858" unitRef="iso4217_USD" decimals="-3" id="id_1168147_016244F5-B102-4FA9-A85F-06D65AF62D3E_4011_1400004">3947000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_542884x516858" unitRef="iso4217_USD" decimals="-3" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_5011_1400001">361000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_542884x516859" unitRef="iso4217_USD" decimals="-3" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_6011_1400009">20000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_542884x516859" unitRef="iso4217_USD" decimals="-3" id="id_1168147_016244F5-B102-4FA9-A85F-06D65AF62D3E_5011_1400005">5329000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_542884x517235" unitRef="iso4217_USD" decimals="-3" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_6011_1400003">10400000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x516922_507189x517123_513696x516922" unitRef="iso4217_USD" decimals="-3" id="id_1168147_5D6D86AB-9A82-441B-B138-4EB82BF62FA7_3001_500007">-1303000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x516922_513696x516922_542884x516858" unitRef="iso4217_USD" decimals="-3" id="id_1168147_5D6D86AB-9A82-441B-B138-4EB82BF62FA7_4001_500005">395000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:IssuanceOfRedeemablePreferredStockShares contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x516922_513696x516922_542884x516858" unitRef="shares" decimals="0" id="id_1168147_5D6D86AB-9A82-441B-B138-4EB82BF62FA7_4001_400005">900000</galt:IssuanceOfRedeemablePreferredStockShares>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x516923_507189x517124_513696x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_3003_700001">-2057000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x516923_507189x517125_513696x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_4003_700008">-685000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x516923_513696x516923_542884x516859" unitRef="iso4217_USD" decimals="-3" id="id_1168147_39B090E1-3B0A-4251-9388-CBE5B9A5DE3A_3003_700001">1174000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:IssuanceOfRedeemablePreferredStockShares contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x516923_513696x516923_542884x516859" unitRef="shares" decimals="0" id="id_1168147_39B090E1-3B0A-4251-9388-CBE5B9A5DE3A_3003_600001">2100000</galt:IssuanceOfRedeemablePreferredStockShares>
  <galt:ValueOfBeneficialConversionFeatureOfPreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x516923_513696x516923_542884x517065" unitRef="iso4217_USD" decimals="-3" id="id_1168147_39B090E1-3B0A-4251-9388-CBE5B9A5DE3A_4003_700003">-1016000</galt:ValueOfBeneficialConversionFeatureOfPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x501039_542884x516858" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_3013_1600004">602000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x501039_542884x516858" unitRef="iso4217_USD" decimals="0" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_3013_1600005">49000</galt:StockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x501039_542884x517233" unitRef="iso4217_USD" decimals="-3" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_3013_1600004">1044000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:EquityIssuanceDates contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x501039_542884x517233" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_3013_1600005">2008-02-25</us-gaap:EquityIssuanceDates>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x501039_542884x517233" unitRef="iso4217_USD" decimals="0" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_3013_1600006">369000</galt:StockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x504935_542884x517223" unitRef="iso4217_USD" decimals="-3" id="id_1168147_29177D8F-89DD-4C3A-8C4D-A52BF998B661_3013_1600005">302000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:EquityIssuanceDates contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_513696x498640_542884x516857" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_4013_1600002">2008-02-04</us-gaap:EquityIssuanceDates>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_513696x498640_542884x516857" unitRef="iso4217_USD" decimals="-3" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_4013_1600001">704000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_513696x498640_542884x516857" unitRef="iso4217_USD" decimals="0" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_4013_1600003">52000</galt:StockIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x516858" unitRef="iso4217_USD" decimals="-3" id="id_1168147_01EC07E9-026F-4CA9-A87B-7A14E62F2087_2013_1600001">261000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x516859" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_4013_1600006">2861000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x516859" unitRef="iso4217_USD" decimals="0" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_4013_1600007">212000</galt:StockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x517221" unitRef="iso4217_USD" decimals="-3" id="id_1168147_29177D8F-89DD-4C3A-8C4D-A52BF998B661_4013_1600001">1070000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x517221" unitRef="iso4217_USD" decimals="0" id="id_1168147_29177D8F-89DD-4C3A-8C4D-A52BF998B661_4013_1600002">18000</galt:StockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x517224" unitRef="iso4217_USD" decimals="-3" id="id_1168147_29177D8F-89DD-4C3A-8C4D-A52BF998B661_5013_1600006">4410000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x517224" unitRef="iso4217_USD" decimals="0" id="id_1168147_29177D8F-89DD-4C3A-8C4D-A52BF998B661_5013_1600007">128000</galt:StockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x517225" unitRef="iso4217_USD" decimals="-3" id="id_1168147_01EC07E9-026F-4CA9-A87B-7A14E62F2087_3013_1600002">1319000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x517225" unitRef="iso4217_USD" decimals="0" id="id_1168147_01EC07E9-026F-4CA9-A87B-7A14E62F2087_3013_1600003">559000</galt:StockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x517226" unitRef="iso4217_USD" decimals="-3" id="id_1168147_01EC07E9-026F-4CA9-A87B-7A14E62F2087_4013_1600005">1898000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x517226" unitRef="iso4217_USD" decimals="0" id="id_1168147_01EC07E9-026F-4CA9-A87B-7A14E62F2087_4013_1600006">466000</galt:StockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x517232" unitRef="iso4217_USD" decimals="-3" id="id_1168147_016244F5-B102-4FA9-A85F-06D65AF62D3E_2013_1600001">490000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x517232" unitRef="iso4217_USD" decimals="0" id="id_1168147_016244F5-B102-4FA9-A85F-06D65AF62D3E_2013_1600002">485000</galt:StockIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x506023_542884x516857" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_5013_1600001">503000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x506023_542884x516858" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_6013_1600009">236000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x508125_542884x516857" unitRef="iso4217_USD" decimals="-3" id="id_1168147_01EC07E9-026F-4CA9-A87B-7A14E62F2087_5013_1600004">74000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x517123_513696x516922" unitRef="iso4217_USD" decimals="-3" id="id_1168147_5D6D86AB-9A82-441B-B138-4EB82BF62FA7_3013_1600007">1303000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x517124_513696x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_3013_1600001">2057000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <galt:AccretionOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x517125_513696x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_4013_1600008">685000</galt:AccretionOfRedeemableConvertiblePreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x532491_542884x516857" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A03BFB5A-1EFA-47D9-936A-954C88058A1F_3013_1600006">1126000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x532491_542884x516860" unitRef="iso4217_USD" decimals="-3" id="id_1168147_A8B28BEA-9361-4183-88BA-0435B497138E_7013_1600008">290000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x534083_542884x517222" unitRef="iso4217_USD" decimals="-3" id="id_1168147_29177D8F-89DD-4C3A-8C4D-A52BF998B661_6013_1600003">12000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x498640" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_1003_22">1691000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x498640" unitRef="iso4217_USD" decimals="-3" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_5013_1600008">47000</us-gaap:DividendsPreferredStock>
  <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_2003_25">2203000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
  <us-gaap:DividendsPreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x501142" unitRef="iso4217_USD" decimals="-3" id="id_1168147_C124A33C-A00A-4A8C-8144-0E452E7FB852_5013_1600007">33000</us-gaap:DividendsPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x501142_542884x516860" unitRef="iso4217_USD" decimals="-3" id="id_1168147_39B090E1-3B0A-4251-9388-CBE5B9A5DE3A_2013_1600006">49000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x501142_542884x516860" unitRef="iso4217_USD" decimals="0" id="id_1168147_39B090E1-3B0A-4251-9388-CBE5B9A5DE3A_2013_1600005">47000</galt:StockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x516922" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_3003_23">1548000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x516922_542884x516858" unitRef="iso4217_USD" decimals="-3" id="id_1168147_5D6D86AB-9A82-441B-B138-4EB82BF62FA7_4013_1600005">1105000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x516922_542884x516858" unitRef="iso4217_USD" decimals="0" id="id_1168147_5D6D86AB-9A82-441B-B138-4EB82BF62FA7_4013_1600006">300000</galt:StockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x516923" unitRef="iso4217_USD" decimals="-3" id="id_1168147_44F7C3DF-9B2E-472A-9C84-D159AAC619BA_4003_24">3935000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
  <galt:IssuanceOfRedeemablePreferredStockValue contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x516923_542884x516859" unitRef="iso4217_USD" decimals="-3" id="id_1168147_39B090E1-3B0A-4251-9388-CBE5B9A5DE3A_3013_1600001">2761000</galt:IssuanceOfRedeemablePreferredStockValue>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x516923_542884x516859" unitRef="iso4217_USD" decimals="0" id="id_1168147_39B090E1-3B0A-4251-9388-CBE5B9A5DE3A_3013_1600002">188000</galt:StockIssuanceCosts>
  <galt:ValueOfBeneficialConversionFeatureOfPreferredStock contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x516923_542884x517065" unitRef="iso4217_USD" decimals="-3" id="id_1168147_39B090E1-3B0A-4251-9388-CBE5B9A5DE3A_4013_1600003">1016000</galt:ValueOfBeneficialConversionFeatureOfPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_542884x516857" unitRef="iso4217_USD" decimals="-3" id="id_1168147_016244F5-B102-4FA9-A85F-06D65AF62D3E_3013_1600003">1745000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_542884x516858" unitRef="iso4217_USD" decimals="-3" id="id_1168147_016244F5-B102-4FA9-A85F-06D65AF62D3E_4013_1600004">3948000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_542884x516858" unitRef="iso4217_USD" decimals="-3" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_5013_1600001">362000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_542884x516859" unitRef="iso4217_USD" decimals="-3" id="id_1168147_281DF155-9565-4FB7-9AE7-E3C246AC6B8F_6013_1600009">20000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_542884x516859" unitRef="iso4217_USD" decimals="-3" id="id_1168147_016244F5-B102-4FA9-A85F-06D65AF62D3E_5013_1600005">5330000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_542884x517235" unitRef="iso4217_USD" decimals="-3" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_6013_1600003">10403000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <galt:StockIssuanceCosts contextRef="eol_PE87402---1210-K0013_STD_4557_20121231_0_542884x517235" unitRef="iso4217_USD" decimals="0" id="id_1168147_1D7305C5-8F86-4897-8833-C231B77942F4_6013_1600004">1597000</galt:StockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_485_20100531_0_513696x516922" unitRef="shares" decimals="INF" id="id_1168147_6C2DD29A-4746-424F-AD9E-E6723EC9B859_1001_0">900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_485_20100531_0_513696x516922" unitRef="shares" decimals="INF" id="id_1168147_6C2DD29A-4746-424F-AD9E-E6723EC9B859_1001_1">1800000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE87402---1210-K0013_STD_485_20100531_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_6C2DD29A-4746-424F-AD9E-E6723EC9B859_2001_2">2100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <galt:ClassOfWarrantOrRightIssuedInPeriod contextRef="eol_PE87402---1210-K0013_STD_485_20100531_0_513696x516923" unitRef="shares" decimals="INF" id="id_1168147_6C2DD29A-4746-424F-AD9E-E6723EC9B859_2001_3">4200000</galt:ClassOfWarrantOrRightIssuedInPeriod>
  <galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod contextRef="eol_PE87402---1210-K0013_STD_60_20040229_0_508454x506554" unitRef="shares" decimals="INF" id="id_1168147_F672F132-C066-4CA5-805C-25674FACF7AB_6004_6">10000</galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE87402---1210-K0013_STD_91_20080630_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_E00CB1DB-C74F-4132-A83E-2FB087D6F812_2_15">2160000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <galt:ChangeInFairValueOfWarrantLiabilities contextRef="eol_PE87402---1210-K0013_STD_91_20080630_0" unitRef="iso4217_USD" decimals="0" id="id_1168147_E00CB1DB-C74F-4132-A83E-2FB087D6F812_2_14">356000</galt:ChangeInFairValueOfWarrantLiabilities>
  <context id="eol_PE87402---1210-K0013_STD_91_20080630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2008-04-01</startDate>
      <endDate>2008-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_60_20040229_0_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-02-29</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_485_20100531_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-02-01</startDate>
      <endDate>2010-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_485_20100531_0_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-02-01</startDate>
      <endDate>2010-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_542884x517235">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_542884x516859">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_542884x516858">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_542884x516857">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x516923_542884x517065">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:PeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x516923_542884x516859">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x516922_542884x516858">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x501142_542884x516860">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x534083_542884x517222">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ConsultingServicesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x532491_542884x516860">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:NotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x532491_542884x516857">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:NotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x517125_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:TransactionThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x517124_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:TransactionTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x517123_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:TransactionOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x508125_542884x516857">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x506023_542884x516858">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x506023_542884x516857">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x517232">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x517226">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x517225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodNineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x517224">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x517221">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x516859">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_542884x516858">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x505866_513696x498640_542884x516857">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x504935_542884x517223">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x501039_542884x517233">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwelveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:CashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_507189x501039_542884x516858">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:CashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x516923_513696x516923_542884x517065">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:PeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x516923_513696x516923_542884x516859">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x516923_507189x517125_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:TransactionThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x516923_507189x517124_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:TransactionTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x516922_513696x516922_542884x516858">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x516922_507189x517123_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:TransactionOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_542884x517235">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_542884x516859">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_542884x516858">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_542884x516857">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_513696x516923_542884x517065">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:PeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_513696x516923_542884x516859">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_513696x516922_542884x516858">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_513696x501142_542884x516860">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x534083_542884x517222">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ConsultingServicesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x532491_542884x516860">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:NotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x532491_542884x516857">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:NotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x508125_542884x516857">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x506023_542884x516858">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x506023_542884x516857">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x505866_542884x517232">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x505866_542884x517226">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x505866_542884x517225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodNineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x505866_542884x517224">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x505866_542884x517221">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x505866_542884x516859">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x505866_542884x516858">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x504935_542884x517223">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x501039_542884x517233">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwelveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:CashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619_507189x501039_542884x516858">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:CashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_542884x517235">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_542884x516859">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_542884x516858">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_542884x516857">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_513696x501142_542884x516860">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x534083_542884x517222">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ConsultingServicesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x532491_542884x516860">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:NotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x532491_542884x516857">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:NotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x508125_542884x516857">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x505866_542884x517232">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x505866_542884x517226">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x505866_542884x517225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodNineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x505866_542884x517224">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x505866_542884x517221">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x505866_542884x516859">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x504935_542884x517223">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x501039_542884x517233">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwelveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:CashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348_507189x501039_542884x516858">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:CashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x501142_513696x501142_542884x516860">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x500343_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x500343_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x500343_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x500343_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x500343_507189x517125_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:TransactionThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x500343_507189x517124_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:TransactionTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x500343_507189x517123_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:TransactionOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x500343">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x498640_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0_505872x498640_507189x505866_513696x498640_542884x516857">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:IssuanceDuringPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_4557_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2000-07-11</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_38_20040407_0_510623x547978">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:PlacementAgentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-03-01</startDate>
      <endDate>2004-04-07</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_38_20040407_0_510623x531324">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:InstitutionalInvestorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-03-01</startDate>
      <endDate>2004-04-07</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_367_20130201_0_506663x511390">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-02-01</startDate>
      <endDate>2013-02-01</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_367_20110131_0_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-30</startDate>
      <endDate>2011-01-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_530649x607894">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:LocationAxis">galt:NorcrossMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_514791x514283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_514791x507958">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_514791x507534">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ContingentlyIssuableSharesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_513696x551546">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_510903x537720">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">galt:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_510903x500372">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x678630">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:TwentyTwelveOfferingPlacementAgentWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x678629">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MarchTwentyEightTwentyTwelveOfferingWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x625048">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:DecemberThirtyTwentyTenPlacementAgentWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x625047">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:DecemberNineTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x624813">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JuneFifteenTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x624812_542884x531497">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTwentyFiveTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x624812_542884x531496">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:FirstIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTwentyFiveTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x624803">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JulyTwentySixTwentyZeroNineConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x624802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JuneThirtyTwentyZeroNineConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x624801">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayOneTwentyZeroNineConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_510623x624800">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AprilFifteenTwentyZeroNineConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624811">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTenTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624810">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AprilThirtyTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624809">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MarchEightTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624808">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JanuaryTwentyNineTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624807">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:DecemberEightTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624806">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:NovemberFourTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624805">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:SeptemberThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624804">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AugustTwelveTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JuneThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624798">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayThirteenTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517825_510623x624797">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:FebruaryTwelveTwentyZeroNineSeriesBOneTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624811">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTenTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624810">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AprilThirtyTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624809">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MarchEightTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624808">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JanuaryTwentyNineTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624807">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:DecemberEightTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624806">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:NovemberFourTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624805">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:SeptemberThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624804">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AugustTwelveTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JuneThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624798">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayThirteenTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517824_510623x624797">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:FebruaryTwelveTwentyZeroNineSeriesBOneTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_509379x517823_510623x624796">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:FebruaryTwentyFiveTwentyZeroEightCommonStockTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_508681x509983">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_508681x502974">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_507189x534240">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:NonCashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x516923_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x516922_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x508619_513696x551546">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:ConsultantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x508619_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x508619_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x508619_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x508619_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x501348_513696x551546">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:ConsultantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x501348_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x501348_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x501348_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x501348_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x500343_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x500343_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x500343_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x500343_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x500343_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_505872x500343">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_504957x514053">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_504957x513639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_498752x510320">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_498752x506779">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0_498429x585047">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:NonQualifiedOptionsPlansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20081231_0_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20081231_0_507189x517066_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:PeriodTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20081231_0_504051x551546_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20081231_0_499506x536060">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProspectiveAdoptionOfNewAccountingPronouncementsAxis">galt:AdoptionOfNewAccountingPronouncementEffectMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20041231_0_504051x624048_507189x624047_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:InvestorRelationsFirmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:OptionsVestedOnJanuaryAndFebruaryTwentyZeroFourMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20041231_0_504051x624048">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:InvestorRelationsFirmMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20041231_0_504051x610121_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:MemberOfScientificAdvisoryBoardMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20041231_0_504051x610121">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:MemberOfScientificAdvisoryBoardMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20041231_0_504051x610120_507189x610125_508454x514283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ThirdConsultingAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20041231_0_504051x610120_507189x610125">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ThirdConsultingAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20041231_0_504051x537581_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:BoardOfDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_366_20041231_0_504051x537581">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:BoardOfDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_557712x580425">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardCompensationPlansAxis">galt:MonteCarloOptionPricingModelMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_514791x514283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_514791x507958">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_514791x507534">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ContingentlyIssuableSharesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517742">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:PeriodAxis">galt:PeriodEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517741">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:PeriodAxis">galt:PeriodSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517070">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:PeriodAxis">galt:PeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517069">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:PeriodAxis">galt:PeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517068">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:PeriodAxis">galt:PeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517067">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:PeriodAxis">galt:PeriodSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517066">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:PeriodAxis">galt:PeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142_530598x517065">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:PeriodAxis">galt:PeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_509379x537561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantTwelveMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_509379x537560_542884x531497">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_509379x517826">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_508454x512177">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_507189x538001_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:FirstPaymentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_507189x538000_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:SecondPaymentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_507189x534240">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:NonCashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_507189x517784">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ScenarioTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_507189x517783">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ScenarioOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_507189x517595_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:DividendPaymentTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_507189x517594_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:DividendPaymentOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x516923_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x516922_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x508619_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x508619_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x508619_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x508619_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501348_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501348_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501348_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501348_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x501142_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x500343_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x500343_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x500343_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x500343_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x500343_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x500343">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_505872x498640_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_504957x514053_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_504957x514053_509379x537560_542884x531497">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_504957x513639_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_504957x513639_509379x537560_542884x531497">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_504051x551546_507189x517784_508454x512177">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ScenarioTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_504051x551546">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_504051x537581_508454x512177">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:BoardOfDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_504051x537581">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:BoardOfDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_498752x510320">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0_498752x506779">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20111231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20101231_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20101231_0_509379x588296_542884x531496">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:FirstIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20101231_0_509379x537561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantTwelveMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20101231_0_509379x537560_542884x531497">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20101231_0_509379x537560_542884x531496">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:FirstIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20101231_0_509379x517827">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantEightMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20101231_0_509379x517826">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20101231_0_507189x599319_509379x517826">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:VestingScenarioTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20101231_0_507189x599318_509379x517826">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:VestingScenarioOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20101231_0_505872x531897_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:BeneficialConversionFeatureMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20101231_0_505872x508619_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20101231_0_504957x514053_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20101231_0_504957x514053_509379x537560_542884x531497">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20101231_0_504957x513639_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20101231_0_504957x513639_509379x537560_542884x531497">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20101231_0_504051x537581">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:BoardOfDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20101231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20091231_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20091231_0_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20091231_0_505872x531897_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:BeneficialConversionFeatureMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20091231_0_505872x508619_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20091231_0_504957x514053_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20091231_0_504957x513639_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20091231_0_504051x551546_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20091231_0_504051x537581">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:BoardOfDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20071231_0_507189x517065_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:PeriodOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20071231_0_504051x551546_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20051231_0_504051x624048">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:InvestorRelationsFirmMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20051231_0_504051x610121_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:MemberOfScientificAdvisoryBoardMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20031231_0_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20031231_0_504296x624057">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:ScientificAdvisoryServicesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20031231_0_504296x533527">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:EmployeeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x624048_507189x624046_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:InvestorRelationsFirmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:OptionsVestedOnDecemberThirtyOneTwentyZeroThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x610122_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:BoardMemberAndMemberOfScientificAdvisoryBoardMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x610121_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:MemberOfScientificAdvisoryBoardMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x610121">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:MemberOfScientificAdvisoryBoardMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x610120_508454x506554_575189x610123">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:AgreementWithPartiesAxis">galt:ConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x610120_507189x610125_508454x514283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ThirdConsultingAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x610120_507189x610125">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ThirdConsultingAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x591663">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:FormerChiefFinancialOfficerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x537581_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:BoardOfDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20031231_0_504051x537581">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:BoardOfDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20021231_0_512768x531939">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">galt:PublicOfferingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20021231_0_504051x610120_508454x506554_575189x610123">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:AgreementWithPartiesAxis">galt:ConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20021231_0_504051x610120_507189x610124_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:SecondConsultingAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20021231_0_504051x610120_507189x610124">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:SecondConsultingAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20021231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20011231_0_509379x517821">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20011231_0_509379x517820">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20011231_0_504051x610120_575189x610123">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:AgreementWithPartiesAxis">galt:ConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20011231_0_504051x610120_508454x506554_575189x610123">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:AgreementWithPartiesAxis">galt:ConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_365_20011231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_35_20080331_0_504051x551546">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-02-26</startDate>
      <endDate>2008-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_35_20091104_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2009-11-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_35_20091104_0_509379x624346_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2009-11-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_35_20091104_0_509379x624345_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2009-11-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_35_20091104_0_509379x531223_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2009-11-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_35_20091104_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2009-11-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_35_20080204_0_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-02-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_35_20080204_0_509379x507958">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-02-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_35_20080204_0_507189x538001_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:FirstPaymentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-02-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_35_20080204_0_507189x538000_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:SecondPaymentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-02-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_35_20080204_0_507189x517784_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ScenarioTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-02-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_35_20080204_0_507189x517783_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ScenarioOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-02-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_35_20080204_0_504957x513639_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-02-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_35_20080204_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-02-04</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_34_20091208_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-11-05</startDate>
      <endDate>2009-12-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_34_20091208_0_509379x624346_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-11-05</startDate>
      <endDate>2009-12-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_34_20091208_0_509379x624345_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-11-05</startDate>
      <endDate>2009-12-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_34_20091208_0_509379x531223_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-11-05</startDate>
      <endDate>2009-12-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_34_20091208_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2009-11-05</startDate>
      <endDate>2009-12-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_32_20080702_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2008-06-01</startDate>
      <endDate>2008-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20130131_0_506663x511390_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-01-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20101231_0_509379x588296_542884x531497">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-12-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20101231_0_509379x588296_542884x531496">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:FirstIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-12-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20071231_0_504051x551546">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-12-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20030114_0_504296x624055">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:FinderAndFindersAgentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2002-12-15</startDate>
      <endDate>2003-01-14</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20030114_0_504296x533527">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:EmployeeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2002-12-15</startDate>
      <endDate>2003-01-14</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20030114_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2002-12-15</startDate>
      <endDate>2003-01-14</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20121031_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2012-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20101031_0_509379x537561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantTwelveMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2010-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20031031_0_504051x591663_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:FormerChiefFinancialOfficerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2003-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20031031_0_504051x591663_507189x534240">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:FormerChiefFinancialOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:NonCashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2003-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20031031_0_504051x591663">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:FormerChiefFinancialOfficerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2003-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20011031_0_498429x610126_504957x514053">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:StockIncentivePlanTwentyZeroOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-10-01</startDate>
      <endDate>2001-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20011031_0_498429x610126_504957x513639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:StockIncentivePlanTwentyZeroOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-10-01</startDate>
      <endDate>2001-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20011031_0_498429x610126">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:StockIncentivePlanTwentyZeroOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-10-01</startDate>
      <endDate>2001-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20010831_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2001-08-01</startDate>
      <endDate>2001-08-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20110731_0_513696x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-07-01</startDate>
      <endDate>2011-07-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20110731_0_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-07-01</startDate>
      <endDate>2011-07-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20110731_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2011-07-01</startDate>
      <endDate>2011-07-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20090531_0_509379x517827">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantEightMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-05-01</startDate>
      <endDate>2009-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20080531_0_497730x551558">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">galt:InvestorRelationsGroupIncMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-05-01</startDate>
      <endDate>2008-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20030531_0_504051x610121">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:MemberOfScientificAdvisoryBoardMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-05-01</startDate>
      <endDate>2003-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20030531_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2003-05-01</startDate>
      <endDate>2003-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20100531_0_509379x537560_542884x531497">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-05-01</startDate>
      <endDate>2010-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20100531_0_509379x537560_542884x531496">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:FirstIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-05-01</startDate>
      <endDate>2010-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20090331_0_504051x551546">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-03-01</startDate>
      <endDate>2009-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20060331_0_504051x551546_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-03-01</startDate>
      <endDate>2006-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20060331_0_504051x551546">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-03-01</startDate>
      <endDate>2006-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20040331_0_504051x624048_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:InvestorRelationsFirmMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-03-01</startDate>
      <endDate>2004-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20040331_0_504051x624048_504957x514053">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:InvestorRelationsFirmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-03-01</startDate>
      <endDate>2004-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20040331_0_504051x624048">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:InvestorRelationsFirmMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-03-01</startDate>
      <endDate>2004-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20020331_0_504051x610120_507189x610124">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:SecondConsultingAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2002-03-01</startDate>
      <endDate>2002-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20120831_0_504051x551546">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-08-01</startDate>
      <endDate>2012-08-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20120831_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2012-08-01</startDate>
      <endDate>2012-08-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20120531_0_504051x551546">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-05-01</startDate>
      <endDate>2012-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20090812_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-07-13</startDate>
      <endDate>2009-08-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20090812_0_509379x624346_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-07-13</startDate>
      <endDate>2009-08-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20090812_0_509379x624345_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-07-13</startDate>
      <endDate>2009-08-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20090812_0_509379x531223_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-07-13</startDate>
      <endDate>2009-08-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20090812_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2009-07-13</startDate>
      <endDate>2009-08-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20090212_0_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-13</startDate>
      <endDate>2009-02-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20090212_0_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-13</startDate>
      <endDate>2009-02-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20090212_0_509379x624346_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-13</startDate>
      <endDate>2009-02-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20090212_0_509379x624345_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-13</startDate>
      <endDate>2009-02-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20090212_0_509379x531223_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-13</startDate>
      <endDate>2009-02-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20090212_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2009-01-13</startDate>
      <endDate>2009-02-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20080225_0_509379x517825">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-26</startDate>
      <endDate>2008-02-25</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20080225_0_509379x517824">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-26</startDate>
      <endDate>2008-02-25</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20080225_0_509379x517823">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFourMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-26</startDate>
      <endDate>2008-02-25</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20080225_0_509379x517822_510623x547978">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:PlacementAgentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-26</startDate>
      <endDate>2008-02-25</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20080225_0_509379x517822">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-26</startDate>
      <endDate>2008-02-25</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20080225_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2008-01-26</startDate>
      <endDate>2008-02-25</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20040812_0_510623x547978">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:PlacementAgentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-07-13</startDate>
      <endDate>2004-08-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20040812_0_510623x531324">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:InstitutionalInvestorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-07-13</startDate>
      <endDate>2004-08-12</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20030131_0_504051x537581">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:BoardOfDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-01-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_31_20030131_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-01-31</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20090930_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-09-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20090930_0_509379x624346_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-09-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20090930_0_509379x624345_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-09-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20090930_0_509379x531223_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-09-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20090930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2009-09-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20031002_0_510623x547978">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:PlacementAgentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-09-03</startDate>
      <endDate>2003-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20031002_0_510623x531324">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:InstitutionalInvestorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-09-03</startDate>
      <endDate>2003-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20030930_0_504051x610122">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:BoardMemberAndMemberOfScientificAdvisoryBoardMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-09-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20030930_0_504051x591663">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:FormerChiefFinancialOfficerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-09-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20020930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2002-09-01</startDate>
      <endDate>2002-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20090630_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-06-01</startDate>
      <endDate>2009-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20090630_0_509379x624346_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-06-01</startDate>
      <endDate>2009-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20090630_0_509379x624345_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-06-01</startDate>
      <endDate>2009-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20090630_0_509379x531223_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-06-01</startDate>
      <endDate>2009-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20090630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2009-06-01</startDate>
      <endDate>2009-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20030630_0_504051x610120_507189x610125">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ThirdConsultingAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-06-01</startDate>
      <endDate>2003-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20100510_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-11</startDate>
      <endDate>2010-05-10</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20100510_0_509379x624346_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-11</startDate>
      <endDate>2010-05-10</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20100510_0_509379x624345_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-11</startDate>
      <endDate>2010-05-10</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20100510_0_509379x531223_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-11</startDate>
      <endDate>2010-05-10</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20100510_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2010-04-11</startDate>
      <endDate>2010-05-10</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20100430_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-01</startDate>
      <endDate>2010-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20100430_0_509379x624346_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-01</startDate>
      <endDate>2010-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20100430_0_509379x624345_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-01</startDate>
      <endDate>2010-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20100430_0_509379x531223_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-01</startDate>
      <endDate>2010-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20100430_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2010-04-01</startDate>
      <endDate>2010-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20090430_0_509379x517826">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-04-01</startDate>
      <endDate>2009-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20080430_0_504051x551546">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-04-01</startDate>
      <endDate>2008-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20040430_0_504051x624048_504957x514053">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:InvestorRelationsFirmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-04-01</startDate>
      <endDate>2004-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20040430_0_504051x624048">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:InvestorRelationsFirmMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-04-01</startDate>
      <endDate>2004-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20101230_0_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-12-01</startDate>
      <endDate>2010-12-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20101230_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2010-12-01</startDate>
      <endDate>2010-12-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20090513_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-04-14</startDate>
      <endDate>2009-05-13</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20090513_0_509379x624346_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-04-14</startDate>
      <endDate>2009-05-13</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20090513_0_509379x624345_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-04-14</startDate>
      <endDate>2009-05-13</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20090513_0_509379x531223_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-04-14</startDate>
      <endDate>2009-05-13</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20090513_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2009-04-14</startDate>
      <endDate>2009-05-13</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_30_20051130_0_504051x610121">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:MemberOfScientificAdvisoryBoardMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-11-01</startDate>
      <endDate>2005-11-30</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_29_20100129_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-01-29</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_29_20100129_0_509379x624346_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-01-29</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_29_20100129_0_509379x624345_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-01-29</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_29_20100129_0_509379x531223_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-01-29</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_29_20100129_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-01-29</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_29_20130329_0_506663x511390_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-03-01</startDate>
      <endDate>2013-03-29</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_28_20111115_0_504051x551546">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-10-19</startDate>
      <endDate>2011-11-15</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_28_20100308_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-02-09</startDate>
      <endDate>2010-03-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_28_20100308_0_509379x624346_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassATwoWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-02-09</startDate>
      <endDate>2010-03-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_28_20100308_0_509379x624345_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassAOneWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-02-09</startDate>
      <endDate>2010-03-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_28_20100308_0_509379x531223_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:ClassBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-02-09</startDate>
      <endDate>2010-03-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_28_20100308_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2010-02-09</startDate>
      <endDate>2010-03-08</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_28_20090228_0_504051x551546">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-02-01</startDate>
      <endDate>2009-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_28_20090228_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2009-02-01</startDate>
      <endDate>2009-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_27_20120328_0_513696x534959">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:CommonStockAndWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-03-02</startDate>
      <endDate>2012-03-28</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_27_20120328_0_513696x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-03-02</startDate>
      <endDate>2012-03-28</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_27_20120328_0_509379x517826">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-03-02</startDate>
      <endDate>2012-03-28</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_27_20120328_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2012-03-02</startDate>
      <endDate>2012-03-28</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_22_20120323_0_497915x536191">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="invest:InvestmentAxis">galt:ReverseSplitMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-03-02</startDate>
      <endDate>2012-03-23</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_22_20120323_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2012-03-02</startDate>
      <endDate>2012-03-23</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_21_20120322_0_512722x547416">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">galt:UnderwritingAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-03-02</startDate>
      <endDate>2012-03-22</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_21_20120322_0_509379x517826">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-03-02</startDate>
      <endDate>2012-03-22</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_21_20120322_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2012-03-02</startDate>
      <endDate>2012-03-22</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_21_20080521_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <startDate>2008-05-01</startDate>
      <endDate>2008-05-21</endDate>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20130201_0_506663x511390">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-02-01</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_530649x607894">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:LocationAxis">galt:NorcrossMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x537761">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510903x537720">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">galt:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510903x500372">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510903x498304">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x678630">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:TwentyTwelveOfferingPlacementAgentWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x678629">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MarchTwentyEightTwentyTwelveOfferingWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x625048">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:DecemberThirtyTwentyTenPlacementAgentWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x625047">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:DecemberNineTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624813">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JuneFifteenTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624812_542884x531497">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTwentyFiveTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624812_542884x531496">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:FirstIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTwentyFiveTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624811">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTenTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624810">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AprilThirtyTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624809">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MarchEightTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624808">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JanuaryTwentyNineTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624807">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:DecemberEightTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624806">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:NovemberFourTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624805">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:SeptemberThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624804">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AugustTwelveTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624803">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JulyTwentySixTwentyZeroNineConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JuneThirtyTwentyZeroNineConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624801">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayOneTwentyZeroNineConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624800">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AprilFifteenTwentyZeroNineConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JuneThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624798">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayThirteenTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624797">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:FebruaryTwelveTwentyZeroNineSeriesBOneTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510623x624796">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:FebruaryTwentyFiveTwentyZeroEightCommonStockTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_510142x511009_511283x503498">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x531497_510623x624812">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTwentyFiveTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x531496_510623x624812">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:FirstIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTwentyFiveTwentyTenConsultantWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624811">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTenTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624810">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AprilThirtyTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624809">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MarchEightTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624808">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JanuaryTwentyNineTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624807">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:DecemberEightTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624806">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:NovemberFourTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624805">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:SeptemberThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624804">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AugustTwelveTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JuneThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624798">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayThirteenTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517825_510623x624797">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:FebruaryTwelveTwentyZeroNineSeriesBOneTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624811">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayTenTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624810">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AprilThirtyTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624809">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MarchEightTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624808">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JanuaryTwentyNineTwentyTenSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624807">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:DecemberEightTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624806">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:NovemberFourTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624805">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:SeptemberThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624804">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:AugustTwelveTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:JuneThirtyTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624798">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:MayThirteenTwentyZeroNineSeriesBTwoTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517824_510623x624797">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:FebruaryTwelveTwentyZeroNineSeriesBOneTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_509379x517823_510623x624796">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:FebruaryTwentyFiveTwentyZeroEightCommonStockTransactionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_508681x509983">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_508681x502974">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x500343">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_505872x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_498429x610127">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:NonEmployeeDirectorStockOptionsPlanTwentyZeroThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_498429x610126">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:StockIncentivePlanTwentyZeroOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_498429x585047">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:NonQualifiedOptionsPlansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0_498429x515840">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:IncentiveCompensationPlanTwentyZeroNineMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_557712x580425">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:ShareBasedCompensationArrangementByShareBasedPaymentAwardCompensationPlansAxis">galt:MonteCarloOptionPricingModelMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_510903x537720">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">galt:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_510903x500372">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_510903x498304">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_510142x511009_511283x503498">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_509379x604655">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:SeriesAAndBWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_509379x544386">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:SeriesATwoWarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_509379x544385">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:SeriesAOneWarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_509379x507958">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_507189x517784">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ScenarioTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_507189x517783">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:ScenarioOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x500343">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_505872x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_504957x514053">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_504957x513639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_504296x624873_504957x514053">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:SeriesBNomineesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_504296x624873">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:SeriesBNomineesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0_504296x624872">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:SeriesBDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20111231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20110131_0_504957x513639_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-01-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20101231_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20101231_0_509379x588296_542884x531497">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20101231_0_509379x588296_542884x531496">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:FirstIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20101231_0_508454x512177">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20101231_0_507189x599319_509379x517826">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">galt:VestingScenarioTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x500343">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20101231_0_505872x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20101231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20100129_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-01-29</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20091231_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20091208_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-12-08</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20081231_0_499506x536060">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProspectiveAdoptionOfNewAccountingPronouncementsAxis">galt:AdoptionOfNewAccountingPronouncementEffectMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20081226_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2008-12-26</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20031231_0_498429x610127">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:NonEmployeeDirectorStockOptionsPlanTwentyZeroThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20030114_0_504296x624055">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:FinderAndFindersAgentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-01-14</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20030114_0_504296x604034">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:AdvisorMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-01-14</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20030114_0_504296x533527">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:EmployeeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-01-14</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20021231_0_504296x624057">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:ScientificAdvisoryServicesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20021231_0_504296x624055">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:FinderAndFindersAgentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20021231_0_504296x604034">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:AdvisorMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20021231_0_504296x533527">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">galt:EmployeeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20021231_0_504051x610120_508454x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis">galt:NonEmployeeBoardMemberAndFormerMemberOfAuditCommitteeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20021231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20011231_0_509379x517821">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20011231_0_509379x517820">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20011231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20011213_0_512768x531939">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">galt:PublicOfferingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-12-13</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20101031_0_509379x537561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantTwelveMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-10-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20090930_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20031002_0_510623x547978">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:PlacementAgentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-10-02</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20031002_0_510623x531324">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:InstitutionalInvestorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-10-02</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20020930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2002-09-30</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20011031_0_498429x610126">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:StockIncentivePlanTwentyZeroOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-10-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20010831_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2001-08-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20120630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2012-06-30</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20110731_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2011-07-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20090630_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-06-30</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20090531_0_509379x517827">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantEightMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-05-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20080702_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2008-07-02</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20080531_0_497730x551558">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">galt:InvestorRelationsGroupIncMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-05-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20030531_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2003-05-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20120328_0_513696x507958">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-03-28</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20120328_0_513696x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-03-28</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20120328_0_509379x517826">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-03-28</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20120328_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2012-03-28</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20120322_0_512722x547416">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">galt:UnderwritingAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-03-22</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20120322_0_509379x517826">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-03-22</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20100531_0_509379x537560_542884x531497">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:SecondIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-05-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20100531_0_509379x537560_542884x531496">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="galt:EquityIssuedByPeriodAxis">galt:FirstIssuanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantElevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-05-31</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20100510_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-05-10</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20100430_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-04-30</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20100308_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-03-08</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20090430_0_509379x517826">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSevenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-04-30</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20040407_0_510623x547978">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:PlacementAgentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-04-07</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20040407_0_510623x531324">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:InstitutionalInvestorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-04-07</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20130329_0_506663x511390_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-03-29</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20130327_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2013-03-27</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20101230_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2010-12-30</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20101229_0_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-29</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20091104_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-11-04</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20090812_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-08-12</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20090513_0_513696x516923">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBTwoPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-05-13</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20090228_0_504957x513639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-02-28</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20090228_0_498429x515840">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">galt:IncentiveCompensationPlanTwentyZeroNineMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-02-28</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20090228_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2009-02-28</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20090212_0_513696x516922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">galt:SeriesBOnePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-02-12</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20090212_0_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-02-12</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20080225_0_509379x517825">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantSixMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-02-25</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20080225_0_509379x517824">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFiveMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-02-25</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20080225_0_509379x517823">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantFourMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-02-25</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20080225_0_509379x517822_510623x547978">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:PlacementAgentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-02-25</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20080225_0_509379x517822">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">galt:WarrantThreeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-02-25</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20080225_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2008-02-25</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20080204_0_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-02-04</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20080204_0_504957x513639_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-02-04</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20080204_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2008-02-04</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20040812_0_510623x547978">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:PlacementAgentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-08-12</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20040812_0_510623x531324">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">galt:InstitutionalInvestorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-08-12</instant>
    </period>
  </context>
  <context id="eol_PE87402---1210-K0013_STD_0_20030131_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001133416</identifier>
    </entity>
    <period>
      <instant>2003-01-31</instant>
    </period>
  </context>
  <unit id="iso4217_USD_per_shares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="shares">
    <measure>shares</measure>
  </unit>
  <unit id="iso4217_USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="iso4217_USD_per_Warrants">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>galt:Warrants</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="iso4217_USD_per_Right">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>galt:Right</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="pure">
    <measure>pure</measure>
  </unit>
  <unit id="Person">
    <measure>galt:Person</measure>
  </unit>
</xbrl>




